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Abstract 
RTKs-mediated signaling systems and the pathways with which they interact 
(e.g., those initiated by G protein-mediated signaling) involve a highly 
cooperative network that sense a large number of cellular inputs and then 
integrate, amplify, and process this information to orchestrate an appropriate set 
of cellular responses. The responses include virtually all aspects of cell function, 
from the most fundamental (proliferation, differentiation) to the most specialized 
(movement, metabolism, chemosensation). The basic tenets of RTK signaling 
system seem rather well established. Yet, new pathways and even new 
molecular players continue to be discovered. Although we believe that many of 
the essential modules of RTK signaling system are rather well understood, we 
have relatively little knowledge of the extent of interaction among these 
modules and their overall quantitative importance. 
My research has encompassed the study of both positive and negative 
signaling by RTKs in C. elegans. I identified the C. elegans 505-1 gene and showed 
that it is necessary for multiple RAS-mediated developmental signals. In addition, 
I demonstrated that there is a SOS-1-independent signaling during RAS-mediated 
vulval differentiation. By assessing signal outputs from various triple mutants, I 
have concluded that this SOS-1-independent signaling is not mediated by PTP-
2/SHP-2 or the removal of inhibition by GAP-1 / RasGAP and it is not under 
regulation by SLI-1/Cbl. I speculate that there is either another exchange factor 
for RASor an as yet unidentified signaling pathway operating during RAS-
mediated vulval induction in C. elegans. 
In an attempt to uncover the molecular mechanisms of negative 
regulation of EGFR signaling by SLI-1/Cbl, I and two other colleagues co-
discovered that RING finger domain of SLI-1 is partially dispensable for activity. 
vi 
This structure-function analysis shows that there is an ubiquitin protein ligase-
independent activity for SLI-1 in regulating EGFR signaling. Further, we 
identified an inhibitory tyrosine of LET-23/ EGFR requiring sli-1( +)for its effects: 
removal of this tyrosine closely mimics loss of sli-1 but not loss of other negative 
regulator function. 
By comparative analysis of two RTK pathways with similar signaling 
mechanisms, I have found that clr-1, a previously identified negative regulator of 
egl-15 mediated FGFR signaling, is also involved in let-23 EGFR signaling. The 
success of this approach promises a similar reciprocal test and could potentially 
extend to the study of other signaling pathways with similar signaling logic. 
Finally, by correlating the developmental expression of lin-3 EGF to let-23 
EGFR signaling activity, I demonstrated the existence of reciprocal EGF signaling 
in coordinating the morphogenesis of epithelia. This developmental logic of EGF 
signaling could provide a basis to understand a universal mechanism for 
organogenesis. 
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Chapter 1 
C. elegans vulval development as a model system to study the cancer 
biology of EGFR signaling 
Part of this published as a review article 
Chieh Chang and Paul W . Stemberg 
Cancer and Metastasis Reviews 18, 203-213 (1999). 
© 1999 by Kluwer Academic Publishers. 
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Introduction 
Model genetic organisms have proven useful in the elucidation of cellular 
regulatory pathways and their normal physiological roles. EGFR is important 
during animal development in the control of cell growth, differentiation, 
metabolism, and migration, among many other biological responses. Here we 
review studies of EGFR signaling in C. elegans and mainly focus on its regulation 
during vulval development. 
C. elegans biology and genetics 
To grow C. elegans, all one needs is an agar plate seeded with E. coli to serve as a 
growth medium, a wire pick to transfer animals from plate to plate for consistent 
log phase propagation and setting up of genetic crosses, and an incubator to 
provide an environment of constant temperature (20°C) [1]. Animals can be 
maintained indefinitely in a frozen state and re-grown after rapid thawing. The 
short life cycle (three days per generation) makes experiments relatively rapid. 
One intriguing feature of C. elegans is its simple anatomy. Both sexes (males and 
hermaphrodites) have an essentially invariant cell lineage, and thus an almost 
constant cell number; the adult male has only 1031 somatic nuclei; the adult 
hermaphrodite has only 959 [2] [3]. Forward or reverse genetics can both be used 
very conveniently in C. elegans to clone or characterize genes. There are three 
facts that make forward genetics practical in C. elegans. First, there are well-
established genetic tools such as genetic markers and balancers distributed 
throughout the entire genome. Second, 80% of the genome are contained within 
cosmid pools and the rest 20% of the genome are covered by the Y ACs, which 
allows positional cloning to be efficiently done [4]. Moreover, a done-based 
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physical map of the C. elegans genome has been properly aligned with the 
existing genetic map. This map allows genetic mapping to pinpoint a small 
physical region covered by a reasonable amount of cosmids and/ or YACs that 
can be tested for rescuing the mutant phenotype in transgenic worms. 
There are several advances that allow facile characterization of a gene 
function by reverse genetics in C. elegans. By microinjection of DNA into 
germline cytoplasm, we can efficiently transfer gene and stably maintain it as 
extrachromosomal arrays from generation to generation, which allows us to 
repeatedly analyze gene function in a specific genetic background after a single 
injection [5]. Recently, a technical breakthrough allows C. elegans experimenters 
to transiently knockout a particular gene function as desired. Double-stranded 
RNA has been shown to robustly and specifically reduce, if not remove, the gene 
expression in several species, including C. elegans, Drosophila, Trypanosoma brucei, 
mice, and plants [6] [7] [8] [9] [10]. Stable knockout of a single gene can also be 
performed by use of the chemical reagents. A desired deletion event is detected 
in a large pool of worms by means of PCR. The pool is consecutively subdivided 
into many small ones with PCR performed in each step till a single animal is 
isolated. Lastly, the essential complete of the C. elegans genome sequencing 
project gives us an opportunity to search for the homologs of genes of interest on 
a genome wide scale, and possibly to estimate the minimal set of players 
required to serve the biological functions of a signaling pathway. 
The characterization of a signaling pathway does not proceed at the same 
pace among different systems. Therefore, a new component found in one system 
will boost the motivation to search for the homolog in other systems since we 
believe evolution favors the conservation of important functions. Until complete 
genome sequences are available, the failure to identify a homolog of gene of 
interest is not unusual. However, if we still fail to do so after the finish of 
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genome sequencing, we should start to consider an alternative mechanism such 
that the function can be bypassed or there is redundancy. 
Signal transmission by RTKs 
All RTKs exhibit a similar molecular architecture and apparently are activated by 
a common mechanism [11] [12]. A general mechanism for ligand-induced 
activation of RTKs has been established. Ligand binding to the extracellular 
domain induces receptor dimerization which in turn leads to activation of the 
catalytic protein kinase domain [13]. Autophosphorylation of tyrosine residues 
that are located in noncatalytic regions leads to the generation of docking sites 
for SH2 (Src homology 2) and PTB (phosphotyrosine binding) domains of 
signaling molecules [14]. These molecules include the adapter GRB-2, which 
leads to RAS activation, phospholipase C-y (PLCy), the tyrosine phosphatase 
SHP-2, RAS-GTPase activating protein, the regulatory subunit of 
phosphatidylinositol-3-0H kinase [14] [15] [16], and the proto-oncoprotein c-Cbl 
[17]. The association between proteins with SH2/ PTB domains and pTyr serves 
as the initial step in the recruitment of an activated RTK signaling complex. 
Specific pTyr sites are recognized by distinct SH2 and PTB domains [18] [19] [20] 
[21] [22]. Interaction of RTKs with different substrates is thought to result in 
activation of distinct signaling pathways, thus producing distinct cellular 
responses [11] [23] . Excessive or inappropriate signaling from RTKs has been 
implied in many cases of malignant transformation [24] [25]. Therefore, proper 
mechanisms must be employed to strongly control the signaling from RTKs to 
prevent ligand independent activation and attenuate signaling after activation 
has occurred. 
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EGF RTK signaling is used multiple times during the normal development 
of C. elegans, mediating vulval induction, viability, male spicule development, 
hermaphrodite ovulation, and differentiation of the ventral uterus and posterior 
ectoderm [26] [27] [28] [29] [30] [31]. Vulval induction was among the first 
processes discovered to be mediated by EGF RTK signaling. The high resolution 
of scoring the phenotype of vulval induction makes it a very sensitive assay to 
identify mutants and to reflect the relative strength of RAS-dependent signaling. 
All the other developmental events are also RAS-dependent, except for 
hermaphrodite ovulation, which will be discussed later. 
EGFR signaling in vulval induction 
The wild-type vulva is derived from three of six multipotential vulval precursor 
cells (VPCs), which receive an inductive signal from the anchor cell (AC) in the 
somatic gonad (Figure 1) [32]. The VPCs that form the vulva undergo three 
rounds of division and subsequent morphogenesis. VPCs that do not receive 
adequate signal from the anchor cell divide only once and become part of a large 
syncytial epidermis that covers most of the worm. The inductive signat LIN-3, is 
an EGF-like growth factor, produced by the anchor cell. LIN-3 activates the LET-
23, a C. elegans homolog of EGF RTK, in the VPCs [33] [34]. LET-23 activation 
initiates a signaling cascade that involves downstream effectors such as SEM-5, 
SOS-1, LET-60, LIN-45, MEK-2 and SUR-1/MPK-1 which are the nematode 
homologs of the mammalian Grb2 adaptor, the mSOS guanine nucleotide 
exchange factor, the Ras GTP-binding protein, the Raf serine/threonine kinase, 
the MAPK kinase and the MAPK, respectively [35] [36] [37] [38] [39] [40] [41] [42] 
[43] [44] [Chapter 2]. Loss-of-function (lj) mutations in any of the signaling 
proteins in the LET-23 RTK pathway result in less than three VPCs undergoing 
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vulval differentiation, whereas gain-of-function (gf) mutations result in more than 
three VPCs undergoing vulval differentiation. 
Apart from the main RAS-dependent signaling pathway, there are two 
accessory proteins identified in a screen for the extragenic suppressors of the 
G13E-activated mutant let-60 ras. ksr-1, which encodes a conserved Raf-related 
serine/ threonine kinase, has been shown to act downstream of or in parallel to 
let-60 ras and upstream of lin-1, a putative ETS transcription factor [45] [46] . sur-
8/soc-2, which encodes a conserved Ras-binding protein with leucine-rich 
repeats, appears to act downstream of or in parallel to let-60 ras but upstream of 
lin-45 raj [47] [48]. Mutations in either loci do not affect normal vulval induction. 
However, a sur-8/soc-2 mutation significantly synergizes with a loss-of-function 
mutation in ksr-1, suggesting that they are collectively essential in the presence of 
the main RAS-dependent signaling pathway. 
A mutant of ptp-2, another positive effector for let-23-mediated vulval 
signaling, identified by a PCR-based screen for transposon-mediated deletion, 
appears not to affect vulval induction [49]. SH2 domain-containing PTP-2 has a 
predicted protein structure similar to the mammalian SHPs and Drosophila 
Corkscrew. Loss-of function in ptp-2 suppresses the multiple vulva (Muv) 
phenotype induced by a loss-of-function lin-15 mutation, and an activated let-23 
EGFR or let-60 ras mutation. The role of ptp-2 function in the vulval signaling 
pathway is not clear. 
A sos-1-independent signaling activity for ras activation is suggested since 
animals removing lin-3 ligand shows more severe phenotype than those 
removing sos-1 [Chapter 2]. This parallel pathway appears to be independent of 
sli-1 regulation, ptp-2 signal transduction, and can not be simply explained by the 
relinquishment of the inhibition from gap-1 . 
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Three negative regulators of LET -23 mediated vulval differentiation were 
isolated as extragenic suppressors of let-23(lj) and have been cloned. UNC-101 is 
a C. elegans homolog of mammalian AP-47 clathrin medium chain protein [50]. 
SLI-1 is a C. elegans homolog of mammalian proto-oncoprotein c-Cbl [51] [52] 
[Chapter 3]. GAP-1 is a C. elegans homolog of mammalian Ras-GTPase activating 
protein (RasGAP) [53]. One negative regulator was isolated as an extragenic 
enhancer of sli-l(lj) and has also been cloned. ARK-1 is a non-receptor protein 
tyrosine kinase (PTK) related to the Ack sub-family [54]. Another negative 
regulator was identified by a comparative analysis of RTK pathways with similar 
signaling logic. CLR-1 is a C. elegans homolog of Drosophila PTP69D receptor 
tyrosine phosphatase [Chapter 4]. Mutations in each of these five negative 
regulators are silent by themselves. However, in combination with mutations in 
any other loci defining negative regulators results in a Muv phenotype (G. 
Jongeward, N. Hopper, C. Chang, C. Lacenere and P. Stemberg, unpublished). 
Yet another set of apparently redundant negative regulators are known. 
Genetically, there are two classes of the so called synthetic multivulva (synMuv) 
genes, class A and class B. Class A genes include lin-8, lin-15A, lin-38, and lin-56 
and class B genes include lin-9, lin-15B, lin-35, lin-36, lin-37, lin-51, lin-52, lin-53, 
lin-54, lin-55, and tam-1 [55] [56] [57] [Appendix 1]. Animals contained mutations 
in only class A or class B genes are wild-type, whereas animals carrying 
mutations in both classes of genes are Muv. Two class B synMuv genes, lin-35 
and lin-53, have been shown to encode proteins similar to Rb and its binding 
protein RbAp48. lin-15, a complex locus containing two mutable genetic activities 
(A and B), encodes two non-overlapping transcripts involved in the negative 
regulation of vulval induction [58, 59]. The predicted proteins from lin-15A and 
lin-15B transcripts are not similar to any identified proteins. Mutations in either 
lin-15A or lin-15B are phenotypically wild-type and a Muv phenotype can be 
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induced only if both activities are removed. There seems to be a fundamental 
difference between synMuv genes and the negative regulators discussed above. 
The negative effects of class A synMuv genes are strictly redundant to class B 
synMuv genes, whereas the negative effects of those negative regulators 
mentioned before are partially redundant among them (Figure 2). It is unclear 
how, mechanistically, the synMuv proteins regulate LET-23-Ras signaling. 
Recently, another negative regulator, sur-5, was identified in a screen for 
the extragenic suppressors of a dominant negative (dn) let-60 ras allele [60]. sur-5 
encodes a novel protein with one potential ATP or GTP binding motif and two 
potential AMP binding motifs. Mutations in sur-5 have no obvious phenotypes of 
their own and does not suppress loss-of function mutations in the let-23 EGFR 
signaling pathway either upstream or downstream of let-60 ras, including let-60 
ras itself. It is interesting that sur-5 mutations specifically suppress one of two 
subsets of let-60 ras (dn) alleles. Since all the let-60 ras (dn) mutations are 
suppressed by the let-60 ras (gj) mutation in trans-heterozygotes [35] [36] [61], it 
is believed that the toxic effect of a dominant negative LET-60 RAS protein is due 
to the competition with wild-type LET-60 RAS protein for the upstream guanine 
nucleotide exchange factor (GNEF) instead of downstream effectors. These 
results raise the possibility that there might be at least two different activators for 
LET-60 RAS and only one of them is titratable by the subset of let-60 ras (dn) 
mutant proteins that is suppressed by the sur-5 mutations. The existence of 
another RasGEF for RAS is also implied in the our genetic studies of sos-1 
mutants [Chapter 2]. 
EGFR signaling in ovulation 
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LET -23 function in the somatic gonad is required for ovulation in 
hermaphrodites and is independent of RAS. While mutations in lfe-1/itr-1 and lfe-
2 suppress the ovulation defects associated with let-23(/f) mutant, mutations in 
the components of RAS pathway do not [29]. lfe-1/itr-1 encodes a C. elegans 
inositol (1,4,5) trisphosphate receptor (IP3R) and lfe-2 encodes an inositol (1,4,5) 
trisphosphate-3-kinase (IP3K). Since a gf mutation in lfe-1/itr-1 and a if mutation 
in lfe-2 rescue the ovulation defects of a let-23(/f) mutant, lfe-1/itr-1 is inferred to 
be a positive effector of LET-23 signaling whereas lfe-2 a negative regulator. The 
comparison of C. elegans vulval development and hermaphrodite ovulation thus 
provides an excellent example of how a RTK evokes its tissue specificity by 
deploying the distinct signaling cascades. The let-23(sy97) mutant animals are 
defective in all let-23-mediated phenotypes except for the hermaphrodite 
ovulation [62]. This mutation deletes the last 56 amino acids of the receptor 
which include the only three tyrosines (pTyr site 6, 7 and 8) in the receptor 
carboxy terminal tail which, if phosphorylated, would create SH2 binding sites 
matching the consensus binding site for the SEM-5 SH2 domain. Consistent with 
these findings, in the let-23(null) background, none of the site deleted by the let-
23(sy97) mutation is able to confer fertility and let-23 construct bearing either 
only site 4 or site 5 confers full or 15% fertility [63]. 
In C. elegans hermaphrodites, there are two developmental events 
affecting fertility, germline meiotic cell cycle progression and ovulation. While 
hermaphrodite ovulation is independent of let-60 ras activity, germline meiotic 
cell cycle progression is not. Although let-60/mek-2/mpk-1 cascade responses to 
let-23 activation in most of tissues, the inductive signal and cognate receptor used 
for let-60/mek-2/mpk-1-mediated germline meiotic cell cycle progression is still 
unknown. 
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Developmental logic of EGFR pathway- Reciprocal signaling 
lin-3 EGF is first produced by the gonadal AC to induce VPCs to divide and 
differentiate into vulval tissue. After vulval induction, lin-3 EGF is also expressed 
in the 1 o vulval lineage (Figure 3) [31]. EGF signaling from cells of the 1 o vulval 
lineages to a subset of ventral uterine cells of the gonad is required for the 
specification of uterine uv1 cells, which form part of the uterine-vulval 
connection [Chapter 5]. While mutation of SLI-1 restores most of the reduced 
LET-23 signaling in the vulva caused by let-23(/f) mutation, the defects in uv1 cell 
fate are only partially rescued. This specificity most likely comes from the 
quantitative difference of sli-1 usage. In contrast, agap-1(/f) mutation suppresses 
the vulval but not the uv1 defect displayed by the same let-23(/f) mutation, 
suggesting that LET-23-mediated signaling is not regulated by GAP-1 in the 
presumptive uv1 cells. This developmental logic of EGF signaling could provide 
a basis to understand a universal mechanism for organogenesis. 
Table 1 shows genes of let-23 EGFR signaling pathway identified in C. 
elegans either by sequence homology search or by genetic mutation. Many 
sequence homology searches are based on information obtained from the 
biochemical studies in mammalian systems where a putative role in EGF RTK 
signaling was implied. Some of the SH2 and PTB domains of signaling 
molecules, although found to be associated with the activated EGF RTK, are not 
formally demonstrated regarding their functional relevance in the regulation of 
signaling (effectors or regulators). For those having a corresponding mutant, the 
phenotypes observed obviously display their physiological involvement in EGF 
RTK signaling. Mutants may be recovered by either a classical genetic screen or 
by a PCR-based screen for deletions. Double-stranded RNA interference is also 
used to identify some of the signaling components or to confirm the mutant 
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phenotypes. 
EGFR signaling is conserved during evolution 
Although the cellular interpretation of signaling are context-dependent, the RAS-
dependent EGF RTK signaling pathways are well conserved at the level of their 
mechanistic aspects during metazoan evolution. As a result, a core set of players 
required for the execution of signaling share high similarity among species in 
terms of their functions, protein structures, and one-dimensional amino acid 
sequences. Differences obtained from evolution predominantly reside in the 
redundancy of signal transduction and the complexity of its regulation. In C. 
elegans, all known effects of LIN-3 are mediated through LET-23 and there is no 
evidence that LET-23 has additional ligands apart from LIN-3. In the VPCs, upon 
the binding by LIN-3, LET-23 is presumably autophosphorylated and that creates 
docking sites for the proteins containing SH2 or PTB domains, such as SEM-5. 
Based on results with the mammalian proteins, SOS-llikely constitutively binds 
SEM-5 via its proline-rich domain. The activated receptor-bound SEM-5 therefore 
brings SOS-1 close to the membrane-anchored LET-60 and that catalyzes the 
release of GDP from LET -60 and allows the loading of GTP onto it. 
Mechanisms of negative regulation of LET-23 RTK signaling 
Sos/Ras/Raf/MAP kinase pathway, now known to mediate signaling by most if 
not all RTKs has become a major target for cancer therapeutics as excess 
signaling through the Ras had previously been linked to tumorigenesis. Unlike 
the intensively studied mechanistic aspects of signaling transduction by Ras-
dependent RTKs, the molecular mechanisms of their negative regulation are still 
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largely unclear. Studies in the negative regulation of LET-23 RTK pathway thus 
provide valuable lessons to signal control and therapeutic strategies. Generally, 
there are two ways to negatively regulate signaling. One is to regulate the basal 
activity of signaling in the absence of the ligand. The other is to attenuate or 
desensitize the signaling after activation by the ligand. RasGAP inhibits the Ras 
activity by stimulating its intrinsic GTPase activity, thereby increasing the level 
of GDP-bound, inactive Ras [64]. Apart from the catalytic domain, C. elegans 
GAP-1 does not display any significant similarity to other proteins in the 
database [53]. SH2 and SH3 domains, that are found in the mammalian p120 
RasGAP, are not present in the C. elegans GAP-1. C. elegans gap-1 acts to inhibit 
the vulval induction since loss-of-Junction mutation in the gap-1 suppresses the 
vulvaless (Vul) phenotype associated with loss-of-function mutations in the let-23 
EGFR/let-60 ras mediated signaling pathway. It remains an open question 
whether C. elegans GAP-1 is a constitutive inhibitor of RAS and not dependent 
upon the ligand/ receptor. 
sli-1 has been shown to inhibit the let-23 EGFR-mediated vulval signaling 
upstream of let-60 ras by genetic suppression analysis (51]. So far, there is no 
report from biochemical studies showing an interaction between c-Cbl and 
rnSOS, but many reports demonstrated the physical association between 
Cbl/SLI-1 and Grb2/SEM-5 or c-Cbl and activated EGFR [Chapter 3]. c-Cbl 
binds to Grb2 through its polyproline motifs and colocalizes with EGFR via its 
diverse SH2 domain, which is dependent upon ligand activation. The sequence 
of D-Cbl, a Drosophila homolog of c-Cbl, ends immediately C-terminal to the 
RING finger motif (17] [65]. Athough D-Cbllacks polyproline motifs, expression 
of the sevenless enhancer-driven D-Cbl significantly abolishes the development of 
R7 photoreceptor neuron, suggesting that polyproline motifs might be 
evolutionarily dispensable for the function of c-Cbl-like proteins in regulating 
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the RTK signaling. Although our preliminary data show that the polyproline 
motifs are not essential for sli-1 function in the vulva, the presence of polyproline 
motifs do help to achieve the full activity of sli-1 [Chapter 3]. Contrary to the 
results from recent biochemical assays in mammalian systems that ubiquitin 
ligase activity of RING finger motif is responsible for the negative effect of Cbl, 
the genetic evidences in C. elegans suggests a RING finger-independent 
regulation by SLI-1 [Chapter 3]. 
Our current models for sli-1 functions propose two roles. The major role of 
sli-1 might be to attenuate signaling after activation has occurred. This model is 
supported by the evidence that c-Cbl-like proteins only associate with EGFR in 
an activation-dependent manner. Indeed, by analyzing the systematically 
mutagenized let-23 constructs containing substitutions in the carboxyl-terminal 
tyrosine residues, we have identified one inhibitory phosphotyrosine residue, 
which can overcome the negative regulation by sli-1 when it is mutated [Chapter 
3]. The observation is strengthened by a recent solved crystallographic structure 
of c-Cbl complexed to a tyrosine-phosphorylated inhibitory site of protein 
tyrosine kinase ZAP-70 [66]. The interaction is mediated by a divergent SH2 
domain of c-Cbl, which is conserved in SLI-1, and a phosphotyrosine of ZAP-70, 
which is in a similar amino acid context to the one in LET -23 we identified. The 
minor role of sli-1 might be to regulate the basal activity of signaling in quiescent 
state by competing with SOS-1 for the binding of SEM-5, thereby decreasing the 
chance that the spontaneously activated receptor recruits the SOS-1-bound SEM-
5 in the absence of ligand. Upon stimulation by the inductive signal, SLI-1 
molecules might switch to bind the tyrosine-phosphorylated receptors, thereby 
relinquishing the interference on the binding between SOS-1 and SEM-5. While 
sli-1 negatively regulates the ras-dependent vulval differentiation, it does not 
affect the Zfe-1-dependent hermaphrodite ovulation. The simplest interpretation 
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is that there is a tissue-specific expression or activation of sli-1. Alternatively, the 
ras-dependent and lfe-1 dependent signaling cascades might have fundamental 
differences such that sli-1 can only inhibit one signaling cascade but not the 
other. For example, ras-dependent and Zfe-1 dependent signaling cascades are 
elicited by distinct phosphotyrosine residues of let-23 EGFR, which could have 
different steric orientations. While the activated receptor-bound sli-1 is able to 
execute its negative regulation in one steric orientation, it fails in the other. 
A localized let-23 EGFR-dependent negative regulation has been proposed 
previously since a reduction-of-function mutation in let-23 EGFR, which results in 
the mislocalized receptor, causes a Muv phenotype in a sli-1 or gap-1 mutant 
background [51] (G. Jongeward and P. Sternberg, unpublished). Genetic mosaic 
analysis showed that the presence of let-23 EGFR in the proximal VPCs inhibits 
the vulval induction in their more AC-distal VPCs [53]. A possible mechanism 
for this observation is that the AC-proximal VPCs bind and sequester the AC-
produced ligand LIN-3 EGF, thereby preventing the ligand from reaching more 
distal VPCs. In this view, the sequestering mechanism serves to down regulate 
the ligand after it activates the receptor in the AC-proximal VPCs. 
The negative regulation of let-23 EGFR-mediated vulval signaling by 
synMuv genes is ligand-independent: gonad ablation does not affect the Muv 
phenotype induced in the lin-15AB mutant background [59] [67]. Mutations in 
let-23 EGFR and its downstream effectors suppress the Muv phenotype induced 
by lin-15 mutations. Taken together, these data suggest lin-15 acts upstream of 
let-23 EGFR but downstream of or in parallel to lin-3 EGF. Although mosaic 
analysis suggests that lin-15 functions in the hyp7 epidermis and hence regulates 
let-23 signaling in the VPCs in a cell non-autonomous manner [68], the LIN-15 
proteins are present in the nuclei of the VPCs (L. Huang, J. DeModena and P. 
Sternberg, unpublished). Indeed, lin-35 Rb and lin-53 p48, two loci previously 
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assigned to the class B synMuv pathway, have been shown to express in the 
VPCs nuclei [57]. If lin-15 does function in the nuclei of the VPCs to negatively 
regulate the let-23-mediated vulval signaling as opposed to its downstream 
nuclear targets, there are two possible targets for lin-15 action, LET-23 EGFR and 
its activators. It is less likely that lin-15 only acts to inhibit the expression of let-23 
since overexpression of let-23 does not cause a Muv phenotype as does by lin-15 
mutations [33] (G. Lesa and P. Stemberg, unpublished). The combinatorial effects 
on the expression of let-23 and its activators might, ultimately, explain lin-15 
function in the VPCs. 
Conclusions 
C. elegans LET-23-mediated vulval induction requires C. elegans homologs of 
Egf, Egfr, Grb-2, Sos, Ras, Raf, Mapk kinase, and Mapk, which are conserved 
during metazoan evolution. New positive effectors and negative regulators of 
EGFR-mediated signaling have been identified by C. elegans genetic screens, 
sequence homology searches, and comparative analyses of RTK pathways with 
similar signaling logic. One way in which EGFR has tissue-specificity is to use 
distinct signaling cascades in different tissues. The developmental logic of EGFR 
signaling discovered in C. elegans can provide a basis for studying the universal 
mechanism for organogenesis. 
Key unanswered questions 
One way to modulate the strength of signaling is by controlling the production 
and presentation of the ligand. Identification of tissue-specific transcriptional 
regulator(s) and protease(s) will be required to understand this signaling 
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regulation. RAS activity is necessary not only for the vulval induction but also 
for the subsequent patterning events [31] (C. Chang and P. Sternberg, 
unpublished). The amplitude and duration of RA5-dependent EGFR signaling 
required for proper vulval development is unclear. To address such a question, it 
is essential to develop an assay to monitor the signaling activity during animal 
development. Although binding to the EGFR seems to be necessary for the 
negative regulation by sli-1, the mechanisms by which sli-1 exerts its negative 
effects are not well understood. Ubiquitin ligase activity of RING finger motif 
only explains partly for regulation by SLI-1. Since sli-1 mutation fails to 
complement a gap-1 mutation (C. Chang, unpublished), sli-1 and gap-1 might act 
in a linear pathway where sli-1 exerts its negative effects by directly or indirectly 
activating gap-1. This hypothesis is supported by the only weak synergy between 
sli-1 and gap-1 mutants [Chapter 3]. How does SOC-2/ SUR-8 fit into the RAS 
signaling? If interaction between SOC-2/SUR-8 and RAS is necessary for the 
normal function of signaling, SOC-2/SUR-8 could be either another effector for 
RASor a modulator to facilitate the association between RAS and effectors. PTP-
2 functions as a supporting component during vulval development. How is it 
integrated into the main signaling framework? The identification of PTP-2 
substrates should allow us to understand its contributions to the signaling. 
In the mammalian model system, RTKs-mediated signaling and G 
protein-mediated pathway involve a highly cooperative network that sense a 
large number of cellular inputs and process these information to orchestrate an 
appropriate set of cellular responses. A recent study shows that the MAPK 
pathway is important for G protein-coupled receptors (GPCRs)-mediated 
chemotaxis to a set of odorants in C. elegans [69]. The elucidation of the molecular 
mechanisms whereby GPCRs activate MAPK is believed to be central to 
understanding how these receptors transmit signals to confer a dynamic 
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regulatory role for the MAPK cascade in perception in olfactory organs. The 
potential candidates for linking signaling from GPCRs to MAPK include f3y 
heterodimers, nonreceptor tyrosine kinase, receptor tyrosine kinase, Ca2+-
dependent RasGEF, PI3 kinase and phospholipase C. 
One aspect of vulval development not explicitly considered here might 
prove especially relevant to tumor cell biology. After inducing the vulva, the 
gonadal anchor cell invades the vulval epithelium, initiating the hole that will 
ultimately connect the lumen of the uterus to that of the vagina [70] [71] (R. 
Palmer, D. Sherwood, K. Tietze and P. Sternberg, unpublished). This process 
appears analogous to tumor cell invasion during metastasis, and might provide a 
genetic model system to investigate invasion. 
In the post-genomic era, the challenges we face are how to create tools for 
analyzing the complex data derived from the high-throughput function 
determination and expression profiling of defined sets of signaling molecules, 
and for producing robust predictions of the stoichiometric and spatial 
interactions among signaling components. From these, mathematical models and 
theories of the biochemical and genetic network structure and dynamics can be 
created. With understanding the basis of a cell's ability to process the complex 
information it receive from the environment into the robust developmental 
consequences, we ought to be able to design pharmacological perturbations to 
redirect abnormal cells to behave in a predictable, designed way. 
References 
1. Brenner, S. (1974).: The genetics of Caenorhabditis elegans. Genetics 77:71-94, 
1974 
2. Wood, W.B., The nematode Caenorhabditis elegans. 1988, Cold Spring Harbor, 
A-18 
New York: Cold Spring Harbor Laboratory. 667. 
3. Riddle, D.L., et al., C. elegans II, ed. J.R. Priess. 1997, New York: Cold Spring 
Harbor Press. 
4. Consortium, T.C.e.G. and R.K. Wilson (1999).: How the worm was won. 
Trends Genet. 15:43-84,1999 
5. Mello, C.C., et al. (1991).: Efficient gene transfer in C. elegans after 
microinjection of DNA into germline cytoplasm: extrachromosomal maintenance 
and integration of transforming sequences. EMBO J. 10:3959-3970, 1991 
6. Fire, A., et al. (1998).: Potent and specific genetic interference by double-
stranded RNA in Caenorhabditis elegans. Nature 391:806-811, 1998 
7. Sharp, P.A. (1999).: RNAi and double-strand RNA. Genes Dev. 13:139-141, 
1999 
8. Tavernarakis, N., et al. (2000).: Heritable and inducible genetic interference by 
double-stranded RNA encoded by transgenes. Nat. Genet. 24:180-183, 1999 
9. Wianny, F. and M. Zernicka-Goetz (2000).: Specific interference with gene 
function by double-stranded RNA in early mouse development. Nat. Cell Biol. 
2:70-75, 2000 
10. Chuang, C.-F. and E. Meyerowitz (2000).: Specific and heritable genetic 
interference by double-stranded RNA in Arabidopsis thaliana. Proc Natl Acad Sci 
USA 97:4985-90,2000 
11. Schlessinger, J. and A. Ullrich (1992).: Growth factor signaling by receptor 
tyrosine kinases. Neuron 9:383-391, 1992 
12. Schlessinger, J. (1997).: Direct binding and activation of receptor tyrosine 
kinases by collagen. Cell91:869-72, 1997 
13. Lemmon, M. and J. Schlessinger (1994).: Regulation of signal transduction 
and signal diversity by receptor oligomerization. TIBS 19:459-463, 1994 
A-19 
14. Pawson, T. (1995).: Protein modules and signalling networks. Nature 373:573-
580,1995 
15. Ullrich, A. and J. Schlessinger (1990).: Signal transduction by receptors with 
tyrosine kinase activity. Cell 61:203-212, 1990 
16. Heldin, C.-H. (1995).: Dimerization of cell surface receptors in signal 
transduction. Cell80:213-223, 1995 
17. Meisner, H., et al. (1997) .: Interactions of Drosophila Cbl with epidermal 
growth factor receptors and role of Cbl in R7 photoreceptor. Mol. Cell Bioi. 
17:2217-2225, 1997 
18. Panayotou, G. and M.D. Waterfield (1993).: The assembly of signalling 
complexes by receptor tyrosine kinases. Bioessays 15:171-7, 1993 
19. Songyang, Z., et al. (1993).: SH2 domains recognize specific phosphopeptide 
sequences. Cell 72:767-778, 1993 
20. Kavanaugh, W.M. and L.T. Williams (1994).: An alternative to SH2 domains 
for binding tyrosine-phosphorylated proteins. Science 266:1862-1865, 1994 
21. Songyang, Z ., et al. (1994).: Specific motifs recognized by the SH2 domains of 
Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Bioi. 14:2777-
2785,1994 
22. Kavanaugh, W.M., C.W. Turck, and L.T. Williams (1995).: PTB domain 
binding to signaling proteins through a sequence motif containing 
phosphotyrosine. Science 268:1177-9, 1995 
23. Pawson, T. and T.M. Saxton (1999).: Signaling networks-do all roads lead to 
the same genes? Cell97:675-8, 1999 
24. Alroy, I. andY. Yarden (1997).: The ErbB signaling network in 
embryogenesis and oncogenesis: signal diversification through combinatorial 
ligand-receptor interactions. FEBS Lett. 410:83-6, 1997 
A-20 
25. Edery, P ., et al. (1997).: RET in human development and oncogenesis. 
Bioessays 19:389-95, 1997 
26. Ferguson, E. and H.R. Horvitz (1985).: Identification and characterization of 
22 genes that affect the vulval cell lineages of Caenorhabditis elegans. Genetics 
110:17-72, 1985 
27. Aroian, R.V. and P.W. Sternberg (1991) .: Multiple functions of let-23, a C. 
elegans receptor tyrosine kinase gene required for vulval induction. Genetics 
128:251-267, 1991 
28. Chamberlin, H.M. and P.W. Sternberg (1994).: The lin-3/let-23 pathway 
mediates inductive signaling during male spicule development in Caenorhabditis 
elegans. Development 120:2713-2721, 1994 
29. Clandinin, T.R., J.A. DeModena, and P.W. Sternberg (1998).: Inositol 
trisphosphate mediates a RA5-independent response to LET -23 receptor kinase 
activation in C. elegans. Cell92:523-533, 1998 
30. Jiang, L. and P.W. Sternberg (1998).: Interactions of EGF, Wnt and HOM-C 
genes specify P12 neuroectoblast fate in C. elegans. Development 125:2337-2347, 
1998 
31. Chang, C., A.P. Newman, and P.W. Sternberg (1999).: Reciprocal EGF 
signaling back to the uterus from the induced C. elegans vulva coordinates 
morphogenesis of epithelia. Curr. Biol. 9:237-46, 1999 
32. Horvitz, H.R. and P.W. Sternberg (1991).: Multiple intercellular signalling 
systems control the development of the C. elegans vulva. Nature 351:535-541, 1991 
33. Aroian, R.V., et al. (1990).: The let-23 gene necessary for Caenorhabditis elegans 
vulval induction encodes a tyrosine kinase of the EGF receptor subfamily. 
Nature 348:693-699, 1990 
34. Hill, R.J. and P.W. Sternberg (1992).: The lin-3 gene encodes an inductive 
signal for vulval development in C. elegans. Nature 358:470-476, 1992 
A-21 
35. Beitel, G ., S. Clark, and H.R. Horvitz (1990).: The Caenorhabditis elegans ras 
gene let-60 acts as a switch in the pathway of vulval induction. Nature 348:503-
509, 1990 
36. Han, M. and P.W. Sternberg (1990).: let-60, a gene that specifies cell fates 
during C. elegans vulval induction, encodes a ras protein. Cell63:921-931, 1990 
37. Clark, S.G., M.J. Stern, and H.R. Horvitz (1992).: Genes involved in two 
Caenorhabditis elegans cell-signaling pathways. Cold Spring Harbor Symp. 
Quant. Biol. 57:363-373, 1992 
38. Clark, S.G., M.J. Stern, and H.R. Horvitz (1992).: C. elegans cell-signalling 
gene sem-5 encodes a protein with SH2 and SH3 domains. Nature 356:340-344, 
1992 
39. Han, M., et al. (1993).: C. elegans lin-45 raj gene participates in let-60 ras 
stimulated vulval differentiation. Nature 363:133-140, 1993 
40. Lackner, M.R., et al. (1994).: A MAP kinase homolog, mpk-1, is involved in 
ras-mediated induction of vulval cell fates in Caenorhabditis elegans. Genes & Dev. 
8:160-173, 1994 
41. Wu, Y. and M. Han (1994).: Suppression of activated Let-60 Ras protein 
defines a role of C. elegans Sur-1 MAP kinase in vulval differentiation. Genes & 
Dev. 8:147-159, 1994 
42. Kornfeld, K., K.-L. Guan, and H.R. Horvitz (1995).: The Caenorhabditis elegans 
gene mek-2 is required for vulval induction and encodes a protein similar to the 
protein kinase MEK. Genes & Dev. 9:756-768, 1995 
43. Wu, Y., M. Han, and K.-L. Guan (1995).: MEK-2, a Caenorhabditis elegans MAP 
kinase kinase, functions in Ras-mediated vulval induction and other 
developmental events. Genes & Dev. 9:742-755, 1995 
44. Chang, C., N.A. Hopper, and P.W. Sternberg (2000).: Caenorhabditis elegans 
A-22 
SOS-1 is necessary for multiple RAS-mediated developmental signals. EMBO J. 
19:3283-3294, 2000 
45. Kornfeld, K., D.B. Hom, and H.R. Horvitz (1995).: The ksr-1 gene encodes a 
novel protein kinase involved in ras-mediated signaling in C. elegans. Cell 83:903-
913,1995 
46. Sundaram, M. and M. Han (1995).: The C. elegans ksr-1 gene encodes a novel 
Raf-related kinase involved in ras-mediated signal transduction. Cell83:889-901, 
1995 
47. Selfors, L.M., et al. (1998).: soc-2 encodes a leucine-rich repeat protein 
implicated in fibroblast growth factor receptor signaling. Proc. Natl. Acad. Sci. 
USA 95:6903-6908, 1998 
48. Sieburth, D.S., Q. Sun, and M. Han (1998).: SUR-8, a conserved Ras-binding 
protein with leucine-rich repeats, positively regulates Ras-mediated signaling in 
C. elegans. Cell94:119-130, 1998 
49. Gutch, M.J., et al. (1998) .: The Caenorhabditis elegans SH2 domain-containing 
protein tyrosine phosphatase PTP-2 participates in signal transduction during 
oogenesis and vulval development. Genes & Dev. 12:571-585, 1998 
50. Lee, J., G.D. Jongeward, and P.W. Sternberg (1994).: unc-101, a gene required 
for many aspects of C. elegans development and behavior, encodes a clathrin-
associated protein. Genes Devel. 8:60-73, 1994 
51. Jongeward, G.D., T.R. Clandinin, and P .W. Sternberg (1995).: sli-1, a negative 
regulator of let-23-mediated signaling in C. elegans. Genetics 139:1553-1566, 1995 
52. Yoon, C.H., et al. (1995).: Similarity of sli-1, a regulator of vulval 
development in Caenorhabditis elegans, to the mammalian proto-oncogene, c-cbl. 
Science 269:1102-1105, 1995 
53. Hajnal, A., C.W. Whitfield, and S.K. Kim (1997).: Inhibition of Caenorhabditis 
A-23 
elegans vulval induction by gap-1 and by let-23 receptor tyrosine kinase. Genes 
Devel. 11:2715-2728, 1997 
54. Hopper, N.A., J. Lee, and P.W. Sternberg (2000).: ARK-1 inhibits EGFR 
signaling in C. elegans. Mol. Cell6:65-75, 2000 
55. Horvitz, H .R. and J.E. Sulston (1980).: Isolation and genetic characterization 
of cell-lineage mutants of the nematode Caenorhabditis elegans. Genetics 96:435-
454,1980 
56. Ferguson, E.L. and H.R. Horvitz (1989).: The multivulva phenotype of certain 
C. elegans mutants results from defects in two functionally-redundant pathways. 
Genetics 123:109-121, 1989 
57. Lu, X. and H.R. Horvitz (1998).: lin-35 and lin-53, two genes that antagonize a 
C. elegans Ras pathway, encode proteins similar to Rb and its binding protein 
RbAp48. Cell95:981-991, 1998 
58. Clark, S.G., X. Lu, and H.R. Horvitz (1994).: The C. elegans locus lin-15, a 
negative regulator of a tyrosine kinase signaling pathway, encodes two different 
proteins. Genetics 137:987-997, 1994 
59. Huang, L.S., P. Tzou, and P.W. Sternberg (1994).: The lin-15locus encodes 
two negative regulators of Caenorhabditis elegans vulval development. Mol. Biol. 
Cell 5:395-412, 1994 
60. Gu, T., 0 . Satoshi, and M. Han (1998).: Caenorhabditis elegans SUR-5, a novel 
but conserved protein, negatively regulates LET-60 Ras activity during vulval 
induction. Mol. Cell Biol. 18:4556-4564, 1998 
61. Han, M. and P.W. Sternberg (1991) .: Analysis of dominant negative 
mutations of the Caenorhabditis elegans let-60 ras gene. Genes & Dev. 5:2188-2198, 
1991 
62. Aroian, R.V., G.M. Lesa, and P.W. Sternberg (1994).: Mutations in the 
Caenorhabditis elegans let-23 EGFR-like gene define elements important for cell-
A-24 
type specificity and function. EMBO J. 13:360-366,1994 
63. Lesa, G.M. and P.W. Sternberg (1997).: Positive and negative tissue-specific 
signaling by a nematode epidermal growth factor receptor. Mol. Biol. Cell8:779-
793, 1997 
64. Boguski, M.S. and F. McCormick (1993).: Proteins regulating Ras and its 
relatives. Nature 366:643-54, 1993 
65. Hime, G.R., et al. (1997).: D-Cbl, the Drosophila homologue of the c-Cbl proto-
oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-
terminal adaptor binding sites. Oncogene 14:2709-2719, 1997 
66. Meng, W., et al. (1999).: Structure of the amino-terminal domain of Cbl 
complexed to its binding site on ZAP-70 kinase. Nature 398:84-90, 1999 
67. Sternberg, P.W. and H.R. Horvitz (1989).: The combined action of two 
intercellular signalling pathways specifies three cell fates during vulval 
induction in C. elegans. Cell58:679-693, 1989 
68. Herman, R.K. and E.M. Hedgecock (1990).: Limitation of the size of the 
vulval primordium of Caenorhabditis elegans by lin-15 expression in surrounding 
hypodermis. Nature 348:169-171, 1990 
69. Hirotsu, T., et al. (2000).: The Ras-MAPK pathway is important for olfaction 
in Caenorhabditis elegans. Nature 404:289-292,2000 
70. Newman, A.P., J.G. White, and P.W. Sternberg (1996).: Morphogenesis of the 
C. elegans hermaphrodite uterus. Development 122:3617-3626, 1996 
71. Sharma-Kishore, R., et al. (1999).: Formation of the vulva in Caenorhabditis 
elegans: a paradigm for organogenesis. Development 126:691-699,1999 
A-25 
Figure 1 
A. C. elegans vulva development occurs postembryonically. Six ventral midline-
located VPCs are competent to adopt any of three cell fates (1 o, 2°and 3°). In 
the early third larval (L3) stage, upon induced by a gonadal AC-produced 
signal, the AC-closest VPC adopts 1 o fate, which gives rise to eight 
descendants, while the adjacent VPCs adopt 2° fate, which gives rise to seven 
descendants. The further away three VPCs adopt 3° nonvulval fate, due to 
insufficient receiving of the inductive signal. 
B. After the last round of cell division, cells of a canonical 1 o lineage move 
dorsally and detach from the ventral cuticle. By the rnid-L4 stage, they form a 
symmetric arch and separate anterio-posteriorly and left-right to create a hole 
so that eggs can pass through it. The 2° lineage is asymmetric: the proximal 
cells detach and migrate dorsally and the AC-distal cells keep attaching to the 




A. A hypothetical regulatory circuit operated by the synMuv genes. Arrows 
indicate a positive effect and bars indicate a negative effect. There is a strict 
redundancy between synMuv class A genes and class B genes in negatively 
regulating the let-23 EGFR signaling pathway. Only mutation(s) in class A 
genes combined with mutation(s) in class B genes will result in the excessive 
signaling and the Muv phenotype. 
B. A hypothetical regulatory circuit operated by sli-1, unc-101, rok-1 and gap-1. 
Arrows indicate a positive effect and bars indicate a negative effect with 
thickness of the line reflects strength of the effect. X, Y and Z represent the 
negative regulations provided by these signaling regulators. The inhibitory 
effects performed by any two of them are partial redundant such that 
mutations in any two of them will lift the restraint on one signaling node, that 






















Reciprocal EGF signaling from the vulva specifies the uv1 cell fate. 
vulF, the granddaughter of the 1 o VPC, is the dorsal-most 1 o vulval progeny. 
uv1, the ventral-most uterine cell, makes the direct contact with vulF during the 
development of the uterine-vulval connection. 
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Table 1 
Genes involved in let-23 EGFR-mediated signaling 
Dfi db t t e ne >ymu an s 
Genes Genetic screens Available Linkage Nature of proteins 
used to isolate mutations groups 
the mutant 
alleles 
Ligand lin-3,., 1,+ lf,gf IV EGF 
Receptor let-23; 1&2,3 lf,gf II EGFR 
Positive effectors in sem-5 2&4 If X Grb2 adaptor 
vulva induction sos-1 2&4&5 If v RasGEF 
let-60,., 2&6,3&7,2 If, gran IV Ras-like GTPase 
ptp-2 8 If II SHPs 
sur-8/soc-i 4&9 If IV leucine-rich repeats 
ksr-1 9 If X Raf-related kinase 
lin-45; 2&9,10,10 lf,gf,dn IV Raf Ser / Thr kinase 
mek-i 9,10,10 lf,gf,dn I MAP kinase kinase 
mpk-1/sur-1; 9 If III MAP kinase 
in ovulation lfe-1/itr-1 11 gf IV IP3R 
Negative regulators lin-15 3 If X Novel protein 
in vulva induction sli-1 5&7 If X Proto-oncogene c-Cbl 
ark-1 12 If IV Non-receptor PTK 
unc-101 7 If I AP47 
gap-1 7 If X RasGAP 
clr-1 13 If II RTP 
sur-5 14 If X Novel protein 
in ovulation Zfe-2 11 If I IP3K 
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D f db e 1ne >Y sequence sniu arity 
Genes Nature of protein 
Dos Daughter of sevenless 
PLCy Phospholipase Cy 
Nck SH2/SH3 adaptor 
Crk SH2/SH3 adaptor 
PI3K pllO Catalytic subunit of PI3 kinase 
PI3K p85 Regulatory subunit of PI3 kinase 
Cnk Connector enhancer of KSR 
1. Direct screening for the Vul mutants from the wild-type animals. 
2. Extragenic suppressors of the Muv phenotype of lin-15(lj) mutants. 
3. Direct screening for the Muv mutants from the wild-type animals. 
4. Extragenic suppressors of the "Clear" phenotype of clr-l(lj) mutants. clr-1 encodes a C. 
elegans homolog of receptor tyrosine phosphatase. "Clear" phenotype indicates the clarity of 
cell boundaries, reflecting a hyperactive FGF receptor signaling [38]. 
5. Double-stranded RNA interference. 
6. Intragenic revertants of let-60(dn) mutants. 
7. Extragenic suppressors of the Vul phenotype of let-23(lj) mutants. 
8. PCR-based screening for transposon-mediated deletion mutant. 
9. Extragenic suppressors of the Muv phenotype of G13E-activated let-60 ras mutants. 
10. Mutations corresponding to either mammalian or Drosophila changes were created by site-
directed mutagenesis and the transgenes are put under control of the heat shock promoter. 
11. Extragenic suppressors of the sterility phenotype of lin-3(lfJ mutants. 
A-33 
12. Extragenic enhancers of the "pre-Muv" phenotype of sli-l(lj) mutants. "pre-Muv" 
represents a state where an excessive let-23 EGFR signaling does not overcome the 
threshold to cause a Muv phenotype but is sensitive to the fluctuation of the signaling. 
13. Extragenic suppressors of the scrawny body morphology of egl-lS(lj) mutants. 
14. Extragenic suppressors of the Vul phenotype of let-60(dn) mutants. 
t When a genetic gain-of-function mutation is not available, increase of gene dosage by the 
wild-type transgene mimics the gain-of-function phenotype. To give an effect by 
overexpressing transgene, the endogenously expressed-gene products must be relatively 
limited when compare to other proteins. 
Multiple copies of transgenes produce the dominant Muv phenotype, suggesting that the 
quantities of their gene products are normally limited in the vulval signaling. 
Multiple copies of transgenes do not produce the dominant Muv phenotype, suggesting 
that the quantities of their gene products are not normally limited in the vulval signaling. 
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Chapter 2 
Caenorhabditis elegans SOS-1 is necessary for multiple RAS-mediated 
developmental signals 
Chieh Chang, Neil A. Hopper* and Paul W. Sternberg 
* MRC-Laboratory of Molecular Biology, Cambridge CB2 2QH, UK 
Published in EMBO J. 19, 3283-3294 (2000). 
© 2000 by European Molecular Biology Organization. 
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Abstract 
Vulval induction in C. elegans has helped define an evolutionarily conserved 
signal transduction pathway from receptor tyrosine kinases (RTKs) through the 
adaptor protein SEM-5 to RAS. One component present in other organisms, a 
guanine nucleotide exchange factor for Ras, has been missing in C. elegans. To 
understand the regulation of this pathway it is crucial to have all positive-acting 
components in hand. Here we describe the identification, cloning and genetic 
characterization of C. elegans SOS-1, a putative guanine nucleotide exchanger for 
LET -60 RAS. RNA interference experiments suggest that SOS-1 participates in 
RAS dependent signaling events downstream of LET-23 EGFR, EGL-15 FGFR 
and an unknown RTK. We demonstrate that the previously identified let-341 
gene encodes SOS-1. Analyzing vulval development in a let-341 null mutant, we 
find a SOS-1-independent pathway involved in the activation of RAS signaling. 
This SOS-1-independent signaling is not inhibited by SLI-1/Cbl and is not 




Polypeptide hormones bind cell surface receptors containing tyrosine kinase 
activity to regulate cell proliferation, differentiation, migration and metabolism. 
All receptor tyrosine kinases exhibit a similar molecular architecture and 
apparently are activated by a common mechanism (Gutch et al., 1998). Ligand 
binding to the extracellular domain induces receptor dimerization which in turn 
leads to activation of the catalytic kinase domain (Lemmon and Schlessinger, 
1994). Autophosphorylation of tyrosine residues that are located in the C-
terminal region leads to the physical recruitment of cytoplasmic signaling 
molecules with phosphotyrosine (pTyr)-recognition modules, such as SH2 (Src 
homology 2) and PTB (phosphotyrosine binding) domains (Pawson, 1995). These 
receptor-binding proteins include the adapter Grb2, which leads to Ras 
activation, Ras-GTPase activating protein, phospholipase C-(PLC)-y, the tyrosine 
phosphatase SHP-2, the regulatory subunit of phosphatidylinositol-3-0H kinase 
(Heldin, 1995; Pawson, 1995; Ullrich and Schlessinger, 1990), the scaffolding 
protein She (Pelicci et al., 1992), and the proto-oncoprotein c-Cbl (Meisner et al., 
1997). The association between proteins with SH2/PTB domains and receptor 
pTyrs serves as the initial step in the recruitment of an activated RTK signaling 
complex. Different SH2/PTB domains have distinct specificities for the pTyr 
residues dependent on the surrounding amino acid residues (Kavanaugh et al., 
1995; Kavanaugh and Williams, 1994; Panayotou and Waterfield, 1993; Songyang 
et al., 1993; Songyang et al., 1994). Association of RTKs with substrates is 
therefore dependent upon the amino acid context of the pTyr, and that, in part, 
determines which proteins join the signaling complex and what cellular 
responses are evoked (Pawson and Saxton, 1999; Schlessinger and Ullrich, 1992). 
The achievement of a precise amplitude and duration of the signaling required 
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for the reproducible developmental consequences observed can be obtained by 
regulating the production of signaling molecules and their presentation to their 
substrates. Excessive or prolonged RTK signaling has been implicated in many 
cases of malignant transformation (Alroy and Yarden, 1997; Cheng et al., 1998). 
Therefore, proper mechanisms must be employed to strongly control the 
signaling from RTKs to prevent spontaneous, ligand-independent activation and 
downregulate signaling after it has been activated. 
EGF RTK signaling is used multiple times during the normal development 
of C. elegans, mediating vulval induction, viability, male spicule development, 
hermaphrodite ovulation, and differentiation of the ventral uterus and posterior 
ectoderm (Aroian and Sternberg, 1991; Chamberlin and Sternberg, 1994; Chang et 
al., 1999; Clandinin et al., 1998; Ferguson and Horvitz, 1985; Jiang and Sternberg, 
1998). The high resolution of the vulval induction assay makes it very sensitive, 
allowing one to identify mutants and to reflect the relative strength of RAS-
dependent signaling (Han and Sternberg, 1991). All the other developmental 
events are also RAS-dependent, with the exception of hermaphrodite ovulation, 
which is instead mediated through an inositol trisphosphate signaling pathway 
(Clandinin et al., 1998). 
The wild-type vulva is derived from three of six multipotential vulval 
precursor cells (VPCs), in response to an inductive signal from the anchor cell 
(AC) in the somatic gonad (Horvitz and Sternberg, 1991). The induced VPCs 
undergo three rounds of division and subsequent morphogenesis to form the 
vulva. VPCs that do not receive adequate signal from the anchor cell divide only 
once and become part of the worm's large syncytial epidermis. The inductive 
signal, LIN-3, is an EGF-like growth factor produced by the anchor cell. LIN-3 
activates LET-23, a C. elegans homolog of EGF RTK, in the VPCs (Aroian et al., 
1990; Hill and Sternberg, 1992). LET-23 activation initiates a signaling cascade 
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that involves downstream effectors such as SEM-5, LET-60, LIN-45, MEK-2 and 
SUR-1/MPK-1 which are the nematode counterparts of the mammalian Grb2 
adaptor, the Ras GTP-binding protein, the Raf serine/threonine kinase, the 
MAPK kinase and the MAPK, respectively (Beitel et al., 1990; Clark et al., 1992a; 
Han et al., 1993; Han and Sternberg, 1990; Kornfeld et al., 1995; Lackner et al., 
1994; Wu and Han, 1994; Wu et al., 1995). Loss-of-function (lj) mutations in these 
signaling proteins result in less than three VPCs undergoing vulval 
differentiation, whereas gain-of-function (gf) mutations result in more than three 
VPCs undergoing vulval differentiation. 
In addition to the main RAS-dependent signaling pathway, several 
accessory proteins have been identified. ptp-2, which encodes a SH2 domain-
containing protein similar to the mammalian SHPs and Drosophila Corkscrew, 
appears to affect vulval induction only in a sensitized genetic background and 
behaves as a positive effector of the LET-23 pathway (Gutch et al., 1998). Loss-of 
function in ptp-2 suppresses the multiple vulva (Muv) phenotype induced by a 
loss-of-function lin-15 mutation, and an activated let-23 or let-60 mutation.lin-15 
encodes two novel proteins that somehow inhibit Ras-dependent vulval 
signaling, and lin-15 mutation formally acts as if LET-23 was activated in a 
ligand-independent manner (Clark et al., 1994; Huang et al., 1994). 
FGFR is another RTK whose developmental roles are dependent upon 
RAS. Genes involved in the FGFR pathway were defined by mutations affecting 
sex myoblast migration, including EGL-17 FGF, EGL-15, SEM-5, and several RA5-
MAP kinase cascade components (Chen et al., 1997; Clark et al., 1992a; Stern and 
Horvitz, 1991; Sundaram et al., 1996). Others, including soc-1 and soc-2, were 
defined by their ability to suppress a clear (Clr) phenotype, which appears to be 
caused by excess EGL-15 signaling (Selfors et al., 1998). 
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Mutations in let-60/mek-2/mpk-1 cause a delay in pachytene exit during 
meiosis resulting in sterility (Church et al., 1995). The inductive signal, cognate 
receptor, and their signal transducers used for let-60/mek-2/mpk-1-mediated 
germline meiotic cell cycle progression are still unknown (Sternberg and Han, 
1998). 
Ras-dependent RTK signaling pathways are well conserved at the level of 
their mechanistic aspects throughout metazoan evolution. Ras is activated 
following the recruitment of Sos to the plasma membrane, which stimulates 
guanine nucleotide exchange. Recruitment of Sos follows receptor activation and 
is dependent upon the adaptor protein Grb2. Sos contains two structural 
domains, CDC25 and DH, which act as exchange factors specifically upon the 
closely related Ras and Rho family GTPases, respectively (Chardin et al., 1993; 
Nimnual et al., 1998). An EGF RTK substrate, Eps8, and its associated protein, 
E3b1, have been shown recently to regulate the transduction of signals from Ras 
to Rae through Sos (Scita et al., 1999). Despite our understanding of Sos function, 
obtained primarily from work on flies and mammals, the identification of the 
exchange factor for RAS in C. elegans has remained elusive. For our goal of 
understanding how receptor tyrosine kinase signaling is regulated, it is necessary 
to identify all the positive and negative acting components. To this end we 
cloned the previously unidentified C. elegans Sos homolog, sos-1, and show that it 
is encoded by the let-341 gene. We demonstrate SOS-1 activity is required for 
normal RAS activation. In addition to a requirement for SOS-1, we show that 
there is a SOS-1 independent pathway operating in vulval induction. This SOS-1 
independent pathway does not utilize PTP-2. This raises the possibility that there 
remain other activators of RAS signaling that are yet to be identified. 
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Results 
Isolation of a Sos homolog in C. elegans 
The C. elegans Sequencing Consortium (1998) identified an incomplete genomic 
sequence, which GeneFinder predicts to encode a C. elegans homolog of Sos. By 
using reverse transcription-PeR (RT-PCR) and 5' and 3' rapid amplification of 
eDNA ends (RACE), we have been able to obtain a nearly complete eDNA of this 
gene and confirm that it encodes a Sos homolog (Figure 1). We will refer to this 
gene as sos-1 (for ~on Qf ~evenless homolog). A SL1 trans-spliced leader 
sequence, which is immediately followed by the putative initiation methionine, 
has been identified in the 5' end of the eDNA. However the eDNA is lacking the 
extreme 3' sequence as the termination codon is still missing. This is due to a 
highly adenylated sequence in the 3' terminus which presumably prevents the 
recovery of the 3' end by use of a poly(dT) primer (Figure 1A). The longest 
eDNA fragment was sequenced and this 4.2-kb eDNA contains a single long 
open reading frame (ORF) (GenBank accession number AF251308). We obtained 
two shorter splice variants predicted to encode proteins that end prematurely 
immediately after exon 12 and 13 (see materials and methods). Sequence analysis 
of the corresponding genomic region encompassing this 4.2-kb eDNA revealed 
that the coding region of this gene spans a region over 30.6 kb and includes a 
long 13.6-kb intron. Conceptual translation of the 4.2-kb ORF predicted a protein 
of 1,413 amino acids with signature motifs that match the guanine nucleotide 
exchange factor for Ras. The predicted structure of SOS-1 contains one Dbl 
homology (DH) domain followed by one pleckstrin homology domain at the 
amino terminus and a carboxyl-terminal CDC25 catalytic domain followed by 
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two PxxP motifs (Figure 1B). CDC25 domain is the most conserved region in 
RAS-binding exchange factors among species (Figure 1C). 
Phenotypic effects displayed by the progeny of sos-1 dsRNA-injected 
hermaphrodites 
To understand the biological functions of sos-1, we used double-stranded RNA 
interference (RNAi) to transiently knock out gene expression during animal 
development. RNAi has been shown to robustly and efficiently interfere, if not 
remove, gene expression, in many model systems including C. elegans, Drosophila, 
Trypanosoma brucei, and plants (Fire et al., 1998; Sharp, 1999). A 1.6-kb sos-1 
eDNA, which represents the sequences encoding the C-terminal portion of the 
DH and the entire PH domains, was subcloned into the pCRII-TOPO vector. The 
nucleotide sequence of this 1.6-kb eDNA is not similar to any other gene 
identified by the C. elegans sequencing consortium (as of Apr. 2000). Sense and 
antisense RNA were synthesized from T7 and Sp6 promoters, respectively, and 
sense/ antisense annealing was carried out in vitro prior to microinjection. 
RNAi reveals that SOS-1 participates in those functions mediated by LET-
60 RAS. Progeny of hermaphrodites injected with sos-1 dsRNA showed a low 
penetrance of L1-L2lethality (8%; n=66). Animals escaping this early larval 
lethality generally displayed slow growth and a scrawny body morphology, 
resembling the phenotype of hypomorphic egl-15 mutants, an FGFR homolog 
(61/61 animals examined) (Figure 4B). When examined under Nomarski optics, 
uterine cells are generally mis-positioned or mis-specified (data not shown). 
During oogenesis, a significant retardation of pachytene exit is observed (11/11 
animals examined) (Figure 3D). By young adult stage, the proximal germline 
nuclei, which normally undergo spermatogenesis in wild-type animals, remain 
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arrested in the pachytene stage of meiosis I. The more distal nuclei, which 
presumably undergo oogenesis, also remain arrested in the pachytene phase. 
Clumped pachytene nuclei can be easily found in the distal arm of the gonad, 
which might be the result of the diminished size of the gonad. 
In addition, adult sos-1 [RNAi] males generally exhibit short and 
crumpled spicules (20/20 animals examined) (Figure 3B). let-60(n1046gf) but 
neither a let-23(sa62gf) nor a lin-15(n765ts) mutation suppresses the lethality and 
scrawny phenotype conferred by the sos-1 RNAi, implying that S05-1 functions 
downstream of LET-23 and upstream of LET-60. The hyperinduced vulval 
phenotypes observed in let-60(n1046gf), let-23(sa62gf) and lin-15(n765ts) mutants 
are suppressed by the sos-1 RNAi. However, the suppression of let-60(n1046gf) is 
weaker than that of let-23(sa62gf) and lin-15(n765ts) based on the distributions of 
vulval induction (Figure 2; Table I). Since all these phenotypes are also exhibited 
by mutants in RAS signaling pathway, we conclude that SOS-1 acts on RAS 
during larval development. 
SOS-1 is encoded by let-341 
sos-1 maps to the left arm of chromosome V in a region that is close to the 
estimated position of let-341 on the genetic map.let-341 alleles were originally 
isolated in a screen for essential genes on the left arm of V Gohnsen and Baillie, 
1991). In addition, let-341 alleles were also isolated as extragenic suppressors of 
the Multivulval phenotype of lin-15(ZJ) mutants (Clark et al., 1992b) and in a 
screen for suppressors of the Clr (soc) phenotype of clr-1(ZJ) mutants (M. Stern, 
personal communication). Genetic studies suggest that let-341 has genetic 
properties consistent with it encoding a RAS exchange factor, namely that it acts 
downstream of lin-15 and upstream of let-60 (Clark et al., 1992b). We therefore 
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tested whether let-341 mutants have lesions in sos-1. Molecular lesions associated 
with three let-341 alleles were found to affect the sos-1 ORF, indicating that sos-1 
transcript corresponds to let-341 gene (Figure 1A). let-341(s1031) mutants display 
a 100% embryonic or early larval lethality, which can be suppressed by a let-
60(gj) mutation. Sequence analysis reveals that s1031 contains an AG-> TT 
mutation at the splice donor of intron 13 in sos-1 . The n2183 mutation, provided 
by M. Stern, changes a glutamic acid to lysine at codon 331 within the DH 
domain (Figure 1). The ku231 allele, provided by z. Chen and M. Han, results in 
the substitution of proline for a conserved histidine at codon 881 right before the 
start of the CDC25 catalytic domain. 
s1031 represents a null allele for sos-1 
As the molecular lesion associated with s1031 is predicted to alter splicing, we 
looked at the sos-1 mRNA produced in this mutant. We could not detect wild-
type sos-1 mRNA in s1031 mutants by RT-PCR (Figure 5). The subsequent 
sequence analysis revealed that in s1031 animals upstream cryptic splice donors 
are used and consequently various deletions in the regions encoding the C-
terminus of the CDC25 catalytic domain occur (Figure 1C and 5). The truncated 
transcripts are predicted to encode either a dominant negative or a loss-of-
function SOS-1 protein, suggesting that s1031 completely eliminates SOS-1 
activity. Consistent with s1031 being a null allele, a sem-5 null or severe 
reduction-of-function mutation does not further reduce the vulval induction in 
let-60(n1046); let-341(s1031) mutant animals (Table II) . To further strengthen this 
conclusion, we use sos-1 RNAi to remove any residual sos-1 activity in let-
60(n1046); let-341(s1031) mutants. The average vulval induction displayed by the 
progeny of sos-1 dsRNA-injected hermaphrodites is 2.6 (n=23), which is not 
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statistically different from that displayed by animals without sos-1 dsRNA 
injection (2.7 (n=54)) (Table I). Together, these three lines of observation provide 
compelling evidence that s1031 is a null allele. 
Since s1031 is a null allele, we tested whether this mutation alters vulval 
induction. We used a let-60(gf) mutation to rescue the lethality of s1031 and 
found that loss of let-341 sos-1 function reduces vulval induction. Specifically, 
41% of let-60(n1046); let-341(s1031) mutant animals exhibit less than wild-type 
vulval induction, further supporting a role of sos-1 during vulval induction. 
ligand-dependent and SOS-1-independent activation of RAS signaling in the 
vulva 
To test whether Zin-3-induced vulval signaling is solely mediated by let-341 sos-1, 
we compared the vulval induction in mutant lacking lin-3 to mutant lacking let-
341 sos-1. Since LIN-3 produced by the gonadal AC is the only inductive source 
for vulval differentiation, ablation of gonad eliminates the ligand for let-23 
mediated vulval signaling. The extent of vulval differentiation in let-60(gf); let-
341(null) mutants is significantly higher than that in gonad-ablated let-60(gf) 
mutants (Table II). This observation suggests that not all of the inductive 
signaling is mediated through SOS-1. This SOS-1-independent pathway could 
also be SEM-5 independent since let-60(gf); sem-S(null) and let-60(gf); let-341(null); 
sem-S(null) mutants also produce significantly more vulval differentiation than 
do gonad-ablated let-60(gf) mutants. A transgenic line that bears multiple copies 
of let-60(n1046gf) DNA displays completely ligand-independent signaling 
(Sundaram and Han, 1995). Importantly, this transgenic array does not confer 
100% induction in all six VPCs. It has been shown that a weak lin-45 mutation 
suppresses the vulval induction conferred by this transgenic line while a weak 
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sem-5 mutation or the gonad ablation does not. This indicates that gonad ablation 
does not affect signaling parallel to LET-60 RAS (Sundaram and Han, 1995). 
Thus, the ligand-dependent and SOS-1-independent pathway most likely acts at 
the level of LET -60 RAS. 
To address the question of whether LET-23 is required for the SOS-1-
independent activation of LET-60 RAS, we assayed the extent of vulval induction 
in let-23(sy17 null); let-60(n1046) double mutants. The average vulval induction of 
sy17; n1046 strain shows no difference from that of n1046 single mutants (Table 
III). Our interpretation of this observation is that there is a LET-23-dependent 
negative regulation for vulval signaling, which can be lifted by the presence of 
the gonadal signal. This model is supported by our other experimental results. 
Because LET-23 has both positive and negative effects on vulval signaling, we 
can not rule out a LET-23-independent response to the gonadal signal. 
To test whether this putative SOS-1-independent pathway is under 
regulation by SLI-1, we crossed a sli-1 mutation to a genetic background where 
the SOS-1-dependent pathway has been removed. SLI-1, similar to mammalian 
proto-oncoprotein c-Cbl, inhibits LET-23 mediated signaling during vulval 
development Oongeward et al., 1995; Yoon et al., 1995). We found that a sli-
1(lfJ mutation fails to enhance the vulval induction in let-60(gf); let-341(null) 
mutants, arguing that SLI-1 does not negatively regulate this other pathway 
parallel to SOS-1 (Table III). This result also supports our interpretation that let-
341(s1031) represents a loss-of-function rather than a severe reduction-of-
function mutation because we expect that fluctuation in the ras-dependent 
signaling caused by a sli-1 mutation would result in a dramatic change in vulval 
induction under the condition where a low level activity of LET-23 / SEM-5/SOS-
1 is present (C. Yoon, C. Chang and P. Sternberg, unpublished). 
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Gonad-ablated let-60(gj); let-341(null) animals have less vulval 
differentiation than do let-60(gj); let-341(null) or gonad-ablated let-60(gj) animals. 
Therefore, gonad ablation not only removes a ligand-dependent and SOS-1-
independent positive signaling pathway but also reveals a ligand-independent 
activation of RAS by SOS-1. Although this ligand-independent activation of RAS 
by SOS-1 does not contribute significantly the vulval induction in gonad-ablated 
let-60(gj) animals, it could explain the difference of vulval induction between let-
60(gj); let-341(null) and let-60(gj); sem-S(null) mutants (Table II). 
PTP-2 is not involved in SOS-1-independent vulval signaling 
Based on the observation that the loss-of function mutation in ptp-2 reduces the 
vulval induction conferred by a let-60(gj) mutation, ptp-2 was previously 
interpreted to act in the vulval signaling pathway as a positive effector 
downstream of, or in parallel to, let-60 ras (Gutch et al., 1998). To determine 
whether the response of PTP-2 to receptor activation is parallel to that of SOS-1, 
we generated triple mutants with activated RAS but lacking PTP-2 and SOS-1 
(ptp-2(null); let-60(gj); let-341(null)), and assessed their vulval differentiation. The 
ptp-2 mutation did not further reduce the vulval induction observed in let-60(gj); 
let-341(null) mutants, suggesting that PTP-2 does not mediate 505-1-independent 
vulval signaling (Table III). 
Lifting inhibition by GAP-1 does not explain the SOS-1-independent signaling 
activity 
Besides a SOS-1-independent activation of RAS, an alternative explanation for 
the elevated signaling activity in the let-60(gj); let-341(null) mutant animals is that 
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activation of LET -23 by the ligand may relieve the inhibition of RAS by GAP-1, 
GTPase activating protein (Hajnal et al., 1997). In this model, LET-23 would be 
able to relieve GAP-1-mediated inhibition of RAS upon activation by the ligand 
in let-60(gj); let-341(null) double mutants, while let-60(gj) single mutants with an 
ablated gonad display constitutively active GAP-1 and cause a further decrease 
in the vulval induction. To test this model, we constructed the triple mutant let-
60(gj); let-341(null); gap-l(null) and compared the average vulval induction in the 
conditions with and without the gonad. We find that gonad ablation significantly 
reduces the vulval induction of let-60(gj); let-341(null); gap-l(null) animals (from 
3.9 (n=20) to 2.4 (n=13); p=0.0048) (Table II), indicating that the anchor cell signal 
is not working solely through let-341 and gap-1 which are absent already in let-
60(gj); let-341(null); gap-l(null) animals. This result rules out the possibility that 
the gonad-dependent sos-1 independent signaling is mediated solely through 
gap-1. 
A role for SOS-1 in FGFR-mediated signaling during development 
Hyperactive EGL-15 FGF receptor signaling, conferred by either an activated egl-
15 or a loss-of-function clr-1 mutation, results in a Clr phenotype. Decreased EGL-
15 signaling, conferred by a partial loss-of-function egl-15 mutation, results in a 
scrawny body morphology phenotype (Kokel et al., 1998). clr-1, which encodes a 
receptor tyrosine phosphatase, is believed to attenuate signaling from FGFR by 
dephosphorylation. A scrawny phenotype was observed in the sos-1 RNAi-
affected animals (Figure 4B), suggesting that SOS-1 normally mediates FGFR 
signaling. To test this possibility, we removed SOS-1 function in the temperature-
sensitive clr-1(e1745ts) mutants by sos-1 RNAi and assessed their Clr phenotype. 
We found that the Clr phenotype of clr-1(e1745ts) mutants was suppressed by 
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sos-1 RNAi (77 /77 animals examined) (Figure 4C and D), indicating a positive 
role for SOS-1 in FGFR-mediated signaling. Indeed, the let-341(ku231) mutation 
also suppresses the Clr phenotype of clr-1(e1745ts) mutants (data not shown) and 
let-341(n2183) was isolated as a soc mutant, as mentioned before. Since many sem-
5 alleles were also isolated as suppressors of the Clr phenotype of clr-1(lj) mutant 
(Clark et al., 1992a), it is likely that SEM-5-dependent recruitment of SOS-1 to the 
active FGFR (EGL-15) plays an analogous role in activating RAS as with the 
EGFR (LET-23). 
Discussion 
S OS-1 participation during vulval development 
We have found the C. elegans homolog of Sos, and demonstrated by RNAi and by 
phenotypic analysis of a null allele, that it is required for vulval induction. sos-1 
RNAi does not affect vulval induction in the wild-type animals at an appreciable 
frequency (1/50 animals examined vulvaless; data not shown). It might be that 
vulval induction occurs late in development or a certain property of vulval 
lineages renders this developmental process more resistant to sos-1 RNAi. 
However, the effect of sos-1 RNAi on vulval signaling becomes obvious in 
sensitized genetic backgrounds. Although sos-1 acts downstream of let-23 and 
upstream of let-60, sos-1 RNAi affects excessive vulval signaling in both let-23(gj) 
and let-60(gj) mutants. The fact that vulval signaling was affected in a greater 
degree in let-23(gj) than let-60(gj) mutants is consistent with our expectation that 
sos-1 RNAi abrogates both ligand dependent and independent activation by let-
23(gj) while only abrogates ligand dependent activation by let-60(gj). The 
involvement of sos-1 during vulval development is further confirmed by our 
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observation that 41 percent of the let-60(gf); let-341(null) animals examined 
displayed less than a wild-type extent of vulval differentiation (Table II). 
SOS-1 involvement in oocyte maturation and uterine differentiation 
Consistent with the observation that sos-1 RNAi prevents meiotic prophase 
progression, sos-1 RNAi-affected hermaphrodites also display a late onset sterile 
phenotype in the adult stage (10/10 animals examined; data not shown). 
Furthermore, this sterile phenotype can be suppressed by a let-60(gf) mutation 
(data not shown). Taken together, these results identify SOS-1 as an activator for 
LET-60 RAS in regulating oogenesis. It remains unknown what is required 
upstream of SOS-1 to permit exit from pachytene (Church et al., 1995). 
As judged by anatomy, we can not tell whether abnormalities in the dorsal 
and ventral uterine lineages are caused by a mis-determination of cell fates, 
defects in cell migration, or both. Most of the adult hermaphrodites affected by 
sos-1 RNAi have an abnormal everted vulva that consists of vulval cells and 
somatic gonadal tissues that have been extruded out of the body cavity (data not 
shown). Uterine cells are known to be required for the proper attachment 
between the uterus and vulva (Newman and Sternberg, 1996), a process that has 
been suggested to prevent the vulva and uterus from slipping out of the body 
cavity during vulval eversion (Seydoux et al., 1993). 
SOS-1-dependent and independent signaling 
The finding that the sli-1(null) mutation fails to enhance the vulval induction in 
let-60(gf); let-341(null) mutants suggests that the synergy between sli-1(null) and 
let-60(gf) in the vulva is dependent upon 505-1. This result is consistent with our 
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previous data suggesting that sli-1 acts upstream of let-60 ras to inhibit signaling 
from let-23 (C. Yoon, C. Chang and P. Sternberg, unpublished). The finding that 
the extent of vulval induction in a let-60(gf); let-341(null) background is higher 
than in gonad ablated let-60(gf) animals reveals that there is a ligand-dependent 
and SOS-1-independent signaling by EGF RTK. The simplest explanation is that 
there is a SOS-1-independent positive signaling pathway in let-60(gf); let-341(null) 
animals. Alternatively, gonad-ablated let-60(gf) animals may be subject to a form 
of negative regulation in the vulva that is independent of SOS-1 and is lifted in a 
let-60(gf); let-341(null) background perhaps by the presence of the ligand. A SOS-
1-independent positive signaling pathway elicited by LIN-3 might involve 
another guanine nucleotide exchange factor for RASor the DOS/PTP-2-cascade. 
It has been previously shown that there may be more than one activator of LET-
60 RAS. Genetic analysis of sur-5 revealed that a sur-S(lj) mutation selectively 
suppresses one group of let-60(dn) alleles but not the other, supporting the 
hypothesis that there could be more than one activator for LET-60 RAS (Gu et al., 
1998b). let-60(dn) alleles have been shown to affect signaling by titrating 
upstream activators rather than downstream effectors (Han and Sternberg, 1991). 
At least seven additional putative guanine nucleotide exchange factors have been 
predicted from the C. elegans genome sequence (as of Apr. 2000), and one or 
more of these could be the hypothetical activator. 
Regulation of RTK pathways by PTP-2 
Csw and SHP-2 are PTP-2 homologs in Drosophila and vertebrates, respectively . 
Csw is normally required for Sevenless, Breathless, Torso, and DER pathways 
while SHP-2 has been shown to function in EGFR, PDGFR, FGFR, and HGFR 
signaling p athways. The best characterized substrate for Csw / SHP-2 are 
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Daughter of sevenless (Dos)-type proteins (Gu et al., 1998a; Herbst et al., 1996; 
Raabe et al., 1996). It is believed that dephosphorylation of Dos by Csw generates 
a positive downstream signal. However, it remains unclear how Dos 
dephosphorylation creates such a positive signal. It is conceivable that PTP-2 
might dephosphorylate specific phospho-tyrosyl residue(s) on aDos-like protein, 
thus controlling the composition of an assembled signaling complex. Based on 
our results that PTP-2 function could be dependent upon SOS-1, several models 
for PTP-2 action can be proposed (Figure 6). PTP-2 could modulate the SEM-5-
directed recruitment of SOS-1 or the catalytic activity of SOS-1. Alternatively, 
PTP-2 could release a negative regulator, such as SLI-1, from the signaling 
complex. 
SOS-1 acts in multiple, RAS-dependent signaling pathways 
SEM-5 recruitment of SOS-1 to the cell membrane seems to be a common 
mechanism involved in transducing signals from the activated EGFR and FGFR 
to RAS (Figure 6). Although SOS-1 also participates in signaling during the 
maturation of germline cells, how it is directed and to what signal it responds are 
unclear. Regulation of signaling upstream of RAS has been intensively studied 
from EGFR by using vulval development as a major paradigm. Several negative 
regulators have been previously implicated as affecting RAS activation by LET-
23, including SLI-1/Cbl, UNC-101/ AP47, and GAP-1/RasGAP. Biochemical 
studies suggest that RasGAP inhibits the signaling by directly acting on Ras 
(Boguski and McCormick, 1993), while Cbl desensitizes the signaling through 
binding to active receptors (Meisner et al., 1997). It is not clear how the UNC-101 
adaptor antagonizes the RAS signaling pathway. In this report, we have 
provided evidence for the existence of a SOS-1-independent signaling pathway, 
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which is dependent upon ligand, independent of PTP-2, and is not negatively 
regulated by SLI-1. Recently, Cbl was shown to function as a ubiquitin-protein 
ligase for active RTKs (Joazeiro et al., 1999). The failure to see an effect of SLI-1 on 
the SOS-1-independent pathway argues that promoting the degradation of active 
EGFR might not be the major activity of SLI-1. SLI-1 and another negative 
regulator of LET-23 EGFR signaling, ARK-1, both have proline-rich domains that 
can interact with the SH3 domain of SEM-5 (C. Yoon, C. Chang, P. Sternberg, 
unpublished; N. Hopper, J. Lee and P . Sternberg, in preparation). Competition 
between SOS-1 and negative regulators for binding to the SEM-5 adaptor is a 
potential mechanism of direct negative regulation of LET-60 RAS activation. 
Alternatively, the SH3 domains of SEM-5 may, in addition to the recruitment of 
SOS-1, also recruit negative regulators simultaneously with SOS-1. It is less likely 
that ptp-2 activates signaling by inhibiting gap-1 function, since a ptp-2 mutation 
did not further reduce the vulval induction in let-60(gf); let-341(null) mutants, and 
a let-60(gf); let-341(null) mutant is sensitive to gap-1 regulation (Table II). 
Regulation of Sos1 by phosphorylation has been proposed previously (Buday et 
al. , 1995; Hu and Bowtell, 1996). Enhanced phosphorylation of Sos1, while not 
altering its catalytic activity for Ras, weakens its binding affinity for Grb2 or 
uncouples the Sos1 / Grb2 complex from tyrosine kinase substrates (Buday and 
Downward, 1993). Although Sos1 is phosphorylated mostly on serine and 
threonine, regulated tyrosine phosphorylation has never been ruled out for Sosl. 
Therefore, it is possible that protein tyrosine kinases/phosphatases might 
modulate RAS signaling strength by directly regulating the phosphorylation 
state of SOS-1. 
Materials and methods 
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Strains 
Strains were handled according to the standard protocol and maintained at 20°C 
(Brenner, 1974). The following alleles were used: for LGII, let-23(sa62), ptp-
2(op194) (Gutch et al., 1998), unc-4(e120), clr-1(e1745) (Hedgecock et al., 1990); for 
LGIV, let-60(n1046) (Ferguson and Horvitz, 1985), unc-31(e169); for LGV, him-
5(e1490), let-341(s1031) (Johnsen and Baillie, 1991), let-341(n2183) (M. Stem, 
unpublished), let-341(ku231) (Z. Chen and M. Han, unpublished); for LGX, lin-
15(n765), sem-5(ay73) (M. Stern, unpublished), gap-1(n1691) (Hajnal et al., 1997), 
sli-1(sy143). 
Construction of double and triple mutants 
Double and triple mutants were constructed using standard genetic methods, 
and markers used are indicated in the tables. For let-60(n1046); let-341(s1031), let-
60(n1046); sli-l(sy143) double mutants and for let-60(n1046); let-341(s1031); sem-
5(ay73), let-60(n1046); let-341(s1031); gap-1(n1691), let-60(n1046); let-341(s1031); sli-
1(sy143), ptp-2(op194); let-60(n1046); let-341(s1031) triple mutants, the presence of 
let-341, sli-1, sem-5, and gap-1 mutations was confirmed by sequencing the 
appropriate region of genomic DNA from each strain. 
sos-1 eDNA isolation and allele sequencing 
Partial sos-1 eDNA was derived from an incomplete genomic sequence, which 
was provided by C. elegans sequencing consortium (1998) and predicted to 
encode a Sos homolog using the program GeneFinder. RT-PCR reactions were 
performed to rectify the GeneFinder prediction and confirmed our further 
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derivation based on the comparative analyses. Two splice variants were 
recovered in addition to the major transcript. One variant results from failure to 
use the normal splice donor site of intron 12. The other results from usage of an 
alternative splice acceptor site in intron 13 
(AG/GAATTGCCGAACATATACTAATCACTCTAA). 5' and 3' rapid 
amplification of eDNA ends (RACE) reactions were carried out as 
manufacturer's instructions to obtain sequences corresponding to the 5' and 3' 
ends of the sos-1 transcript (5' /3' RACE kit, BOEHRINGER MANNHEIM). 
To identify molecular lesions, PCR was performed on both reverse-
transcribed RNA and genomic DNA from mutants, the products were purified 
and sequenced. The consequence of splice site mutation was determined by PCR 
amplification of reverse-transcribed RNA from mutants and sequencing purified 
PCR fragments directly. 
RNAi 
dsRNA corresponding to sos-1 was generated by in vitro transcription using 1.6-
kb sos-1 eDNA corresponding to the nucleotides 1,045 to 2,613 relative to the 
initiation codon inserted into pCRII-TOPO (Invitrogen). Transcripts were 
prepared using T7 and Sp6 RNA polymerase and annealed prior to injection 
(Fire et al., 1998). Progeny of injected animals were assayed at 20°C unless 
indicated otherwise. 
Vulval induction assay 
The extent of vulval induction was determined by examining vulval anatomy in 
the early to mid-L4 stage of development under Nomarski optics using a Plan 
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100 objective (Sternberg and Horvitz, 1986). Wild-type animals have three VPCs 
generating vulval progeny; vulvaless animals have fewer than three VPCs 
generating vulval progeny; multivulva or hyperinduced animals have more than 
three VPCs generating vulval progeny. In some cases, a VPC generates one 
daughter that makes vulval progeny and another daughter that becomes 
nonvulval epidermis; such VPCs are scored as one-half VPC differentiating into 
vulval tissue. 
Cell ablation 
Ablations of the AC was performed with a laser microbeam as described by 
Sulston and White (1980). 
DAPI staining 
Animals were washed in M9 buffer before picked into a small drop of 
Vectashield with 4',6-diamidino-2-phenylindole (Vector laboratories) in a 
depression slide. After 30-60 minutes at room temperature, animals were dried in 
a vacuum for one hour before mounted on agarose pads for observation. 
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Fig. 1. 
(A) Genomic structure of the sos-1 locus. The solid bars represent exons, which 
were inferred by comparing the nucleotide sequence of a sos-1 eDNA with that of 
the genomic DNA; 5' untranslated region is depicted as an open box. Sizes of the 
16 introns are noted by the numbers above each intron. The start and tentative 
end of the let-341 sos-1 coding sequences are indicated by the corresponding 
nucleotide numbers from YAC Y61A9LA. Diagonal line labeled SL1 trans-spliced 
leader attachment site. The positions of let-341 mutations and corresponding 
amino acid or splice site changes are shown. Exonic sequence is shown in 
uppercase lettering, intronic sequence in lowercase. The approximate locations of 
primers up8 and dn18 used to analyze s1031 transcripts are indicated. (B) 
Comparative analyses of signature motifs in SOS-1 homologs. The protein 
predicted to be encoded by the sos-1 gene is depicted schematically. The numbers 
listed below represent the percent identity between DH domain, PH domain, and 
CDC25 catalytic domain of SOS-1 and those domains of human Sos1 and 
Drosophila sos. Motifs were identified using the ProfileScan program. (C) 
Sequence alignment of CDC25 domains of RA5-binding exchange factors from 
C. elegans (Ce), Drosophila melanogaster (Dm), and Homo sapiens (Hs) with 
residue numbers of C. elegans (Ce) SOS-1 indicated. Residue identity between 
species is highlighted in black, and similarity is highlighted in gray. The arrows 






























































N E s p K E 
1130 1740 
STFVNKSPPHGAAGAQK 
QQK D D L K A 
B-34 
Fig. 2. 
Suppression of excessive vulval signaling by sos-1 RNAi. Nomarski 
photomicrographs of the vulval induction in the L4 stage hermaphrodites. (A) 
lin-15(n765) mutant, which displays a total of six VPCs adopting vulval fates and 
forms three vulval invaginations. (B) sos-1 RNAi-affected lin-15(n765) mutant, 
which displays a one cell induction that forms one vulval invagination. (C) let-
23(sa62) mutant, which displays a total of four VPCs undergoing vulval 
differentiation and forms two vulval invaginations. (D) sos-1 RNAi-affected let-
23( sa62) mutant, which displays only two induced vulval cells that form one 
vulval invagination. (E) let-60(n1046) mutant, which displays a total of five VPCs 
adopting vulval fates and forms three vulval invaginations. (F) sos-1 RNAi-
affected let-60(n1046) mutant, which displays a wild-type vulval induction and 




Table I. sos-1 mediates the ectopic vulval induction during excessive let-23 
signaling 
Genotype sos-1 %<3 %=3 %>3 Numbers of Average vulval 
RNAi animals induction 
let-60(n1046) 0 0 100 20 5.0 
let-60(n1046) RNAi 0 62 38 21 3.3 
let-23( sa62) 0 7 93 15 4.2 
let-23( sa62) RNAi 14 72 14 14 2.9 
lin-15(n765) 0 0 100 20 5.3 
lin-15(n765) RNAi 33 67 0 12 2.5 
let-60(n1046); let-341(s1031) 41 52 7 54 2.7 
let-60( n1046); let-341( s1031) RNAi 39 52 9 23 2.6 
Vulval induction was scored at 20°C using Nomarski optics during the early-mid 
L4 stage. The complete genotypes for strains listed are: let-60(n1046)unc-31(e169) 
[for let-60(n1046)]; let-23(sa62); him-5(e1490) [for let-23(sa62)]; lin-15(n765) [for lin-
15(n765)]; let-60(n1046); let-341(s1031)unc46(e177) [for let-60(n1046); let-
341(s1031)] . Average vulval induction represents average number of VPCs 
undergoing vulval differentiation per animal; 3.0 is wild-type level. 
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Fig. 3. 
sos-1 RNAi affects male spicule development and hermaphrodite oocyte 
maturation. (A) Nomarski photomicrograph of a him-5(e1490) male shows a long 
and straight spicule, denoting by an arrow head. (B) A male progeny of him-
5(e1490) hermaphrodite injected with sos-1 dsRNA shows a short and crumpled 
spicule, denoting by an arrow head. (C,D) Fluorescence micrograph of wild-type 
(bottom left) and sos-1 RNAi-affected (bottom right) hermaphrodites stained 
with DAPI. Regions of pachytene nuclei are indicated by a white bar and nuclei 
in diakinesis by a semi-gray bar. Arrow indicates the first diakinesis nucleus seen 
in the sos-1 RNAi-affected hermaphrodite. All animals shown are in their young 





sos-1 RNAi-affected animals display the phenotypes associated with reduction-of-
function FGFR pathway mutants. All the animals were photographed at the same 
magnification. (A) Wild type (N2). (B) sos-1 RNAi-affected N2 animal, which 
confers a scrawny body morphology. (C) clr-1(e1745ts) mutants, which confer a 
temperature-sensitive Clr phenotype. The biological basis of the Clr phenotype is 
not understood but the abnormality appears to result from clear fluid 
accumulating in the pseudocoelom (Kokel et al., 1998). (D) sos-1 RNAi-affected 
clr-1(e1745ts) mutant, which confers a non-Clr phenotype. Animals shown in A 
and Bare young adults and were raised at 20°C. L4larvae shown inC and D 
were raised at 20°C and then switched to the nonpermissive temperature of 25°C 







let-341(s1031) is a putative null allele of sos-1. (A) The sequence of the let-
341(s1031) mutation. The upper panel shows the genomic sequence around the 
boundaries of exon 13-intron 13 and intron 13-exon 14. Exons are shown in 
uppercase lettering, introns in lowercase. The large downward-pointing arrow 
indicates the 5' location of the wild-type splice. The upward-pointing arrow 
indicates the 3' splice junction used. The lower panel shows the same 
information in the presence of the s1031 mutation. The mutation is indicated in 
bold and by carets. The 5' splice donors have shifted upstream. (B) RT-PCR 
analysis of wild-type and s1031 RNA. PCR amplification for 35 rounds of wild-
type and s1031 reverse-transcribed RNA was performed with primers up8 and 
dn18 (see Figure 1A). Lanes: 1, 1-kb ladder; 2, amplification of s1031 eDNA; 3, 
amplification of wild-type eDNA. Correctly spliced mRNA yields a product of 
678 bp (correct joining of exons 12-16). In s1031 animals, a 647 bp product results 
from usage of a upstream cryptic splice donor at nucleotide 119,792 of YAC 
Y61A9LA and removal of 31 bp from exon 13. Exon 13 skipping in s1031 animals 
results in a 543 bp product. A putative heteroduplex (het), expected to form from 




exon 13 t 
0 ooTCAACGGTACTCGCTGACGTTGGAGCCGACGATTCGAgttagt..o 
13,738 nt 
f exon 13 W 















• exon 14 
00 0 tttcagCAA TIC 
• exon 14 
00 0 tttcagCAA TIC 
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Table II. A sos-1-in dependent activation of ras signaling in the vulva 
Genotype %<3 %=3 %>3 Numbers of Average Vulval 
let-60 let-341 g_ae_-1 sem-5 gonad animals induction 
1. n1046 + + + + 0 15 85 20 
2.n1046 + + + 89 0 11 18 
3.n1046 s1031 + + + 41 52 7 54 
4. n1046 + + ay73 + 0 87 13 30 
5.n1046 s1031 + ay73 + 50 25 25 8 
6. n1046 s1031 + + 95 5 0 22 
7.n1046 s1031 n1691 + + 0 35 65 20 
8. n1046 s1031 n1691 + 54 15 31 13 
Vulval induction was scored at 20°C using Nomarski optics during the early-mid 
L4 stage.let-341(s1031) was marked with unc-46(e177). sem-5(ay73) is a putative 
null allele resulting in a Q10Stop (Clark et al., 1992a; M. Stem, personal 
communication). gap-1(n1691) corresponds to a Q149Stop which defines a 
putative null allele. The distributions generated from each genotype were 
en tered into the InStat program (GraphPad Software, version 2.0) and compared 
in pairs using the Mann-Whitney test to generate two-tailed P values. The 
differences result from the following comparisons are considered very 
significant. 2 versus 3, P value < 0.0001; 2 versus 4, P value < 0.0001; 2 versus 5, P 
= 0.0021; 3 versus 6, P value < 0.0001; 3 versus 7, P value < 0.0001; 7 versus 8, P = 










Table III. sli-1 regulates let-23 signaling upstream of ras, in a sos-1-dependent 
manner 
Genotype Average vulval Proportion of animals 
t!_tp-2 let-23 let-60 let-341 sli-1 induction with >3 cells induced 
1. + + n1046 + + 4.4* 17/20 
2. + sy17 n1046 + + 4.6 19/20 
3. + + n1046 + sy143 5.5* 20/ 20 
4. + + n1046 s1031 + 2.7 4/54 
5. + + n1046 s1031 sy143 2.9 1/ 20 
6.ot!_194 + n1046 s1031 + 3.0 2 / 20 
Vulval induction was scored at 20°C using Nomarski optics during the early-mid 
L4 stage. ptp-2(op194) and let-341(s1031) were marked with unc-4(e120) and unc-
46(e177), respectively. ptp-2(op194) is a putative null allele resulting in a genomic 
deletion of 1458 nucleotides (Gutch et al., 1998). sli-l(sy143) is also a putative null 
allele resulting in a Q152Stop (Yoon et al., 1995). *The difference of average 
vulval induction between let-60(n1046) and let-60(n1046); sli-l(sy143) mutants is 
highly significant (P = 0.0002) based on the Mann-Whitney test. The most 
significant difference occurs in the P8.p induction with 33% of P8.p induced for 
let-60(n1046) and 78% for let-60(n1046); sli-1(sy143). The differences result from 
the following comparisons are considered not significant. 4 versus 5, P value is 
0.1629; 4 versus 6, P = 0.1313. 
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Fig. 6. 
Models for EGFR, FGFR, and an unknown RTK pathways. The order of linear 
pathways was either determined by double mutants analyses or inferred from 
biochemical assays in other model systems. For example, the relationship 
between sem-5 Grb2 and let-341 Sosl was adapted from the previous molecular 
characterization of mammalian counterparts. Arrows indicate a positive effect 
and bars indicate a negative effect. For simplicity, only events upstream of RAS 
are presented. The dashed pathway X is insufficient to allow signaling in the 
absence of let-60 activity. The putative relationships between ptp-2 and target 
genes are yet to be defined. A, B and X are hypothetical receptor tyrosine kinase, 
adaptor and RasGEF, respectively. 
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SLI-1, a C. elegans homolog of the proto-oncogene product c-Cbl, is a negative 
regulator of LET-23-mediated vulval differentiation. Lack of SLI-1 activity can 
compensate for decreased function of the LET -23 EGFR, the SEM-5 adaptor but not the 
LET-60 RAS, suggesting that SLI-1 acts prior to RAS activation. SLI-1 and c-Cbl 
comprise anN-terminal region (termed SLI-1:N/Cbl-N containing a four helix bundle, 
an EF hand and a divergent SH2 domain) followed by a RING finger domain and a 
proline rich C-terminus. In a transgenic functional assay the proline rich C-terminal 
domain is not essential for sli-1(+) function. A protein lacking the SH2 and RING 
finger domains has no activity, but a chimeric protein with the SH2 and RING finger 
domains of SLI-1 replaced by the equivalent domains of c-Cbl has activity. The RING 
finger domain of c-Cbl has been recently shown to enhance ubiquitination of active 
RTKs by acting as an E3 ubiquitin-protein ligase. We find that the RING finger 
domain of SLI-1 is partially dispensable. Further, we identify an inhibitory tyrosine 
of LET-23 requiring sli-1(+) for its effects: removal of this tyrosine closely mimics 
loss of sli-1 but not of another negative regulator, ark-1. Thus we suggest that this 
inhibitory tyrosine mediates its effects through SLI-1, which in turn inhibits signaling 




Receptor tyrosine kinase (RTK)/Ras/MAPK signaling pathways are functionally 
conserved among metazoans in various aspects of cell growth and differentiation (Fantl 
et al., 1993; Schlessinger and Ullrich, 1992). As unregulated RTK signaling can promote 
abnormal cell growth or differentiation, precise control of both the duration and the 
level of RTK activation is important (Cantley et al., 1991; Rodrigues and Park, 1994) and 
thus it is crucial to understand the negative regulation of RTK signaling. 
RTK-mediated signal transduction is initiated by ligand binding, dimerization 
and subsequent autophosphorylation of cytoplasmic tyrosines within the C-terrninal of 
the receptor (Claesson-Welsh, 1994; Fantl et al., 1993; Ullrich and Schlessinger, 1990). 
Phosphotyrosine (pTyr) sites in activated RTKs recruit the Grb2/SEM-5/Drk adaptor 
protein (Clark et al., 1992; Lowenstein et al., 1992; Oliver et al., 1993; Simonet al., 1993). 
This adaptor protein is associated with the Sos guanine nucleotide exchange factor 
(GNEF) (Egan et al., 1993; Gale et al., 1993; Li et al., 1993). Once recruited to the 
membrane, Sos activates the membrane-bound Ras protein by enhancing the exchange 
of GTP for GDP (Aronheim et al., 1994; Gale et al., 1993; Li et al., 1993; Quilliam et al., 
1994; Rozakis-adcock et al., 1993; Simonet al., 1991). Activated Ras recruits the Raf 
serine/threonine kinase to the membrane where Raf is activated by unknown 
mechanisms (Campbell et al., 1998; Rommel and Hafen, 1998). Raf phosphorylates and 
activates MAPK kinase (MEK), which in turn phosphorylates and activates MAPK (Dent 
et al., 1992; Howe et al., 1992; Kyriakis et al., 1992; Tsuda et al., 1993), leading to diverse 
cellular responses. The development of the Caenorhabditis elegans vulva provides a 
readily accessible genetic system for the study of RTK signaling and regulation in vivo 
(Chang and Sternberg, 1999; Kornfeld, 1997; Sternberg and Han, 1998; Sundaram and 
Han, 1996). The wild-type vulva is derived from precisely three of six multipotential 
vulval precursor cells (VPCs) that generate vulval tissue when induced by the gonadal 
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anchor cell (Horvitz and Sternberg, 1991). The induced VPCs undergo three rounds of 
division and a characteristic morphogenesis to form the vulva. VPCs that do not 
receive adequate signal from the anchor cell divide only once and become part of the 
hyp7 syncytial epidermis. The LIN-3 protein has a single epidermal growth factor 
(EGF) domain and is produced by the anchor cell (Hill and Sternberg, 1992). LET-23, a 
homolog of the EGF receptor (EGFR) and likely receptor for LIN-3, is necessary for not 
only vulval differentiation but also other aspects of development (Aroian et al., 1990; 
Aroian and Sternberg, 1991; Chang et al., 1999; Clandinin et al., 1998; Jiang and 
Sternberg, 1998). LET-23 activation initiates a signaling cascade that involves SEM-5 
(Grb2), LET-341 S05-1 (Sos), LET-60 (Ras), LIN-45 (Raf), MEK-2 (MAPK/ERK Kinase), 
and MPK-1 (MAP Kinase) (Chang et al., 2000; Clark et al., 1992; Han et al., 1990; Han et 
al., 1993; Kornfeld et al., 1995; Lackner et al., 1994; Wu and Han, 1994; Wu et al., 1995). 
Reduction-of-function (rf) mutations in any of the signaling proteins in the LET-23 RTK 
pathway result in less than three VPCs undergoing vulval differentiation. In the most 
severe cases, the disruption of the LET-23-mediated signaling results in the complete 
failure to generate vulval tissue (vulvaless, or Vul, phenotype). In contrast, an 
abnormal increase in signaling due to activating mutations in the pathway or the 
removal of two or more negative regulators of the pathway causes the opposite effect 
in which greater than wild type numbers of VPCs differentiate into vulval tissue (multi-
vulva, or Muv, phenotype). 
The sli-1 locus was identified in a screen for suppressors of the Vul phenotype 
associated with let-23(rj) mutations (Jongeward et al. , 1995). sli-1 encodes proteins of 582 
and 540 amino acids that are similar to the mammalian proto-oncogene products c-Cbl, 
Cbl-b, and Cbl-3 (Keane et al. , 1999; Keane et al. , 1995; Langdon et al., 1989). SLI-1 and c-Cbl 
proteins are composed of an N-terminal region, followed by a RING finger domain and 
a proline rich C-terminus (see Figure 3). The N-terminal region (termed SLI-1:N/ Cbl-N) 
contains three interacting domains: a four helix bundle, an EF hand and a divergent SH2 
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domain (Meng et al., 1999). Genetic analysis has revealed that sli-1 is a negative regulator 
of those let-23 signaling functions that are mediated though RAS activation (Jongeward et 
al., 1995). Mice lacking c-Cbl have inappropriate ZAP-70 activity in T cells, indicating that 
c-Cbl plays a negative role in signaling (Murphy et al., 1998). Experiments performed in 
vitro suggest that c-Cbl directly controls down regulation of RTKs. This is dependent 
upon the SH2 domain which mediates binding to activated receptor followed by 
phosphorylation of c-Cbl at a site adjacent to the RING finger domain. The RING finger 
domain is then essential for the last step of catalyzing receptor ubquitination (Joazeiro et 
al., 1999; Levkowitz et al., 1999; Levkowitz et al., 1998). 
Here we show that c-Cbl and SLI-1 are functionally equivalent. Genetic analysis 
reveals that SLI-1 acts to negatively regulate EGFR signaling upstream of LET-60 RAS, 
either at the receptor or Grb2/SEM-5 step. We compare sli-1 function to that of other 
negative regulators of this pathway, gap-1 (Hajnal et al. , 1997) and ark-1 (Hopper et al., 
2000). We provide evidence that SLI-1 inhibition is partly mediated through an 
inhibitory tyrosine in the carboxy terminus of the LET-23 EGFR and, in contrast to the 
ubiquitin ligase activity, this inhibition is not wholly dependent upon the RING finger of 
SLI-1. 
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MATERIALS AND METHODS 
Strain construction and maintenance 
Strains were maintained at 20°C and handled according to Brenner (1974). The 
following alleles were used for strain construction: for LGI, unc-38(x20); LGII, dpy-
10(e128), let-23(syl, sy97), unc-4(e120), clr-1(e1745); for LGIV, unc-24(e138), dpy-
20(e1282), ark-1(sy247), let-60(sy127, n1876, n2021, n2022, n2034, n2035) (Beitel et al. 1990; 
Han et al. 1990); for LGX, sli-1(sy143), sem-5(n1619, ay73),gap-1(n1691), unc-2(e55) 
(Clark et al. 1992a; M. Stern, personal communication). szT1 is a reciprocal I;X 
translocation used as a balancer for sem-5 (Fodor and Deak 1985). DnT1 is a reciprocal 
IV; V translocation used as a balancer for let-60 (Ferguson and Horvitz 1985). sDfB is a 
small deficiency in LGIV which uncovers let-60 (Rogalski et al. 1982). 
sli-1 sem-5 double mutants were constructed in the following manner: For sli-1 
sem-5(n1619), N2 males were mated into unc-4; sli-1 hermaphrodites. Non-Unc male 
progeny were selected and mated into clr-1(e1745); sem-5(n1619) hermaphrodites. non-
Egl (egg laying positive) healthy progeny were picked singly on to individual plates and 
checked for non-Clr Unc Egl progeny. These non-Clr Unc Egl progeny were again 
picked singly on to individual plates. If sli-1 suppressed sem-5, then only those 
recombinants of the genotype unc-4; sli-1 sem-5(n1619)/+ sem-5(n1619) would survive to 
give F2 progeny as sem-5(n1619) homozygotes do not propagate beyond F1 from 
heterozygous mothers. Otherwise, no Unc Egl progeny would survive (except the 
small number of cases where there was a clr-1 unc-4 recombinant chromosome; these 
were selected against by checking for the lack of a Clr phenotype). unc-4 was removed 
from sli-1 sem-5(n1619) by mating N2 males and selecting non-Unc F1 progeny. Non-
Unc, sickly, slow-growing progeny were individually isolated in F2 and again in F3 and 
checked for non-Unc F4 progeny. For the construction of sli-1 sem-5(ay73), N2 males 
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were mated into sli-1 hermaphrodites. Resulting male progeny were mated into unc-
38(x20)/szT1; sem-5(ay73)/szT1 hermaphrodites. Many healthy progeny were picked 
singly on to individual plates from this cross. F2 notch-heads (an indication of the 
presence of sli-1 were then picked singly from only those Fl plates which did not 
segregate phenotypically long males (szT1 segregates lon-2 males) . The notch-head F2's 
could be categorized into three classes depending on their F3 progeny. The first class 
yielded only healthy progeny (F2 homozygous for sli-1. The second class yielded 
healthy progeny, no dead larvae, no dead eggs, and many Egl animals with dead larvae 
or dead eggs inside (sli-1 almost completely suppresses the Fllethality caused by sem-
5(ay73) mutation). These F2s were likely to be sli-1 sem-5(ay73)/sli-1 +recombinants. 
The third class produced no progeny and were Egl by themselves. This final class of F2s 
were sli-1 sem-5(ay73). Since sli-1 sem-5(ay73) strain can not be maintained as 
homozygotes, szTl was used to balance sli-1 sem-5(ay73). The presence of sli-1 
mutation in Egl animals was further confirmed by sequencing. 
To construct sli-1 gap-1 double mutants, sli-1 males were mated into gap-1 unc-2 
hermaphrodites. Non-Unc cross progeny were individually isolated and checked for 
Unc progeny. These Unc progeny were then picked singly. Only those recombinants 
of the genotype sli-1 gap-1 unc-2/ + gap-1 unc-2 can segregate Muv progeny if sli-1 and 
gap-1 synergize to confer the excessive vulval differentiation. On rare plates, Muv 
progeny were observed and picked singly in the next generation. In their progeny, the 
low penetrance of notch-head phenotype was used to confirm the presence of sli-1 
mutation. 
The let-60; sli-1 strains were constructed as follows: N2 males were mated into 
unc-24(e138) let-60(rf or null)/DnT1; +/DnT1 strains. let-60(rj) alleles used were 
mentioned above. Non-Unc cross progeny males were selected and mated into dpy-20; 
sli-1 hermaphrodites. Non-Dpy cross progeny males were then picked and mated into 
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dpy-20; sli-1. Non-Dpy hermaphrodites were then picked singly. From those Fl plates 
that yielded Unc progeny, Unc non-Dpy and non-Unc non-Dpy progeny were 
individually isolated. Since sli-1 did not suppress let-60 lethality, non-recombinant Unc 
non-Dpy progeny did not survive past Fl. The strains were maintained as nbn-Unc 
non-Dpy heterozygotes of the following genotype: unc-24(e138) let-60(rf or null)+!++ 
dpy-20; sli-1. F1 Unc non-Dpy progeny were then picked singly and scored for vulval 
differentiation. Each scored worm was recovered from the slide and allowed to 
propagate to check for F2 progeny. Vulval differentiation scores from those that gave 
viable F2 progeny yielding a proportion of Dpy animals were discarded as they 
represented recombinants that were not homozygous for let-60 . 
To construct the hetero-allelic series, the strain dpy-10(e128); unc-34(e138) let-
60(n2021)/DnT1; +/DnT1 was made by standard methods. let-60(n2021) is a weak 
reduction of function allele. To generate the various hetero-allelic worms, N2 males 
were mated into the unc-24(e138) let-60(rf or null)/DnT1; +/DnT1 strains carrying the 
different severe let-60 mutations. Non-Unc cross progeny males were selected and 
mated into the dpy-10(e128); unc-34(e138) let-60(n2021)/DnT1; +/DnT1 strain. Unc-24, 
non-Dpy, non-DnT1 F1 hermaphrodites from these crosses were scored for vulval 
differentiation. Scored worms were recovered and their progeny were checked to 
ensure that let-60(rf or null) remained homozygous. 
Other strains were constructed following standard methods. 
An in vivo transgenic assay for the activity of sli-1 minigenes 
To establish a system in which to study the relationship between SLI-1 structure and its 
function, we constructed sli-1 eDNA minigene constructs driven by the heat shock 
promoter hsp16-41 (Mello and Fire, 1995; Stringham et al., 1992). To facilitate 
expression, an artificial intron is present between the promoter and the eDNA insert. 
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Heat shock promoters were used in these experiments because initial tests using 
genomic sequences 5' to the start codon of sli-1 fused to the full-length sli-1 eDNA failed 
to confer significant wild-type SLI-1(+) activity in the vulva (data not shown), 
presumably because sequences present within the introns of sli-1 are necessary for 
expression. 
Germline transformation was performed according to the methods of Mello et al. 
(1991). Heat shock constructs were injected at 50 ng/pl along with 150 ng/pl of SK+ 
plasmid and 15 ng/}11 ofpMH86 (dpy-20(+) marker) into the germline of let-23(syl); dpy-
20; sli-1 animals. Independent non-Dpy transformant lines were maintained and 
selected for transgene stability. F3 stable transgenic progeny were selected for egg-lay 
cohorts and heat shock analysis. For the egg-lay cohorts, we selected only those 
worms with a egg-laying rate similar to that of wild-type hermaphrodites(::: 5-10 eggs 
laid per worm per hour). 
Thirty egg laying young hermaphrodites were moved onto fresh agar plates, ten 
worms per plate. These were then allowed to lay eggs on given plates for one hour 
before being moved to fresh plates. The hourly transfer of worms was continued for 
six consecutive hours and the egg-laying hermaphrodites were then removed from the 
plates. The plates were maintained at 20 oc during and after establishment of egg 
cohorts. 36 hours after the hermaphrodites' removal from the final cohort of eggs, the 
plates were heat shocked for 30 minutes at 33 oc. We thus generated worms 
synchronized in age into hourly cohorts that had been heat shocked between 36 and 42 
hours after egg lay. This interval encompasses the early L3 stage during which vulval 
induction occurs in the transgenic animals. The heat shocked plates were returned to 20 
oc for 18 to 24 hours following heat shock. 
Vulval differentiation was scored in non-Dpy progeny at early to mid L4 stages. 
A minimum of two independent lines were scored per heat shock construct. 15 to 30 
worms were scored per one hour time interval per stable line following heat shock. The 
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distributions generated from each heat shock construct (as seen in the histograms of 
Figure 4B) were entered into the InStat program (GraphPad Software, version 2.0) and 
compared in pairs using the Mann-Whitney test to generate two-tailed P values. There 
is -2 cell range in the average induction levels between the no insert control and the 
full-length sli-1 eDNA construct. This range allows comparisons of the various 
induction levels in different minigene constructs. In the structure-function experiments, 
SLI-1activity is inferred in those minigene constructs that lower average vulval 
differentiation to significantly below 2.5 vulval cells/ worm. 
sli-1 minigenes and mutagenized let-23 constructs 
Standard molecular biological techniques were used as described by Sambrook et al. 
(1989). Site directed in vitro mutagenesis was carried out in double stranded DNA 
according to the method prescribed by Deng and Nickoloff (1992) and with reagents 
and specific protocols from Clonetech (Palo Alto, CA). The mutagenesis was carried 
out in the plasmid pCY-D6, a pSK+ vector containing the full-length sli-1 eDNA inserted 
into the EcoRI site. A selection primer which changed the novel Notl site in the vector 
to an Nhel site was used in conjuction with mutagenic primers which mutated or 
removed sequences of varying length within the sli-1 coding region. Mutagenized sli-1 
eDNA was then digested with Spel/EcoRV and inserted into the Nhel/EcoRV sites of 
the pPD49.83 and pPD.49.78 nematode heat shock minigene vectors. Mutagenesis was 
confirmed by restriction mapping and by sequencing. The deletion constructs SLI-
1.~N~G~C, SLI-l.~C, SLI-l.~~RING, SLI-l.~ro2, and SLI-l.~ro3 replace the 
deleted sequences with an Nhel site which codes for alanine and serine in frame with 
the remainder of the sli-1 construct. Primers used for in vitro mutagenesis of the sli-1 
eDNA are as follows: SKNotNhe; Del-NC(Nhe); Del-C(Nhe); Del-N(Nhe); Altspli; Del-
PR02(Nhe); Del-PR03(Nhe); Del-RING. 
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For the deletion of the putative myristylation site, we utilized a selection primer 
which changed a unique Xhol site into a Clal site in the various rnutagenized sli-1 
cDNAs. Primers used were SKXhoCla and Del-MYRl. The cloning into heat shock 
vectors followed identical procedures as above. 
The conserved N-terminal domain of human c-Cbl was PCR amplified from the 
eDNA in a pUC vector (provided by W. Langdon) using the primers hCbl-NlA(Nhe) 
and hCbl-N2R(Nhe). The ends of the amplification primers contained in-frame Nhel 
sites. The amplified conserved N-terminal fragment of c-Cbl was then purified, 
digested and ligated into the Nhel site of the SLI-l.~N construct in pPD49.83. The 
directionality of the insert was checked by restriction digests and the sequence of the 
amplified c-Cbl fragment was verified by DNA sequencing. DNA sequencing was 
carried out on automated sequencers (Applied Biosystems) by the Caltech DNA 
Sequencing Facility. 
All the systematically mutagenized let-23 constructs were made as described by 
Lesa and Sternberg (1997). Engineered let-23 constructs were injected into the germline 
of let-23(sy17)unc-4/mnc1; dpy-20; sli-1 or let-23(sy17)unc-4/mnc1; dpy-20 ark-1 mothers; 
the Unc-4, non-Dpy stable transformed progeny (F2 or later generation) were tested 
for effects in vulval differentiation. 
Primer designations 
Primer names and their corresponding sequences used during in vitro mutagenesis are 
as follows: 
SKNotNhe:5' - ACCGCGGTGGCTAGCGCTCTAGAAC 
Del -NC(Nh e) :5'- GCCCGGTTTCTGCAGTGAAGAGGCTAGCTAGACTTGTGTAAATGTTCATCTTACC 
Del-C(Nhe) :5'- GTGTGATTATTGACAGGTTCAAGCCCGCTAGCTAGACTTGTGTAAATGTTCATCTTACCG 
Del-N(Nhe) :5'- GATGCCCGGTTTCTGCAGTGAAGAGGCTAGCACTCCGGTAGAAATTGAAAAAGCG 
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Altspli:5'- CCCGACGTGCCTCCCAGAACGTCGTCACAAACATCCTCTTCATACG 
Del-PR02(Nhe) :5'- CTCAATTCCGTCGGTCGACGAGGCTAGCGCATTGGGTACCCTGGACAC 
Del-PR03(Nhe) :5'- GGCACAAGTGGTAAACCGGCAACGGGCTAGCTCAGCGAGCGAGCACCAACCACACC 
DEL-RING :5'- TTGTGAGATGGGCACAACATTCGAGTACGAAATCAAAGGAACAAATCGTGT 
SKXhoCla:5 '- ACCGTCGACATCGATGGGGGGCCCG 
Del-MYR1:5'- GTTTCACCGGGAATGGCTAGCATAAACACAATTTTTC 
hCbl-N2R( Nhe) :5' - GCCACTGCTAGCAGGATCAAACGGATCTACCAC 
hCbl-NlA(Nhe) :5'- CCGCCGGGGGCTAGCGACAAGAAGATGGTGGAG 
Microscopy 
The extent of vulval differentiation was measured by examining vulval anatomy in 
early to mid L4 stage animals (Sulston and Horvitz 1977; Stemberg and Horvitz 1986). 
Hermaphrodites were placed on 5 % Noble Agar pads and scored with a Plan 100x 
objective, Nomarski differential interference-contrast optics. 1 o and 2° vulval fates were 
scored as vulval cells. Wild-type=3 VPCs undergoing vulval differentiation/worm=100 
% vulval differentiation. 
RESULTS 
sli-l(lft suppresses a severe reduction of function allele but not a null allele of sem-5 
Mutations in sem-5 result in a partial or complete lack of a vulva. sem-5 encodes 
an SH3-SH2-SH3 domain containing Grb2 homolog that is required to transduce the 
signal from LET-23 to LET-60 Ras (Clark et al., 1992; Clark et al., 1992; Katz et al., 1996; 
Lesa and Sternberg, 1997; Stern et al., 1993). sem-5(ay73) is an early missense mutation, 
Q10amber (Qat codon 10 mutated into amber stop), that removes all of the functional 
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domains of the SEM-5 protein and is therefore a putative null allele (M. Stern, personal 
communication). Animals homozygous for ay73 are inviable in the F2 generation, with 
F1 escapers (due to maternal rescue) being completely vulvaless (Table 1). The sem-
5(n1619) allele generates a P49L substitution which most likely results in a non-
functional N-terminal SH3 domain (Clark et al., 1992). Animals homozygous for n1619 
are also inviable in the F2 and viable F1 animals have, on average, only 0.4 vulval cells 
induced/ animal. In wild-type animals 3 cells are invariably induced to form the vulva. 
We constructed sli-1 sem-5 double mutants using the sli-1 reference allele, sy143. 
The molecular lesion associated with sy143 is Q152amber, which removes the carboxyl-
terminal 75% of the SLI-1 protein. In addition, it is the most severe allele and likely 
generates a non-functional product (Jongeward et al., 1995; Yoon et al., 1995). sli-1 
strongly suppresses the vulval defect in sem-5(n1619) mutants: sli-1 sem-5(n1619) have 
near wild-type levels of vulval differentiation (average 3.0 vulval cells/worm; not all 
animals have wild type level of vulval induction; Table 1, Figure 2d). The lethality of the 
sem-5(n1619) allele is also partially suppressed: double mutants can be maintained as 
homozygotes. In contrast, sli-1 does not suppress the sem-5(ay73) null allele: sli-1 sem-
5(ay73) double mutants are Vul when scored as F1 homozygotes and can not be 
maintained as homozygotes beyond F2 from heterozygous mothers (Table 1, Figure 
2f). However, there is increased survival of sli-1 sem-5(ay73) F1 homozygotes from 
heterozygous mothers in comparison to sem-5(ay73) single mutant F1 homozygotes. 
Thus, mutations in sli-1 can enhance maternal rescue of lethality associated with sem-5, 
consistent with the absence of sli-1 compensating for a reduction in sem-5 activity. 
sli-l(lj) does not suppress severe reduction of function alleles of let-60 
We tested three let-60 alleles for suppression by sli-1. These let-60 alleles, n1876 
(Ala66Thr), n2034 (Ala66Thr) and n2035 (Ala66Val), are described by Beitel et al. (1990); 
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corresponding mutations have been made in Ha-Ras and shown to interfere with 
exchange factor interaction (Boriack-Sjodin et al., 1998; Howe and Marshall, 1993). We 
find that sli-1 fails to suppress the vulvaless phenotype of these alleles (Table 1). In 
addition, sli-1 also fails to suppress the lethality associated with these three let-60 alleles. 
However, as in the case with sem-5(ay73), there is an increase in F1 homozygote 
survival from let-60(rj)/+ heterozygous parents in a sli-1 background, indicating 
enhanced maternal rescue of lethality (data not shown). 
sli-1 fails to suppress null alleles of let-23 and sem-5 while it strongly suppresses 
severe reduction of function alleles of let-23 and sem-5 Oongeward et al., 1995; this 
report). It was therefore crucial to determine whether the tested let-60 alleles, n1876, 
n2034 and n2035, were non-null alleles. To distinguish between severe non-null alleles 
and nulllet-60 alleles, we measured the extent of vulval differentiation in a series of F1 
trans-hetero-allelic animals using a weak reduction of function let-60 allele (n2021), in 
trans to the three let-60 alleles (n1876, n2034 and n2035), as well as a putative let-60 null 
allele (sy127) and sDJB, a deficiency which uncovers the let-60 locus as controls. let-
60(n2021) is also an exchange factor defective mutant (G75S) (Howe and Marshall, 
1993).lf n1876, n2034 and n2035 are non-null mutations then in trans to let-60(n2021) 
should be less severe than let-60(null)/let-60(n2021) heterozygote controls in a vulval 
induction assay. In these experiments, n2035 and n1876 had significantly more activity 
than the sy127 null allele and the sDJB deficiency in the vulva (1.6 and 1.4 cells versus 0.8 
and 0.6 cells being induced on average (n>22)). Therefore, n1876 and n2035 are likely to 
be reduction of function alleles. Thus, sli-1(rj) fails to suppress non-nulllet-60(rj) 
mutations in the vulva. Since lack of sli-1 activity can compensate for decreased function 
of let-23 and sem-5, but not let-60, we conclude that SLI-1 acts upstream of RAS 
activation. 
Mutations in sli-1 give a Muv phenotype in a gap-1 mutant background 
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GAP-1 is a negative regulator of vulval signaling that likely acts at the level of LET-60 
Ras (Hajnal et al., 1997). A gap-1(lj) reference allele suppresses the Vul phenotype of let-
60(n1876) while only weakly suppressing the sem-5(n2019) mutation (Hajnal et al., 
1997). As in the case with sli-1 single mutants, gap-1 mutations by themselves are silent. 
We constructed sli-1 gap-1 double mutants. This strain has a partially penetrant 
Muv phenotype, with 7 of 24 observed double mutants exhibiting an excessive vulval 
induction (Table 1). gap-1 corresponds to a Q149ochre nonsense mutation which results 
in early truncation and presumably defines a null allele (Hajnal et al., 1997). The 
simplest interpretation of this result is that SLI-1 and GAP-1 have, at least partially, 
distinct activities. 
The conserved N-terminal region and RING finger domain rather than the proline-rich 
C-terminal region is sufficient for the inhibitory function of SLI-1 
We established an in vivo transgenic assay for the activity of sli-1 minigenes being 
expressed from the hsp16-41 heat-shock promoter in the genetic background of let-
23(sy1); sli-1 (see methods). The vulvaless phenotype of let-23(syl) animals is strongly 
suppressed by sli-1 (see table 1). In control transgenic animals of genotype let-23(syl); 
dpy-20; sli-1; syEx[dpy-20( + ); hsp16-41], heat-shocked at the time of vulval induction, the 
average vulval induction is 2.5 cells/ worm (Figure 4). Under the same experimental 
conditions and genetic background, the full-length sli-1 eDNA driven by the hsp16-41 
promoter confers full SLI-1(+) activity with animals having on average 0.5 VPCs 
executing a vulval fate per worm (henceforth referred to as vulval cells/ worm; Figure 
4). This is a full2 cells lower than the vulval induction seen in the no insert control and 
is comparable to the levels of vulval differentiation seen in let-23(syl) single mutants in 
a non-Dpy-20 germline transformed background (0.3 vulval cells/worm) (Yoon et al., 
1995). 
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In this transgenic assay, SLI-1 proteins lacking either the second or third proline 
rich domain retained full activity (average induction 0.7 and 0.3 vulval cells/ animal; 
P=0.14 and 0.39 respectively). Likewise, expression of the alternatively spliced sli-1 
eDNA which deletes the lOth exon of the genomic sequence has activity similar to that 
of full length SLI-1 (average 0.9 vulval cells/worm; P=0.05; Figure 4A). Moreover, we 
found that expression of a SLI-1 protein truncated after residue 447 and thus lacking the 
entire proline-rich C-terminal domains also retains significant SLI-1(+) activity (average 
1.0 vulval cells/worm; P<O.OOOl versus no insert control; Figure 4A, B). However, this 
level of activity is also significantly weaker than that of the full-length sli-1 eDNA 
(P=0.0002). To test whether proline-rich C-terrninal domains are partially sufficient for 
SLI-1 function, a sli-1 construct lacking the N-terrninal region and RING finger domain 
(deleting residues 58 to 447) was tested; it does not have SLI-1(+) activity under identical 
assay conditions (vulval induction levels similar to the no insert control, P=0.8; Figure 
4A, B). 
Consensus myristylation site is not required for SLI-1(+) activity 
In the conceptual translation of SLI-1, the initiator methionine is followed in sequence 
by Gly-Ser-Ile-Asn-Thr, a myristylation site (reviewed by Resh 1994). Myristylation 
may play a role in localizing proteins to the cell membrane, usually in combination with 
other lipid modifications or nearby basic residues (Resh, 1994). Using site directed 
mutagenesis, we substituted the second codon glycine with alanine (G2A substitution); 
alanine should maintain the charge neutral hydrophobic character of glycine but 
prevent the covalent addition of myristate at the second codon. Constructs expressing 
the full-length and truncated SLI-1 proteins with G2A substitutions do not have less 
activity than control constructs (Figure 4A; P>0.2). In addition, the SLI-1 construct that 
lacks the N-terrninal conserved SH2 and RING finger domains has no activity in the 
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vulva after the G2A substitution (Figure 4A). As mentioned previously, the first -50 
amino acid residues of c-Cbl are highly divergent in sequence from those of SLI-1 and 
the consensus myristylation sequence is conserved neither in c-Cbl, Cbl-b or Cbl-3. 
The conserved N-terminal region of c-Cbl containing the SH2 and RING finger 
domains can functionally replace that of SLI-1 
The human c-Cbl protein is 906 amino acid residues in length. The -400 amino acid 
stretch of high sequence similarity (-55 % identity) between c-Cbl and SLI-1 begins after 
a stretch of -50 N-terminal residues in the two proteins (Figure 3). This region contains 
the SH2 and RING finger domains strongly implicated in Cbl function Goazeiro et al., 
1999; Levkowitz et al., 1999). The N -terminal45 and 58 residues of c-Cbl and SLI-1, 
respectively, are highly divergent in sequence. Furthermore, although both proteins 
have several putative SH3-binding polyproline motifs in their respective C-terminal 
domains, the amino acid sequence following residue 447 in SLI-1 and residue 437 in c-
Cbl are also largely divergent. 
To test for the functional similarity between the conserved domains of SLI-1 and 
c-Cbl, we constructed a chimeric sli-1/c-cbl eDNA by replacing the coding sequence of 
SLI-1's N-terminal region and RING finger domain (residues 58 to 447) with that of c-
Cbl (residues 45 to 437). We find that this c-Cbl/SLI-1 chimeric construct driven by the 
hsp16-41 promoter exhibits partial SLI-1(+) activity (1.5 vulval cells/ worm; P<0.0001 
versus both no insert control and the full-length sli-1 eDNA; Figure 4A, B). As a control, 
a sli-1 construct lacking the N-terminal region and RING finger domain (deleting 
residues 58 to 447) was tested; it was shown not to have SLI-1(+) activity under identical 
assay conditions (vulval induction levels similar to the no insert control, P=0.8; Figure 
4A, B). However, the full-length c-Cbl eDNA driven by the hsp16-41 promoter does not 
have SLI-1(+) activity in the vulva (data not shown). 
C-18 
A SLI-1 protein lacking the RING finger domain retains some activity 
Both sli-1 and c-Cbl function as negative regulators of signaling. c-Cbl has recently been 
shown to have a ubiquitin ligase activity that is proposed to explain the negative 
regulation of RTKs signaling observed (Joazeiro et al., 1999; Levkowitz et al., 1999). 
Thus, the SH2 domain presumably mediates binding to activated receptor, and the 
RING finger domain then catalyzes receptor ubiquitination. The SH2 and RING finger 
domains of c-Cbl share 55% identity with those of SLI-1 and can functionally replace 
them in our transgenic assay. We sought to test whether the RING finger domain of 
SLI-1 was essential for activity. We found that significant SLI-1(+) activity is observed in 
constructs lacking the RING finger (average 1.5 vulval cells/worm; P<0.0001 versus no 
insert control; Figure 4A, B). However, in comparison to the full length eDNA, the 
RING deletion significantly reduces the SLI-1(+) activity (P<0.0001). Thus, although the 
RING finger domain is important for SLI-1 activity, a ubiquitin ligase function for SLI-1 
is not the sole inhibitory function of sli-1. 
pYKTEP defines an inhibitory site in the C-terminal tail of LET-23, mediating the 
negative effect of SLI-1 
We next explored the possibility that SLI-1 exerts its inhibitory effect by direct or 
indirect binding to specific pTyr sites in LET-23. The let-23(sy97) mutation deletes the last 
56 amino acids of the receptor which include the only three tyrosines (pTyr site 6, 7 and 
8) in the receptor carboxy terminal tail which, if phosphorylated, would create SH2 
binding sites matching the consensus binding site for the SEM-5 SH2 domain. sli-l (lj) 
strongly suppresses let-23(sy97) which suggests that pTyr site 1 through pTyr site 5 
could mediate, directly or indirectly, negative regulation of let-23 signaling by sli-1 
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under the above hypothesis. We introduced engineered let-23 constructs, with certain 
codons specifying LET-23 carboxy-terminal tyrosine residues mutated to phenylalanine 
codons, into nematodes with a let-23(null) background with or without a sli-1 or ark-1 
mutation and assayed their activity by scoring transgenic animals for vulval 
differentiation. Our results suggest that SLI-1 function is dependent upon LET-23 
carboxy-terminal tyrosine residues. Particularly, we observed that the inhibition of 
signaling by the presence of pTyr2 could be overcome by mutations in sli-1 (Table 2). 
We therefore sought to determine whether the absence of this site would synergize 
with mutations in genes known to negatively regulate let-23 signaling. We did not 
observe any synergy between let-23(null); syEx[LET-23 (Y2-)] and sli-1. However, we 
observed that let-23(null); syEx[LET-23 (Y2-)] did synergize with ark-1 resulting in 34% 
of animals having greater than wild-type levels of vulval induction (Table 2). This 
synergy was not observed in ark-1 animals over-expressing an intact LET-23 construct 
(table2). ark-1 was isolated as an enhancer of sli-1 and encodes a non-receptor tyrosine 
kinase related to Ack that inhibits LET-23 signaling (Hopper et al., 2000). 40% of ark-1; 
sli-1 double mutant animals have a hyperinduced vulval phenotype with the extra 
induction usually being in P4.p (Table 3). This phenotype is distinct from ark-1; gap-1 
double mutant animals which have a higher penetrance of extra induction, usually as a 
consequence of P8.p induction (Table 3). It is striking that the hyperinduced vulval 
phenotype of let-23(null); ark-1; syEx[LET-23 (Y2-)] is nearly identical to that seen in ark-
1; sli-1 animals, both in penetrance and frequency of P4.p induction versus P8.p 
induction (Table 3).Together, this lead us to conclude that pTyr 2 (pYKTEP) mediates its 
effects through sli-1 . This conclusion is strengthened by a recent solved crystallographic 
structure of c-Cbl complexed to a tyrosine-phosphorylated inhibitory site of protein 
tyrosine kinase ZAP-70 (Meng et al., 1999). The interaction is mediated by a divergent 
SH2 domain of c-Cbl, which is conserved in SLI-1, and a phosphotyrosine of ZAP-70, 
which is in a similar amino acid context to the one in LET-23 we identified (pY:XXEP 
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versus pYKTEP; XX represents pY+1 and pY+2 residues which are not in the interface of 
the binding complex). 
DISCUSSION 
The sli-1locus was originally defined by mutations that suppress partially defective 
LET-23, a C. elegans homolog of EGF-receptor subfamily tyrosine kinases (Jongeward et 
al., 1995). The overall sequence of SLI-1 resembles that of the mammalian proto-
oncoprotein c-Cbl and related proteins (Cbl-b and Cbl-3). In this study we have found 
that: 1} Mutations in SLI-1 suppress reduction-of-function mutations in SEM-5 but not 
LET-60 RAS mutations that likely interfere with exchange factor interaction. 2} 
Mutations in SLI-1 do not bypass the requirement for SEM-5: a sem-5 null allele is not 
suppressed by sli-1. 3} The SLI-1 N-terrninal region and RING finger domain is 
sufficient to confer partial wild-type SLI-1 activity in the vulva. 4) The conserved N-
terrninal region and RING finger domain in c-Cbl can substitute for that of SLI-1 such 
that a chimeric protein can negatively regulate vulval differentiation. 5) The ubiquitin 
ligase domain of SLI-1 is not absolutely required for negative regulation by SLI-1. 
Our genetic analyses led us to believe that SLI-1 inhibits signaling between LET-
23 and RAS for the following reasons. Reduced activity of SLI-1 can increase vulval 
signaling in a sem-5(rj) background: sli-1, the reference allele, strongly suppresses the 
vulvaless phenotype of non-null sem-5 reduction of function alleles (Jongeward et al., 
1995); (this report). However, we have also shown that sli-1 does not suppress a sem-5 
null allele. Thus, SEM-5 activity is essential for RTK-mediated vulval signaling with or 
without the presence of wild-type SLI-1. We conclude that SLI-1 is a negative regulator 
of SEM-5-dependent signaling following LET-23 activation. In contrast, severe 
reduction of LET-60 Ras activity is not compensated for by the absence of SLI-1. We 
thus infer that SLI-1 affects vulval signaling upstream of LET-60 Ras. Furthermore, the 
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Muv phenotype of sli-1 gap-1 double mutant animals indicates that SLI-1 and GAP-1 
define, at least partly, independent pathways. Recently, another GAP gene, gap-2, has 
been identified in C. elegans (Hayashizaki et al., 1998); however, mutations of gap-2 do 
not suppress the vulvaless phenotype of let-23 mutations (Hayashizaki et al., 1998); (C. 
Chang, unpublished observations). gap-1 and gap-2 are the only RasGAPs found in C. 
elegans by genome-wide blast search. 
Results from our SLI-1 I c-Cbl chimeric construct indicate that theN-terminal 
region and RING finger domains of SLI-1 and c-Cbl are functionally conserved with 
respect to vulval signaling. Our structure-function studies show that the conserved N-
terminal region and RING finger domain of SLI-1 are necessary and almost sufficient 
for negative regulatory activity in LET-23-mediated signal transduction. That theN-
terminal region and RING finger domain may have a conserved regulatory function in 
RTK signaling is supported by two lines of evidence from elsewhere: 1) Identification 
of a Drosophila c-cbl homolog (Drosophila-Cbl; or D-Cbl) revealed that the D-Cbl product 
shares the conserved N-terminal domain with c-Cbl and SLI-1 (Hime et al., 1997; 
Meisner et al., 1997). As in the alignment of SLI-1 and c-Cbl, the sequence similarity of 
D-Cbl begins after a stretch of divergent N-terminal residues that are different from 
both c-Cbl and SLI-1. However, unlike SLI-1 and c-Cbl, the D-Cbl sequence ends 
shortly C-terminal to the RING finger motif and contains no polyproline motifs. As 
expected from the lack of poly-proline motifs, D-Cbl does not bind Drk, the Drosophila 
homolog of SEM-5/Grb2 adaptor (Hime et al., 1997; Meisner et al., 1997). Furthermore, 
both reports show that D-Cbl associates with the Drosophila EGF receptor in an 
activation-dependent manner. Finally, Meisner et al. (1997) show that the expression of 
D-Cbl under the sevenless enhancer in Drosophila negatively regulates R7 photoreceptor 
development. These results suggest that the conserved N-terminal domains of SLI-1 
and D-Cbl play analogous roles and that these domains are sufficient for the negative 
regulation of the LET-23 and Drosophila Sevenless pathways. 2) It was previously 
C-22 
shown that introduction of a hypomorphic Gly to Glu missense mutation found in SLI-
1's N-terminal domain (Yoon et al., 1995) can abolish c-Cbl binding to ZAP-70 and 
EGFR and ablate the transforming function of v-Cbl (Lupher et al., 1996; Thien and 
Langdon, 1997). Thus, identical mutations in a conserved residue in the N-terminal 
domains disrupts function in both SLI-1 and c-Cbl, suggesting structural and functional 
conservation. 
It is unclear why the full length c-Cbl construct does not have SLI-1(+) function in 
our assays despite the fact that the conserved N-terminal domain of c-Cbl can 
functionally replace the corresponding domain in SLI-1 in a chimeric construct. Several 
explanations are possible. One reason may be that the size of c-Cbl's C-terminal 
domain prevents sterically an effective association with the cytoplasmic portion of the 
LET-23 protein: the C-terminal domain of c-Cbl is three times the mass of that of SLI-1. 
Or, the nematode translational machinery does not properly recognize the initiator 
methionine of c-Cbl, therefore preventing effective expression. A third possibility is 
that the highly divergent stretch of residues N-terminal to the conserved domains could 
serve important species-specific functions. 
The C-terminal polyproline motifs, though not essential for SLI-1 function, are 
necessary for the full wild-type negative regulatory activity: the SLI-1:N+RING finger 
protein is significantly less effective than the full length SLI-1 (39% Vul for the SLI-
1:N+RING finger protein vs. 74% Vul for full-length SLI-1, Figure 4B; P=0.0002). This 
effect may simply be caused by a reduction in protein stability due to early truncation. 
However, we have found that the polyproline rich C-terminus of SLI-1 can interact with 
SEM-5 in a yeast 2 hybrid assay (in this study and Walhout et al., 2000). This raises 
another possibility for the function of the C-terminal polyproline motifs: SEM-5, or a 
similar adaptor, may bind to SLI-1 and increase the efficacy of SLI-1localization to the 
RTK complex, due to the binding of the adaptor to the receptor pTyr sites. In 
mammalian cells, c-Cbl's C-terminal polyproline domains have been shown to bind 
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adaptors such as Grb2 and Nck via PPII helix-SH3 interactions (Clements et al., 1999; 
Donovan et al., 1996; Meisner and Czech, 1995; Rivero-Lezcano et al., 1994). 
Furthermore, it has been shown that Grb2 can mediate an indirect association between 
c-Cbl and EGFR (Meisner and Czech, 1995). In a similar manner, the SLI-1's C-terminal 
polyproline domains may bind to SH3 domains of adaptor proteins which in turn 
enhance the localization of SLI-1's N-terminal domain to the activated LET-23 receptor. 
In addition, it is also possible that SLI-1's polyproline domains may compete with the 
polyproline domains of Sos in binding SEM-5, thereby enhancing SLI-1's inhibition of 
the LET-23 RTK pathway. 
The RING finger domain of c-Cbl has been recently shown to enhance 
ubiquitination of active RTKs by acting as an E3 ubiquitin-protein ligase Qoazeiro et al., 
1999; Levkowitz et al., 1999; Levkowitz et al., 1998). Thus, the effects of loss of sli-1 
activity might be explained by the failure of the LET-23 RTK to be down-regulated by a 
ubiquitination dependent degradation pathway. However, we find that the RING 
finger domain of SLI-1 is partially dispensable: a SLI-1 variant lacking its RING finger 
domain retains a significant amount of biological activity. Thus the ubiquitin-ligase 
activity of SLI-1 I c-Cbl is unlikely to be the sole activity of SLI-1. This conclusion is 
strengthened by other findings. It might be expected that if the sole function of SLI-1 
was to target activated receptor for degradation that a) there might be more LET-23 
observable in a sli-l(lj) background and b) that over expression of LET-23 might mimic 
sli-1(/f). Neither of these effects have been observed (Table 2). 
In summary, we find that SLI-1 inhibits LET-60 RAS activation by LET-23. We 
suggest that SLI-1 interacts with the LET-23 signaling complex via at least two domains. 
One of these domains, the proline-rich C-terminal portion, is necessary for the wild-
type level of activity of SLI-1 in the context of a full-length protein; its role is likely to 
interact with a SH3 domain-containing protein. SEM-5 is a candidate due to the 
interaction between SLI-1 and SEM-5 we observe in our yeast two-hybrid assays. Since 
C-24 
the C-terminal proline-rich domain alone is not sufficient to inhibit signaling, we infer 
that SLI-1 does not simply titrate SEM-5 from the RTK/Ras pathway. In addition, a SLI-
1 protein lacking this proline rich C-terminal portion retains inhibitory function on 
signaling. Thus, the remaining N terminal and RING finger domains must be able to 
interact with some of the components of the signaling complex directly by a different 
mechanism. In mammalian cell lines, the conserved N-terminal domain of c-Cbl 
associates directly with the autophosphorylated C-terminal region of the EGF receptor 
(Bowtell and Langdon, 1995; Galisteo et al., 1995; Lupher et al., 1997). TheN-terminal 
domain has also been shown to associate with the non-receptor tyrosine kinase ZAP-70 
in a phosphorylation-dependent manner in T cells (Lupher et al. 1996). In both cases, 
the association requires theN-terminal divergent SH2 domain, and not the C-terminal 
polyproline motifs. We explored the possibility that SLI-1 may exert its inhibitory effect 
by direct or indirect binding to specific pTyr sites in LET-23. By analyzing the 
systematically mutagenized let-23 constructs containing substitutions in the carboxyl-
terminal tyrosine residues, we have identified an inhibitory tyrosine residue, that can 
overcome the negative regulation by sli-1 when it is mutated. Our current models for 
sli-1 functions propose two roles (Figure 1). The major role of sli-1 might be to 
attenuate signaling after activation has occurred. Upon induction, SLI-1 is recruited into 
the receptor signaling complex by itself or an adaptor protein and negative regulation 
ensues by some other means, possibly by preventing the association and activation of 
downstream effectors such as the SEM-5 adaptor and/ or LET -341 S05-1, and catalysing 
the ubiquitination of the receptor and thus targeting it for degradation. The minor role 
of sli-1 might be to regulate the basal activity of signaling in quiescent state by 
competing with LET-341 S05-1 for the binding of SEM-5, thereby decreasing the chance 
that the spontaneously activated receptor recruits the SOS-1-bound SEM-5 in the 
absence of ligand. Other models are possible since we can not rule out the possible 
existence of uncharacterized catalytic domains in SLI-1. 
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Table 1. 
sli-1 suppression of mutations in let-23, sern-5 and let-60 
Average number of VPCs 
undergoing vulval differentiation 
Genotype sli-1(+) sli-1(sy143) 
+ 3.0 (*) 3.0 (n=20)# 
let-23( sy1) 0.8 (n=29)# 4.3 (n=30) 
let-23( sy97) 0.0 (n=20)# 2.9 (n=131) 
sem-5(n2019) 0.5 (n=20)# 2.6 (n=23)# 
sem-5(n1619) 0.4 (n=40) 3.0 (n=84) 
sem-5(ay73) 0.0 (n=20) 0.02 (n=23) 
gap-l(n1691) 3.0 (n=21) 3.2 (n=24) 
let-60(n1876) 0.0 (n=62) 0.08 (n=80) 
let-60( n2034) 0.02 (n=62) 0.03 (n=87) 
let-60( n2035) 0.05 (n=66) 0.09 (n=81) 
Legend: Extent of vulval differentiation in let-23, sern-5, gap-1 and let-60 mutants in sli-
1( +)and sli-1(-) backgrounds. The number values represent average number of VPCs 
C-37 
undergoing vulval differentiation per worm; 3.0 is wild-type level. n=number of 
animals scored. (*), n=many. #, data from Jongeward et al. (1995). 
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Table 2. 
pTyr site 2 in the carboxyl terminal tail of LET -23 mediates negative regulation of LET-
23 signaling by SLI-1 
% A veracre vulval induction a 
C-terminus ark-1(+); sli-1(+) b sli-1(-) ark-1(-) 
1 2 3 4 5 6 7 8 99 (n=22) 91 (n=63) c 
4 (n=42) 
- 2 - d d 
- - 3 3 (n=ll) 8 (n=28) 
- - - 4 93 (n=42) 94 (n=8) 
- 5 - 11 (n=53) 21 (n=22) 
- - 6 100 (n=65) 89 (n=67) 
- 2 - 4 42 (n=85) 86 (n=47) 48 (n=76) 
1 - 3 4 5 6 7 8 99 (n=26) 82 (n=41) 107 (n=32)e 
Legend: Carboxyl-terminal sites 1, 2, 3, etc., indicate that tyrosine(s) at that putative 
SH2-binding sited has not been changed; a dash indicates that each tyrosine in the 
corresponding site has been substituted with phenylalanine. At least two stable lines 
were analyzed per construct, except for the site 3 construct which has only one stable 
line analyzed. 
a Average percentage of vulval precursor cells adopting vulval fates per animal. 
b Taken from Lesa and Stemberg (1997). 
cOne animal from 63 had greater than 3 cells induced (3.5 cell induction). 
d The presence of site 2 in the absence of other carboxyl-terminal sites confers animals 
inviability in the genetic backgrounds of let-23(lj). sli-l(lj) weakly suppresses this 
lethality. e 34% of scored animals are Muv. 
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Table 3. 
Frequency of induction of the Pn.p cells in different mutants 
Frequency of being induced Average 
induction 
P3.p P4.p P5.p P6.p P7.p P8.p 
ark-1; sli-1 1.3% 26.3% 100% 100% 100% 6.3% 3.35 
ark-1; gap-1 5% 15% 100% 100% 100% 80% 4.0 
ark-1; Y2- 3.2% 25.8% 100% 100% 100% 5.6% 3.35 
Legend: Animals scored at 20°C. ark-1; Y2- animals actual genotype is let-23(null) 
unc-4; dpy-20 ark-1; syEx[ dpy-20(+); let-23(¥2-). Only those animals with greater 








Models for negative regulation of LET-23 EGFR signaling by SLI-1. The interpretation 
is based on our molecular genetic analyses presented here or biochemical assays of 
others presented in other model systems. LIN-3 binding to the extracellular domain 
induces LET-23 dimerization and autophosphorylation of tyrosine residues that are 
located in its C-terrninal region, including Y2. The latter targets for the SH2 domain of 
SLI-1. Localization of SLI-1 to the active receptor presumably enables RING finger (RF) 
domain to recognize the substrates and promote their ligation to ubiquitin via E2 
molecule, marking active receptor for degradation. The recruitment of SLI-1 to the 
active receptor might be helped by the binding of the SEM-5 to the receptor Yx sites. 
The interaction between SLI-1 and SEM-5, which is mediated by the proline-rich 
domain of SLI-1 and the SH3 domain of SEM-5, might interfere with the localization of 






Nornarski micrographs of vulval induction in various genetic backgrounds. 
(a) wild-type. (b) sli-1(sy143). (c) sem-5(n1619). (d) sli-l(sy143) sem-5(n1619). (e) sem-
5(ay73). (f) sli-l(sy143) sem-5(ay73). (a), (b) and (d) have phenotypically wild-type 
vulvae. (c), (e) and (f) are phenotypically Vul where all VPCs have generated 
epidermal progeny (note the lack of vulval openings in these panels). In all panels, 




Schematic alignment of SLI-1 and human c-Cbl. Conserved domains between the two 
proteins have been marked in the same manner. Residues 58 to 447 of SLI-1 share 55% 
amino acid sequence identity to residues 45 to 437 of human c-Cbl. The four helix 
bundle (4H), EF hand, SH2 domain, the RING finger, and the putative SH3-binding 
polyproline domains are indicated. Arrow marks the C-terminal truncation point of v-
Cbl. The figure is a modified version from Yoon et al. 1995 and Meng, et al. 1999. The 







EF II SH2 













1 Potential SH3 binding sites 
C-46 
Figure 4. 
(A) Vulval differentiation in gerrnline transformed progeny carrying various minigene 
constructs, as indicated. Vulval differentiation is scored in L4 non-Dpy progeny 
following heat shock in early L3 (genotype let-23(syl); dpy-20; sli-1; syEx[heat shock 
construct+ pMH86(dpy-20+)]). The first column contains schematic representations of 
the mutant constructs inserted into the heat shock minigene pPD49.83. The second 
column lists construct designations. Average number of VPCs that undergo vulval 
differentiation are calculated in the third column for each independent stable line. The 
results are averaged from the combined data of column 3 in column 4. (B) Histograms. 
The distribution of vulval differentiation levels of the combined data (column 4, part A) 
obtained using the various heat shock minigene constructs described in part A. 
Horizontal scale (1-6) represents the number of VPCs that became vulval tissue per 
worm, scored in half-cell increments. Vertical scale (0% -100%) represents the percent 
of total worms scored with a given level of vulval differentiation. The constructs are 
listed directly below each histogram and the names correspond to the construct 
designations of part A. 
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0.36 ~n=40~ 0.56 n=40 
0.30 ~n=33~ 0.37 n=30 
0.47 ~n=31 ~ 1.00 n:24 
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Receptor tyrosine phosphatase CLR-1 negatively regulates EGFR signaling 
D-2 
Recent studies in mice suggest EGFR functions as a survival factor in oncogenic 
transformation and provides a valuable target for therapeutic intervention. By 
comparative analysis of two RTK pathways with similar signaling mechanisms, 
we demonstrate that clr-1, a previously identified negative regulator for egl-15 
mediated FGFR signaling, is also involved in let-23 EGFR signaling. 
Specifically, a reduction-of-function mutation in clr-1 suppresses the lethality 
and vulvaless phenotypes of non-null mutations in lin-3 EGF, let-23 EGFR, 
sem-5 Grb2, and let-341 Sos and thereby rescuing their vulvaless and lethal 
phenotypes. Further, a clr-1(rft mutation synergized with an activated let-60 
Ras mutant and with mutations in any other loci defining negative regulators 
of let-23 EGFR mediated vulval signaling, including sli-1, ark-1, unc-101, and 
gap-1. Epistasis analysis orders clr-1 action upstream of let-60 Ras. Since clr-1 
encodes a single pass transmembrane protein with two putative tyrosine 
phosphatase domains in its carboxyl terminus, it is conceivable that CLR-1 acts 
to inhibit EGFR signaling by dephosphorylating active LET -23. Here, we show 
that RTKs share common mechanisms of negative regulation and that EGFR 
signaling as well as FGFR signaling is regulated by the Clr recognition of 
tyrosine kinase. This study presents a feasible approach to identifying new 
players in RTK pathways and we show that CLR-1 is the first receptor tyrosine 
phosphatase discovered in any model system acting to attenuate EGFR 
signaling. 
D-3 
Excessive or prolonged RTK signaling is associated with, and may be the cause 
of, both malignant transformation and progression of multiple tumour types I. 2, 
3. Therefore, proper mechanisms must be employed to strongly control the 
signaling from RTKs to prevent spontaneous, ligand-independent activation and 
downregulate signaling after it has been activated. Negative regulators of EGFR 
signaling therefore have significant pharmaceutical potential, either as 
therapeutic agents themselves, or by promoting a strategy to engineer 
therapeutic molecules. There are three such inhibitors identified recently in 
Drosophila and four in C. elegans. For Drosophila, they are Argos, Kekkon-1, and 
Sprouty, which encode a secreted protein with an atypical EGF motif, a 
transmembrane adhesion molecule, and a novel Drk and RasGap1 interacting 
protein, respectively 4,5,6. All three are transcriptionally dependent on EGFR 
signaling and participate in negative feedback control of receptor activation. This 
feature allows complex developmental patterning. For C. elegans, they are UNC-
101, GAP-1, ARK-1, and SLI-1, encoding a homolog of mammalian AP-47 clathrin 
medium chain protein, a Ras-GTPase activating protein, a non-receptor tyrosine 
kinase related to Ack, and a Cbl proto-oncoprotein, respectively 7,8. Mutations in 
each of these four negative regulators are silent by themselves. However, in 
combination with mutations in any other loci defining negative regulators results 
in a Multivulval (Muv) phenotype. 
Generally, there are two ways to identify genes involved in the let-23 
EGFR-mediated vulval induction pathway. Genetic screens have been proven 
efficiently to uncover loci determining vulval cell fates. Direct screens for the 
Multivulva and the Vulvaless mutants reveals several major positive effectors of 
the pathway. These mutants were then served as the starting materials to look 
for the remaining members of positive effectors and negative regulators by 
extragenic suppressors screens. Sequence homology searches, motivated by new 
D-4 
components discovered in EGFR signaling pathway in other model organisms, 
also helped to identify several modulators in C. elegans, for example mpk-1 and 
sos-1. The approach we adopted in this study is the comparative analysis of two 
RTK pathways with the similar signaling logic. We started with the alignment of 
FGFR pathway against EGFR pathway, candidate genes that modified egl-15 
FGFR were tested for their ability to alter signaling by the let-23 EGFR 
(reasoning that the signal transduction pathways downstream of different RTKs 
would be similar). clr-1, a previously described inhibitor of egl-15 FGFR signaling 
9, is found to regulate let-23 EGFR signaling activity in our vulval assay. The 
conceptual translation of clr-1 transcript predicts a transmembrane domain 
followed by two intracellular tyrosine phosphatase domains 9. The localization of 
CLR-1 at the periphery of body muscles is consistent with it acts as a receptor 
tyrosine phosphatase 9. The temperature-sensitive mutation clr-1(e1745ts) was 
used in the following studies. This clr-1 mutation was found to correspond to a 
nonsense mutation affecting the very carboxyl terminus of the D1 phosphatase 
domain (W1072-opal), resulting in the destabilization of CLR-1(e1745) protein at 
the nonpermissive temperature 9. clr-1 mutation suppresses vulvaless and lethal 
phenotypes caused by severe reduction-of-function mutations in positive 
effectors of let-23 EGFR pathway (Table 1, 2). LET-23 is induced by LIN-3, an 
EGF-like growth factor and is properly localized to the basolateral membrane 
domain of vulval precursor cells (VPCs) by the PDZ protein LIN-10 10,1 1. LET-23 
activation initiates a signaling cascade that involves downstream effectors such as 
SEM-5, LET-341, LET-60, LIN-45, MEK-2 and SUR-1/MPK-1 which are the 
nematode counterparts of the mammalian Grb2 adaptor, the Sos guanine 
nucleotide exchanger, the Ras GTP-binding protein, the Raf serine/threonine 
kinase, the MAPK kinase and the MAPK, respectively 7 12. Animals with 
significantly reduced activities in lin-3 EGF, let-23 EGFR, lin-10 PDZ, sem-5 Grb2, 
D-5 
and let-341 Sos display high penetrance of vulvaless phenotypes. Their vulvaless 
phenotypes were reversed by the reduced CLR-1 activity (Table 1). Rescue of 
vulval phenotype was determined based on two criteria, the average vulval 
induction and proportion of animals with less than three cells induced. The 
inference drawn from these observations is that CLR-1 normally acts as a 
negative regulator of EGFR signaling during vulval induction. Although 
mutation in clr-1 suppresses strongly a severe reduction-of-function mutation in 
sem-5, it does not bypass the requirement of sem-5 for EGFR-mediated vulval 
signaling since it does not overcome a sem-5 null mutation. To address the 
question of whether the effect of clr-1 on EGFR signaling is indirect through its 
regulation on egl-15 FGFR, we introduced a severe egl-15 mutation into the 
double mutant of clr-1(e1745) let-23(syl) and test if the up-regulation of EGFR 
signaling by clr-1 mutation is dependent upon egl-15 activity. The elevated vulval 
signaling conferred by the clr-1 mutation in a let-23 EGFR mutant is not 
abolished by the egl-15 mutation, suggesting that the effect of clr-1 on EGFR 
signaling is most likely direct and not mediated through FGFR signaling. 
Although clr-1(e1745ts) is silent with regards to vulval induction by itself, in 
combination with a mutation in any other loci defining negative regulators 
results in a Muv phenotype (Table 1). Animals of the genotype clr-1(e1745); gap-
1(n1691) have a hyperinduced vulva phenotype with 35% of animals having 
greater than three VPCs induced at 15°C (average number of VPCs induced = 
3.2; Table 1). clr-1 also synergizes with mutations in ark-1, sli-1 and unc-101, 
resulting in a hyperinduced vulva phenotype. The percentile of animals having 
greater than three VPCs induced ranges from 15 to 40 (Table 1). Double mutants 
of clr-1(e1745); gap-1(n1691) can not be assayed at 20°C since animals are not 
viable. Interestingly, animals of the genotype unc-101(sy108); clr-1(e1745) display 
both vulvaless and Muv phenotype, suggesting that UNC-101 has both positive 
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and negative effects on the EGFR signaling. This feature is similar to that of 
proteins involved in localizing LET-23 to the sub-membrane domain of VPCs, 
indicating that UNC-101 might function in a similar way. 
C. elegans development uses EGFR signaling repetitively; mediating vulval 
induction, viability, male spicule development, hermaphrodite ovulation, and 
differentiation of the ventral uterus and posterior ectoderm 7. The alleles for lin-
3, let-23 and lin-10 we used in this study do not cause any noticeable lethality, 
while sem-5 and let-341 display high penetrance of embryonic and early larval 
lethality. The lethality displayed by the reduction-of-function sem-5 and let-341 
mutants is significantly suppressed by the clr-1 mutation, further supporting an 
inhibitory role for clr-1 in EGFR-mediated signaling (Table 2). While clr-
1(e1745ts); sem-5(n1619) and clr-1(e1745ts); let-341(ku231ts) double mutants can be 
maintained at the nonpermissive temperature, the individual single mutants can 
not. The lethal phenotype of clr-1 mutation is due to the excessive FGFR 
signaling while that of sem-5/let-341 mutation is due to insufficient EGFR 
signaling. The mutual suppression between severe alleles of clr-1 and sem-5/let-
341 observed here suggests that clr-1 and sem-5/let-341 are important for both 
EGFR and FGFR signaling. To determine the site of action for clr-1, we 
eliminated by gonad ablation the signaling flow upstream of an activated let-60 
Ras mutant and test the ability of clr-1 to regulate the signaling flow elicited by 
the activated RAS variant; Ablation of gonad eliminates the ligand for let-23 
mediated vulval signaling 13. The activated RAS allele, n1046, used in this study is 
still sensitive to the regulation by the ligand activation 12 . While clr-1 mutation 
synergizes with n1046 mutation in the presence of gonad, it does not in the 
absence of the gonad. Since clr-1 mutation does not enhance the signaling flow 
from the activated RAS, we interpret that clr-1 normally acts upstream of let-60 
Ras to regulate the EGFR signaling (Table 3). 
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In this study, we have demonstrated that clr-1, a previously identified 
negative regulator of egl-15 mediated FGFR signaling, is also involved in let-23 
EGFR signaling. CLR-1 is the first receptor tyrosine phosphatase discovered in 
any model system acting to attenuate EGFR signaling. The success of this 
approach promises a similar reciprocal test and could potentially extend to the 
study of other signaling pathways with similar signaling logic. Indeed, our 
preliminary results suggest that one of the negative regulators of let-23 EGFR-
mediated signaling is also involved in egl-15 FGFR signaling (our unpublished 
results) . The negative regulatory circuit operating on FGFR signaling in C. 
elegans is apparently dominated by clr-1 since a clr-1 mutation by itself expresses 
the clr phenotype of an activated egl-15 FGFR variant. In contrast, the negative 
regulatory circuit operating on EGFR signaling in C. elegans is composed of 
multiple functionally partial redundant inhibitors. The complexity of this 
regulatory network in the vulva ensures a robust developmental consequence. 
Alternatively, it might provide the temporal and spatial specificity for EGFR 
signaling during the inductive event, e.g. EGFR signaling is reused a few hours 
later 14 . 
Methods 
Strain construction and maintenance 
Strains were maintained at 20°C and handled according to Brenner (1974). The 
following alleles were used for strain construction: for LGI, unc-101(sy108), lin-
10(e1439); for LGII, clr-1(e1745), let-23(sy1); for LGIV, lin-3(n378), ark-1(sy247), let-
60(n1046); for LGV, let-341(ku231), for LGX, egl-15(n1477), sli-1(sy143), sem 
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5(n1619, ay73) (Clark et al. 1992a; M . Stern, personal communication), gap-
l(n1691). 
Vulval induction assay 
The extent of vulval induction was determined by examining vulval anatomy in 
the early to mid-L4 stage of development under Nomarski optics using a Plan 
100 objective 15. Wild-type animals have three VPCs generating vulval progeny; 
vulvaless animals have fewer than three VPCs generating vulval progeny; 
multivulva or hyperinduced animals have more than three VPCs generating 
vulval progeny. In some cases, a VPC generates one daughter that makes vulval 
progeny and another daughter that becomes nonvulval epidermis; such VPCs 
are scored as one-half VPC differentiating into vulval tissue. 
Cell ablation 
Ablations of the AC was performed with a laser microbeam as described by 
Sulston and White (1980). 
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Table 1 clr-1 mutation restores reduction-of-function in let-23 signaling and 
synergizes with mutations in other negative regulators 
Genotype Average number of VPCs induced At 
temperature 
clr-1(+) clr-1(e1745) 
+I+ 3.0 (n=many) 3.0 (n=20) 
lin-3(n378) 0.4 (n=25; %<3=96)* 2.0 (n=28; %<3=46)* 
let-23(syl) 0.8 (n=29; %<3= )# 2.0 (n=27; %<3= )* 
lin-10( e1439) 0.5 (n=20; %<3=95) 2.7 (n=24; %<3=33) 
sem-5(n1619) 0.4 (n=40; %<3=98) 2.7 (n=20; %<3=25) 
sem-5(ay73) 0.0 (n=18; %<3=100) 0.0 (n=20; %<3=100) 
let-341(ku231) 2.1 (n=20; %<3=60) 3.0 (n=20; %<3=20) 
let-341(ku231) n.d 0.9 (n=20; %<3=95) 
gap-1(n1691) 3.0 (n=20; %>3=0) 3.2 (n=20; %>3=35) 
ark-1(sy247) 3.0 (n=20; %>3=0) 3.3 (n=20; %>3=30) 
ark-1( sy247) 3.0 (n=20; %>3=0) 3.4 (n=20; %>3=35) 
sli-1(sy143) 3.0 (n=20; %>3=0) 3.4 (n=60; %>3=30) 
unc-101(sy108) 3.0 (n=20; %>3=0) 2.9 (n=20; %<3=35; %>3=15) 
*data of N. Moghal, personal communication. 















Table 2 clr-1 mutation suppresses lethality caused by the reduced let-23 
signaling 
Genotype %viability At temperature 
sem-5(n1619) 0 (n=many) 20°C 
clr-l(e1745); sem-5(n1619) 40 (n=464) 20°C 
let-341(ku231) 7 (n=135) 25°C 
clr-l(e1745); let-341(ku231) 78 (n=128} 25°C 
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Reciprocal EGF signaling back to the uterus from the induced 
C. elegans vulva coordinates morphogenesis of epithelia 
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Background: Reciprocal signaling between distinct tissues is a general feature 
of organogenesis. Despite the identification of developmental processes 
whose coordination requires reciprocal signaling, little is known regarding 
the underlying molecular details. Here, we use the development of uterine-
vulval connection in Caenorhabditis elegans as a model system to study 
reciprocal signaling. 
Results: In C. elegans, development of the uterine-vulval connection requires 
the specification of uterine uv1 cells and morphogenesis of 1 °-derived vulval 
cells. LIN-3, an EGF family protein, is first produced by the gonadal anchor 
cell to induce vulval precursor cells to generate vulval tissue. We show that 
lin-3 is also expressed in the 1 °-vulvallineage after vulval induction. In 
addition, and that the 1 o vulva is necessary to induce the uv1 cell fate. Using 
genetic and cell biological analyses, we find that the specification of uterine 
uv1 cells is dependent of EGF signaling from cells of the 1 o vulval lineages to 
a subset of ventral uterine cells of the gonad. RAS and RAF are necessary for 
this signaling. We also find that EGL-38, a member of the PAX family of 
proteins, is necessary for transcription of lin-3 in the vulva but not the anchor 
cell. A let-23 mutation that confers ligand-independent activity bypasses the 
requirement for EGL-38 for specification of the uv1 cell fate. 
Conclusions: We have shown how relatively simple EGF signals can be used 




During metazoan development, patterns of cell types are often established by 
inductive signaling between tissues. The molecular basis of inductive signaling 
can involve peptide signals (growth factors) acting through transmembrane 
receptors to activate signal transduction pathways in responding cells [1,2]. 
Reproducible pattern formation likely involves tight regulation of ligand 
production in the inductive cell and threshold-setting mechanisms in the target 
cell. LIN-3 is used multiple times as an inductive signal during development of 
Caenorhabditis elegans. The responses are likely mediated through LET-23, an EGF 
receptor tyrosine kinase. The outcome of signaling is context-dependent. 
Reduction-of-function mutations in both lin-3 and let-23 can affect the 
development of vulva, male spicules and posterior ectoderm, cause larval 
lethality and result in hermaphrodite sterility [3-7]. The question of how the 
production of LIN-3 is regulated in a tissue-specific manner is important because 
in a system in which multiple responses can occur in response to the relative 
strength of signaling, the precise response can be modulated by control of ligand 
production. The organization of cis-regulatory elements in lin-3 genomic DNA 
and the transcription factors which bind to them will provide mechanisms which 
ensure precise spatial and temporal pattern of lin-3 expression. A 5 kb lin-3 
genomic region that confers anchor cell (AC)-specific expression [8] has been 
identified. 
There are several steps in the formation of the uterine -vulval connection. 
The first step is to induce vulval and uterine development by the same inductive 
source (AC), which ensures that the two share a center for the future registration 
[9]. The AC first induces three of six multipotential vulval precursor cells (VPCs) 
to adopt vulval cell fates via LIN-3/LET-23-mediated signaling [3,8,10-14] and 4 
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hours later induces six of twelve multipotential ventral uterine intermediate 
precursor cells to adopt then cell fate via LAG-2/ LIN-12-mediated signaling 
([15]; A. Newman and P. Sternberg, unpublished observations). The inductive 
signaling pathways likely lead to changes in gene expression, such that specific 
vulval and uterine cell fates are executed, and ultimately that a functional uterine-
vulval connection is ensured. The subsequent morphogenetic events include the 
following. The vulval cells form an invagination, with 1 o vulval cells at the apex 
of the invagination (vulF) attached to the ventral most uterine cells (n cell 
progeny). All then cell progeny (except the four which make the direct contact 
with vulF and become uv1 cells) fuse with the ACto form the thin laminar 
process (utse cells) that resides between the uterus and the vulva [16]. This fusion 
and differentiation of the utse moves the bulky AC and extra n cell progeny out 
of the way, thereby permitting a connection to be formed. In the meantime, the 
1° vulval cells separate anterio-posteriorly and left-right to create a hole so that 
eggs can pass through it. Two sets of observations led us to consider that proper 
morphogenesis of the uterus might be dependent on signaling from the vulva to 
the uterus. We observed that lin-3 is expressed in the vulva and let-23 is 
expressed in the uterus; and that uv1 cells are absent in animals lacking vulval 
tissue. In addition, we examined existing mutants for the abnormal expression of 
lin-3 and found a tissue-specific regulator for lin-3. 
Results 
The expression pattern of lin-3 and let-23 during the development of the 
connection between uterus and vulva 
We constructed a lin-3::lacZ expression vector containing 12.5 kb lin-3 genomic 
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sequence with approximately 2 kb regulatory sequence 5' to the transcriptional 
start site, which was inferred from known cDNAs ([8]; P. Tzou, R. Hill and P. 
Sternberg, unpublished observations). This construct is expressed in several 
tissues as expected from previous genetic analysis (data not shown). AC 
expression is required for vulval development (see [8]). Spermatheca expression 
might be involved in hermaphrodite fertility function. K lineage expression 
might be required for the development of posterior ectoderm. In all cases 
expression can be detected at the appropriate time. In addition, we found 
unexpected vulval expression from the early to mid fourth larval (L4) stage in 
the vulF cells, which are the dorsal most 1 o vulval progeny (Figure 1D,E). The 
expression appears to be 1 o vulva specific since the vulvallin-3::lacZ expression is 
absent in animals bearing a strong lin-12(gf) mutation (data not shown), which 
confers a multivulva phenotype consisting of only 2° lineages [17]. The presence 
of multiple copies of this construct induces a multivulva phenotype with low 
penetrance with all the vulval invaginations expressing lin-3::lacZ (Figure 1F). 
Since the uterus-connected 1 o vulva is not the only one whose cells express lin-
3::lacZ, it is unlikely that a second gonad dependent signal is required late to 
induce lin-3::lacZ expression in the 1° vulva derived cells. 
To determine whether this expression could have functional significance, 
we examined the expression pattern of let-23::GFP during the period which 
corresponds to vulval expression of lin-3::lacZ. A S65T GFP cassette was fused in 
frame in an intact let-23 genomic clone, pk7-13.8, which rescues the defects 
associated with loss-of-function alleles of let-23 [11]. We detected expression of 
let-23::GFP in the uv1 cells, which are the ventral most uterine cells, suggesting 
possible signaling from the vulva to the uterus (Figure 1B,C). Since expression of 
let-23::GFP in uv1 cells peaks later than the proposed induction, its expression 
might be upregulated by lin-3. We have not formally demonstrated that let-23 is 
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expressed more broadly than in the presumptive uv1 cells. Therefore, it is 
conceivable that the LIN-3/LET-23 induction is permissive. 
Progeny of the 1 o vulval cell lineage signal the uterus to specify the uvl cell 
fate 
In vulvaless let-23(sy97) hermaphrodites, in which all six VPCs adopt the non-
vulval 3° cell fate, the presumptive uv1 cells instead adopt a utse cell fate (Table 
1). Since the presumptive uv1 cells are born after the vulva is induced, these 
observations suggest that the vulva might be necessary for the uv1 cell fate. To 
test this hypothesis, we used laser microsurgery to ablate all or some of the six 
VPCs. Ablation of either all 6 VPCs or of only P6.p (the progeny derived from 
P6.p adopt the 1 o vulval cell fate in a wild-type animal) results in transformation 
of the uv1 cell fate into a utse cell fate (Table 1). Ablation of all the VPCs except 
P6.p does not affect uv1 cell fate. These observations suggest that uv1 
specification is dependent upon a signal from the 1 o vulval cell lineages. 2° vulval 
cell lineages (descendants of PS.p and P7.p) appear to be neither necessary nor 
sufficient to induce the uv1 fate . To further localize the source of inductive signal, 
we ablated P6.p descendants at the 2 and 4 cell stage. In addition, we ablated just 
the ForE grandprogeny of P6.p (F, P6.pap and P6.ppa; E, P6.paa and P6.ppp) at 
the 4 cell stage. Our results suggest that the inductive signal is produced by P6.p 
descendants during or after the 4 cell stage. Ablation of the two E does not affect 
the uv1 cell fate, and ablation of two F has less effect than ablation of all 4 cells (E 
and F; uv1-to-utse transformation of 25% and 75% respectively). This 
observation suggests that either there is a window within the 4 cell stage used 
for the production of inductive signal in F lineages, or that E lineages can replace 
F lineages for the production of inductive signal when F lineages are removed. 
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LET -23-mediated signaling is required for uvl cell specification 
As discussed above, while vulvaless let-23 hermaphrodites fail to specify the uv1 
cell fate, this result alone is not sufficient to implicate the LIN-3/LET-23 pathway 
in vulva-to-uv1 signaling, since laser ablation of the VPCs also results in uv1-
defective animals. We therefore examined animals containing partial loss-of-
function mutations in genes functioning in the LIN-3/LET-23 signal transduction 
pathway mediating vulval induction. These strains had defects in uv1 cell fate 
specification (Table 2), indicating that multiple components of the vulval 
induction pathway are used again in vulva-to-uv1 signaling. In let-60(n2021) 
animals, the defect was only partially penetrant, consistent with the fact that the 
mutants studied can not be too severe as a functional vulva has to be specified in 
order to assay a more direct effect on uv1 specification. Mutations in other genes 
(let-23, lin-45 and lin-1) result in a highly penetrant failure to specify the uv1 cell 
fate without severely affecting vulval induction, suggesting that these mutations 
preferentially affect one tissue, and that the defect in vulval induction is not 
responsible for the uv1 defect. 
Another way to examine LET-23 pathway function in uv1 specification is 
to alleviate the vulval induction defect by mutating negative regulators. SLI-1, a 
homolog of the proto-oncogene product c-Cbl, is a negative regulator of LET-23-
mediated vulval differentiation in C. elegans. [18,19]. GAP-1 is a negative 
regulator of vulval signaling that likely acts at the level of LET-60 Ras, similar to 
the Ras GTPase-activating proteins identified in other systems [20]. While 
mutations in SLI-1 and GAP-1 restore most of the reduced LET-23 signaling in 
the vulva caused by the severe hypomorph of let-23, with average vulval 
inductions of 2.9 and 2.7 respectively (Table 2), the specification of uv1 cell fate is 
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still compromised (Figure 2C,D). The high penetrance of uvl defect observed in 
let-23; gap-1 suggests that LET-23-mediated signaling is less regulated by GAP-1 
in the presumptive uv1 cells than in the VPCs. However, since a weak 
hypomorph of let-60 shows the uv1 defect, we believe that uv1 specification is a 
RAS-dependent event (see below). 
RAS and RAF activities are required for the uvl cell fate during the 
development of uterine-vulval connection 
A let-60::lacZ reporter construct is expressed in the uv1 cells during the 
development of uterine-vulval connection ([21]; C. Chang and P. Sternberg, 
unpublished observations), and thus RAS might have a function in these cells at 
this time. The use of an inducible and tissue-general hsp 16-41 heat shock 
promoter-driven putative dominant negative RAS variant (hsrasDN) allows us to 
test this possibility. This construct, which contains a G10R substitution in the let-
60 equivalent, is from another nematode, Pristionchus pacificus [22]. C. elegans 
hermaphrodites heterozygous for this GlOR mutation have a reduction of gene 
activity and a vulvaless mutant phenotype [23]. Animals transformed with this 
construct, when subjected to heat shock after VPC cells have divided one round, 
had a low penetrance (7 /33) vulval morphogenetic defect. Of animals that have a 
wild-type vulval morphology in the mid-late L4 stage (n=26), 50% had a failure 
to specify the uv1 fate (Table 3). Animals were judged to have a wild-type vulval 
morphology by three criteria: wild-type number of vulval cells; normal cell 
lineages; characteristic physical appearance. Most of these animals can lay eggs 
well in the adult stage, indicating wild-type function of their vulvae (see 
discussion). 
lin-45(sy96) alters the 3' splice acceptor of intron 4 of Ce-raf, resulting in 
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decreased vulval induction and viability [24]. Not alllin-45 animals with wild-
type extent of vulval induction observed at the mid-late L4 stage had wild-type 
vulval morphology. To avoid any complication of incompletely induced vulvae, 
we only scored animals with not only a wild-type extent of vulval induction, but 
whose vulval morphology was normal by four criteria: wild-type number of 
vulval cells, normal cell lineages, characteristic physical appearance and correct 
marker gene expression. Of these animals having a normal vulval morphology, 
there is a 92% failure to specify the uv1 fate (n=20) (Table 3). Despite this uterine 
defect, most of the animals can lay eggs well in the adult stage (17 /20), further 
demonstrating the proper functioning of their vulvae (see discussion). 
egl-38 acts upstream of lin-3 to regulate uterine differentiation 
egl-38 is a member of the PAX family of genes, which encode transcription 
factors implicated in a variety of developmental patterning events. egl-38(n578) 
has defects in the egg-laying system resulting from the absence of uv1 cells and 
abnormal morphogenesis of 1 o vulval tissue [25]. At the mid-L4 stage in wild-
type animals, vulE and vulF generated by 1 o vulval lineage, separate to produce 
a hole through which sperm and fertilized eggs pass. In egl-38 animals, there is 
no defect in the number of vulval cell lineages produced, but vulF cells fail to 
separate (Figure 3A). The egl-38(n578) allele is a substitution of Glu for Gly 69 in 
the DNA-binding paired domain of EGL-38 [25]. We examined the expression 
pattern of lin-3::lacZ construct in the genetic background of egl-38(n578) and 
found that there is no expression of lin-3::lacZ in the vulva (Figure 3B); by 
contrast lin-3::lacZ expression in other tissues was unaffected. We infer that EGL-
38 acts upstream of lin-3 as a positive regulator of its transcription. Furthermore, 
the resulting lack of vulvallin-3 expression in egl-38 animals might be the cause 
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of the uvl defect, the vulval morphogenetic defect involving a failure of the vulF 
cells to separate, or both. 
let-23(sa62), a gain-of-function mutation of let-23, is able to suppress the 
uvl defect in egl-38 (Table 4). Thus, let-23(sa62) bypasses the requirement for lin-3 
expression in the vulva to mediate uvl specification. While the uvl defect is 
rescued by let-23(sa62), the vulval morphogenetic defect remains. Therefore, the 
uvl defect can not be the cause of the egl-38 vulval morphogenetic defect. These 
experiments leave open the possibility that the vulval morphogenetic defect is 
the cause of uvl defect, however, data from another mutant suggests that it is 
not (see discussion). 
Discussion 
We have shown that a vulval signal is needed to specify uterine n cell daughters 
as uvl rather than utse. Using phenotypic analysis of mutants and lin-3::/acZ 
expression analysis, we have demonstrated that this signal is mediated by the 
same set of proteins- LIN-3, LET-23, LET-60, LIN-45 and LIN-1- required for 
vulval induction. 
A vulval signal is needed for uterine n cell daughters to adopt a uvl, rather 
than a utse, cell fate 
During larval development of the C. elegans hermaphrodite, two sequential 
inductions by the AC specify the differentiated cells needed to connect the uterus 
and vulva, and thereby create a functional egg-laying system. First, the uterine 
AC induces a subset of the underlying epidermal precursor cells to adopt vulval 
cell fates and produce the vulva. The AC then induces adjacent ventral uterine 
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intermediate precursor cells to adopt then (rather than the default p) cell fate 
and produce the two uterine cell types that connect to the vulva: utse and uvl. 
AC-to-n cell signaling requires the lin-12-encoded receptor. lin-12 gain-of-
function mutants [lin-12(d)], have a p-to-n cell fate transformation, observable 
under Nomarski optics, and a corresponding excess of utse tissue (EM analysis of 
one lin-12(d) mutant animal revealed 33 nuclei in the utse, compared to nine in 
the wild-type; [15]). EM analysis of lin-12(d) mutants did not reveal excess uv1 
cells (John White, personal communication), suggesting that utse might be the 
ground state for 1t daughters, with an additional signal required for uvl. This 
hypothesis was supported by the finding that in egl-38 mutants, presumptive uv1 
cells instead adopt a utse cell fate [25]. Here we demonstrate that a signal from 
the vulF cells induces the directly overlying n cell daughters to become uv1; 
n daughters that do not receive this signal become utse. We also find that lin-3 is 
expressed in the vulF cells at the right time and place to be the ligand for this 
induction; furthermore, specification of the uv1 cell fate is defective in animals 
bearing mutations in let-23 or in downstream components of the LET-23-
mediated vulval induction pathway, suggesting that these genes are required for 
uv1 cell fate specification as well. 
Reciprocal EGF signaling from the vulva specifies the uvl cell fate 
The fact that egl-38 has defects in the egg-laying system resulting from the 
absence of uv1 cells and abnormal 1 o vulval morphogenesis, and the observation 
that vulval expression of lin-3 specifically disappears in this genetic background, 
suggest that the expression of lin-3 in the vulva might be required for uv1 
specification, vulval morphogenesis, or both. Strong evidence that a 1 o vulva-
produced LIN-3 signal is required for uv 1 specification comes from the 
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suppression of the uv1 defect in egl-38 animals by the let-23(sa62) mutation. All 
known effects of LIN-3 are mediated through LET-23 and there is no evidence 
that LET -23 has additional ligands apart from LIN-3. 
The failure of the let-23(sa62) mutation to suppress the vulval 
morphogenetic defect of egl-38 animals raises the possibility that this defect is not 
mediated through LIN-3 expression. However, the dosage of let-23(sa62) might 
not be strong enough to suppress vulval morphogenetic defect caused by the 
egl-38 mutation or the let-23(sa62) mutation might have cell-type specificity. 
Moreover, in addition to LIN-3, there could be another signal, also regulated by 
EGL-38, required for vulval morphogenesis. 
A lin-3::lacZ transgene is expressed in the 1 °-derived vulval cells in the 
early L4 stage, as well in the AC as reported previously [8]. Since the AC and the 
1 °-derived vulval cells are in proximity to the presumptive uterine-vulval 
connection, LIN-3 produced by either cell could be a potential inductive source 
required for the development of the uterine-vulval connection in the early-mid 
L4 stage. Ablation of P6.p descendants but not the AC after VPC cells have 
divided two rounds results in a uv1-to-utse cell fate transformation (Table 1). We 
infer that the inductive source used for uv1 cell specification is from the 1 o _ 
derived vulval cells and that LIN-3 expression in the AC is neither necessary nor 
sufficient to induce the uv1 cell fate. Consistent with this hypothesis, we observe 
lin-3::lacZ expression in the 1 o vulva throughout the period when the uterine-
vulval connection is developing, whereas lin-3::lacZ expression in the AC 
gradually disappears during this time interval (data not shown). We could not 
use the same experiments to address the issue of whether LIN-3 protein in the 
AC or 1 o vulval tissue is used for the 1 o vulval morphogenesis as suggested by 
the observations from egl-38 mutants because physical invasion of the AC 
between the inner-most grand-daughters of P6.p, F lineages, is required for later 
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separation of the 1 o vulval cells (K. Tietze and P. Sternberg, unpublished 
observations); and, P6.p descendants are the target we need to assay. 
lin-3 regulation by EGL-38 
Our finding that EGL-38 acts upstream of lin-3 as a positive regulator suggests 
three possible models. First, EGL-38 might act upstream of gene X, which is 
required for vulval morphogenesis. Proper vulval morphogenesis would then 
allow lin-3 to be expressed in the vulva to regulate uv1 specification. Second, 
EGL-38 might act upstream of lin-3 to regulate uv1 specification and upstream of 
gene X to regulate vulval morphogenesis. These two events do not have an 
epistatic relationship. Third, EGL-38 might act upstream of lin-3 to regulate uvl 
specification and vulval morphogenesis. In addition to being necessary for lin-3 
expression in vulF cells, EGL-38 also regulates expression of other genes in the 
same cells (M. Wang, C. Chang and P. Sternberg, unpublished observations). We 
speculate that lin-3 is an immediate target gene of EGL-38 in these cells. 
The relationship between vulval morphology and uvl cell fate 
Even some mutants that confer a severely abnormal vulval morphology in both 
1 o and 2°-derived vulval cells do not affect vulval expression of lin-3 and uv1 cell 
specification (unpublished observations). Proper vulval morphology is hence not 
required for vulval expression of lin-3 and uv1 cell specification. By contrast, 
there are many examples of LET-23 signaling pathway mutants in which uv1 cell 
fate is compromised but vulval morphogenesis is normal. We infer that uv1 cell 
fate is not required for vulval morphogenesis. Therefore, uv1 cell specification 
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and vulval morphogenesis are independent events once a 1 o vulval fate has been 
specified. 
The working model 
We favor the following model (Figure 4). EGL-38 acts upstream of lin-3 as a 
positive regulator of its expression in the 1 o vulval lineage. The 1 o vulval 
expression of lin-3 would then specify uv1 cell fate through RAS-RAF dependent 
signaling in a cell non-autonomous manner. lin-3 produced by the 1 o vulva could 
conceivably specify 1 o vulval morphogenesis in a 1 °-lineage autonomous 
manner. However, since the uv1 defect in an egl-38 mutant is rescued by let-
23(sa62) while the vulval morphogenetic defect remains, EGL-38 likely controls 
1 o vulval morphogenesis independent of its effect on lin-3 expression. 
Reciprocal signaling and organogenesis 
Reciprocal signaling between distinct tissues is a general feature of 
organogenesis [26,27]. For example, during mouse nephrogenesis, several 
checkpoints occur at which a positive signal is needed for development to 
continue [28]. Reciprocal signaling is one mechanism for developmental 
checkpoints. In Drosophila, reciprocal signaling occurs between the approaching 
muscles and the epidermal muscle attachment cells during embryonic 
development [29]. The epidermal muscle attachment cells signal the myotubes 
and induce myotube attraction and adhesion to their target cells. Following this 
binding, the muscle cells signal back to the epidermal muscle attachment cells 
inducing their terminal differentiation into tendon-like cells. 
In the Drosophila egg, an EGF signal (Gurken) from the oocy te patterns the 
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overlying follicle cells by inducing a dorsal-anterior follicle cell fate [30]. These 
specialized follicle cells then express another EGFR ligand, Vein and an accessory 
protein, Rhomboid, which are then used in an autocrine manner to amplify 
EGFR signaling in the follicle cells. Consequent high-level EGFR activation leads 
to localized expression of the diffusible inhibitor Argos, which modifies the initial 
EGFR activation profile, producing two peaks of activity displaced from the 
midline and hence the positions of the two dorsal appendages. In C. elegans, the 
initial paracrine signaling event by LIN-3 from the somatic gonad specifies vulval 
cell fates. We propose that this signaling event triggers expression of LIN-3 in the 
vulval cells, which in turn specifies the uvl cell fate involved in the intimate 
connection of vulva and uterus. It is possible that LIN-3 expression in the vulva 
also has an autocrine amplification role upon which proper vulval development 
depends. 
Conclusions 
We find that the reciprocal EGF signaling from the vulva to the uterus 
coordinates the uterine-vulval connection. We demonstrate that uvl cell 
specification is mediated by a RA5-RAF-dependent signaling transduction 
pathway. We show that lin-3 expression in the 1 o vulval cells, which is positively 
regulated by EGL-38, is required for uvl cell specification. Since the uvl defect 
but not the vulval morphogenetic defect of an egl-38 mutant is rescued by 
activation of let-23, we think it likely that another signaling pathway, also 
regulated by EGL-38, is required for vulval morphogenesis in addition to or 
independent of LIN-3/LET-23. In general, since EGF Receptor activation of RAS 
is essential for the specification and differentiation of epidermal cells, the 
reciprocal EGF signaling might have evolved to mediate the coordinated 
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morphogenesis of epithelia as described here for the development of uterine-
vulval connection. 
Materials and methods 
General methods and strains 
C. elegans strain N2 and derivatives were maintained at l8°C-21 oc and handled 
as described [31]. The following alleles were used: LGI, ayls4[egl-17::GFP; dpy-
20(+)] [32]; LGII, let-23(sy97) [4], let-23(n1045) [3], let-23(sa62) [33], unc-4(e120); 
LGIV, let-60(n2021) [34], lin-45(sy96) [24], lin-l(n1790) [35], egl-38(n578) [36], dpy-
20(e1282); LGV, him-5(e1490) [37]; LGX, sli-l(sy143) [18], gap-l(n1691) [20], unc-
2(e55) [31]. 
Nomarski microscopy and cell ablation 
Vulval differentiation: The extent of vulval differentiation was measured as 
described previously [38]. The anatomy of L4 hermaphrodites were examined 
under Nomarski optics and the fate of individual VPCs inferred from the 
anatomy. Wild-type animals have three VPCs generating vulval progeny; 
vulvaless animals have fewer than three VPCs generating vulval progeny; 
multivulva or hyperinduced animals have more than three VPCs generating 
vulval progeny. In some cases, a VPC generates one daughter that makes vulval 
progeny and another daughter that becomes nonvulval epidermis; such VPCs 
are scored as one-half VPC differentiating into vulval tissue. 
Uterine uv1 differentiation: By Nomarski optics, then progeny that 
contribute to uv1 cells can be easily distinguished from those that become the 
utse since the nuclei of the latter undergo long-range migrations whereas those 
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of the former remain closely associated with the vulva. In wild-type animals, the 
nuclei of both ventral outer n progeny (VT4 and VT8) remain proximal to the 
vulva, while other n progeny nuclei (VT5, VT6, VT7, and VT9) co-migrate with 
the AC nucleus to either anterior or posterior of the presumptive vulval 
opening. For let-23(sy97) mutant animals and wild-type animals with P6.p 
daughters ablated at the two cell stage, n progeny nuclei were followed on either 
the left or the right side of the animal during mid to late L4 stage as described 
previously [16]. In these experiments, we observed a uvl-to-utse cell fate 
transformation, with VT4 and VT8 co-migrating with other nuclei of the utse. In 
the let-23(sy97) experiments, we sometimes observed a general delay in 
migration of n cell progeny and the AC; this may reflect the fact that in vulvaless 
animals, n daughters are born more ventrally, and contact the forming uterine 
lumen later, than in wild-type animals. In subsequent experiments, we scored 
the number of vulva-proximal cells with the characteristic uvl cell morphology 
as our assay for uvl cell fate specification. 
Cell Ablations were performed with a laser microbeam as described 
previously [39]. 
Plasm ids 
The plasmid pCC2, containing the lin-3::lacZ fusion, was constructed as follows: 
A Stui-BamHI fragment containing 7.6 kb of a 5' lin-3 genomic sequence with 2 
kb of regulatory sequence 5' to the transcriptional start site was excised from the 
cosmid F36H1 and end-filled at the Stu! site. A BamHI-Saci fragment containing 
the last 5 kb of a 3' lin-3 genomic sequence in pMob KS with a lacZ cassette fused 
in the first cytoplasmic exon of lin-3 was excised from the plasmid pRH56 [8] and 
end-filled at the Sad site. The lacZ cassette includes a trpS::lacZ fusion, a nuclear 
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localization signal, and 3' untranslated sequence from unc-54. These two 
fragments were ligated to create plasmid pCC2. 
The plasmid pk7GL44.2, containing the let-23::GFP fusion, was constructed 
as follows: Site-directed mutagenesis of let-23 genomic DNA was carried out, as 
described previously [40], in pk7-5.5, a Hindlll clone of let-23 that contains the 
last 3 kb of a 3' coding sequence plus -2 kb of 3' untranslated sequence, so that 
the let-23 stop codon and surrounding sequences were changed to an Sphl site. 
At this site, a S65T GFP cassette [41] amplified by PCR with primers containing 
Sphl site was cloned. This fragment was then excised with Sal! and Hindill and 
ligated with an -12-kb EcoRI-Sall genomic let-23 fragment and with an 3-kb 
EcoRI-Hindiii pBluescript II fragment generating the plasmid pk7GL44.2. 
Construction of transgenic strains 
Transgenic animals were generated by standard methods, which produce high 
copy number extrachromosomal arrays, commonly lost at mitosis and meiosis 
but still heritable [42]. Three sets of transgenes were used. The transgene syEx241 
was used to determine the expression pattern of the lin-3::lacZ fusion construct. It 
was obtained by microinjection of pCC2 at 27 ng/J.d, pMH86 (dpy-20(+)) at 26 
ng/~1, and carrier DNA (pSK+) at 100 ng/~1, into dpy-20(e1282) egl-38(n578) 
mutant animals, followed by crossing into dpy-20(e1282) to remove egl-38(n578) 
mutation but retain the extrachromosomal array. The transgene syEx234, used to 
analyze let-23::GFP expression, was obtained by microinjection of pk7GL44.2 at 
100 ng/~1, pMH86 at 15 ng/~1, and carrier DNA at 60 ng/ul into dpy-20(e1282) 
mutant animals. The transgene syEx284, provided by M. Wang, was generated 
by injecting a solution of hsrasDN (pPD49.83:ras"149"; 10ng/J.!l), pMH86 (15 
ng/~1) and carrier DNA (125 ng/~1) into dpy-20(e1282) mutant animals. This 
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transgene was used for the heat shock induced expression of dominant negative 
RAS variant. Heritable lines bearing the marker DNA (scored by rescue of dpy-
20(e1282)) were tested for their ability to interfere with vulval and uterine 
differentiation in response to heat shock. 
Analysis of lin-3::lacZ and let-23::GFP expression 
X-gal staining was performed as described [43] except that acetone fixation was 
omitted as this better preserved the morphology of the animals. For 
characterization of GFP expression, fluorescence was observed on a Zeiss 
Axioplan microscope with a 200-watt HBO UV source, using a Chroma High Q 
GFP LP filter set. 
Heat shock of transgenic animals 
For heat shock of syEx284, worms in which the VPC cells had divided were 
placed on 5 ern culture plates seeded with bacteria, sealed in parafilm, and 
incubated in a covered water bath at 33°C 30-35 min. 
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Figure 1. Expression pattern of lin-3 and let-23 reporter constructs in 
hermaphrodites during development of the uterine-vulval connection. 
(A) Schematic representation of cell positions in the early phase of the 
developing uterine-vulval connection. 
(B,C) GFP and Nomarski lateral images of a let-23::GFP transgenic 
hermaphrodite in the rnid-L4 stage showing let-23::GFP expression in the uvl 
cells (arrows) as a thin lateral ring connecting the uterus to the vulva. let-23::GFP 
was expressed from the let-23 promoter in the syEx234 transgenic array in a 
wild-type animal. 
(D) Ventral view of a rnid-L4larva showing expression of f)-galactosidase from 
the lin-3::/acZ reporter construct in the vulF descendants of P6.p (arrows). 
(E) Ventral-lateral view of a rnid-L4larva showing lin-3::/acZ expression in the 
vulF cells (arrows). 
(F) Lateral view of a rnid-L4larva with a multivulval phenotype showing lin-




Figure 2. Nomarski photomicrographs illustrating the cellular defects in the 
uterine-vulval connections of mid-L4let-23; sli-1 mutants. 
In wild-type (A) and sli-l(sy143) mutant (B) animals, the two specified uvl cells 
(arrows) are proximal to the vulva. In let-23(sy97); sli-l(sy143) mutant animals 
(C,D) uvl cell fate specification is abnormal. The anterior presumptive uvl cell 
was not specified and has migrated dorsally rather than attaching to the vulva. In 
all panels, anterior is to the left and dorsal is toward the top. The nuclei of the 
vulE and vulF cells are also indicated. 
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Figure 3. Expression of a lin-3::lacZ reporter construct is abolished in the vulF 
cells of egl-38 animal. 
(A) Nomarski photomicrograph of a rnid-14 egl-38(n578) hermaphrodite 
showing the failure of 1 o vulval cells to separate. 
(B) ~-galactosidase expression can not be detected from the lin-3::lacZ reporter 
construct in the vulF descendants (arrows) of P6.p of a mid-14 stage egl-38 
animal. Staining directly above the vulF cells represents expression in the 
partially out-of-focus anchor cell. 
(C,D) Heterozygous egl-38 animals were obtained by directly mating the egl-38 
transgenic hermaphrodites which carry the lin-3::lacZ reporter construct with N2 
males. Fl cross progeny express ~-galactosidase from the lin-3::lacZ reporter 
construct in the vulF descendants (arrows) whereas their homozygous parents 
did not. 
Lateral (A-C) and ventral (D) views. 
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Figure 4. A model for the uvl cell specification by a RAS-RAF dependent 
signaling pathway during development of the uterine-vulval connection. 
Each circle represents a specific cell with the name indicated in white. Arrows 
outside the cells indicate the direction toward which cells will move upon 
induction by a signaling pathway. EGL-38 acts directly or indirectly upstream of 
lin-3 as a positive regulator in the vulF cells. Expression of lin-3 in the vulF cells 
will then specify the uvl cell fate through a RAS-RAF dependent srgnaling 
pathway in a cell non-autonomous manner. 
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Table 1. 
Specification of the uv1 cell fate by 1 o vulval tissue occurs late in uterine 
development. 
Genotype Ablation % of uv1 to utse Number of 
transformation animals 
+ 0 20 
let-23( sy97) 100 12 
+ P(3-8).p 100 6 
+ P6.p descendants at 2 cell 100 4 
stage 
+ P6.p descendants at 4 cell 75 4 
stage 
+ F lineages of 25 8 
P6.p at 4 cell stage 
+ E lineages of 0 9 
P6.p at 4 cell stage 
+ P(3,4,5,7,8).p 0 8 
+ anchor cell at 4 cell stage 5 11 
+ anchor cell at 4 cell stage 5 11 
P6.p 
a p 
a p a p 
E F F E 
~ I r I r ~ 
vulE vulE vulE vulE 
vulF vulF vulF vulF 
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Table 1. 
All ablations were done during the L3 stage. Pn.p designates the VPCs at the one 
cell stage; 2-cell stage= daughters of the VPCs; 4-cell stage= granddaughters of 
the VPCs. Beneath the Table is a schematic representation of 1 o vulval cells and 
their lineal origins; adapted from Sulston and Horvitz (1977) [44]. The debris was 
not cleared in some of the ablation experiments; thus, these data demonstrate a 
requirement for the ablated cells at the indicated time points, but do not permit 
definitive conclusions regarding the ability of adjacent cells to replace them. 
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Table 2. 
LET -23-mediated signaling is required for uvl cell specification. 
Genotype % of specified uv1 cells Average number of VPCs 
a undergoing vulval differentiation 
a.+ 100 (n=20) 3.0 (n=20) 
b. sli-l(sy143) 100 (n=22) 
b 
3.0 (n=20) 
c. gap-l(n1691) 100 (n=20) 3.0 (n=21) 
d . let-23(sy97) 0 (n=12) 0.0 (n=20) 
b 
e. let-23(sy97); sli-l(sy143) 71 (n=28) 2.9 (n=l31) 
c 
f. let-23(sy97); gap-l(n1691) 10 (n=30) 2.7 (n=48) 
g. let-23(n1045) 17 (n=20) 2.5 (n=20) 
b 
h. let-60(n2021) 60 (n=20) 2.3 (n=20) 
i. lin-45(sy96) 7 (n=20) 1.4 (n=24) 
j.lin-l(n1790) 0 (n=12) 2.5 (n=15) 
Extent of uv1 and vulval differentiation in certain LET-23 mediated signaling 
pathway mutants. The number values represent percentage of specified uvl cells 
and average number of VPCs undergoing vulval differentiation per animal; 3.0 is 
wild-type level. n=number of animals scored. 
a Data scored from only animals with a morphologically normal vulva in the 
mid-late L4 stage with the exception of let-23(sy97). 
E-36 
b Data from Jongeward et al. (1995) [18]. 
c Data from Yoon et al. (1999) [45]. 
Full genotypes: 
a, N2 (wild-type); b, sli-l(sy143); c, gap-l(n1691)unc-2(e55); d, let-23(sy97)unc-
4(e120); e, let-23(sy97)unc-4(e120); sli-l(sy143); f, let-23(sy97)unc-4(e120); gap-
l(n1691)unc-2(e55); g, let-23(n1045)unc-4(e120); h, unc-24(e138)let-60(n2021); i, 
lin-45(sy96); j, lin-l(n1790) 
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Table 3. 
RAS and RAF are involved in uvl cell fate specification. 
Number of animals displaying 
wild-type vulval development 
Number of animals displaying 
abnormal vulval development 
Specified uv1 cell fate 
Laid eggs at the adult stage 
expressing dominant 
negative RAS variant 










a Animals were judged to have a wild-type vulval morphology by three criteria: 
wild-type number of vulval cells; normal cell lineages by anatomyc; characteristic 
physical appearanced. 
b Animals having wild-type vulval morphology have to match four criteria, wild-
type number of vulval cells, normal cell lineages by anatomy, characteristic 
physical appearance and correct marker gene expressione,f. 
c We refer to the group of cells descended from a single VPC as a lineage; in the 
wild-type animal, the vulva is formed by one 1 o lineage flanked by two 2° 
lineages. After two rounds of Pn.p cell division, we can easily distinguish three 
cell types (T, Land N) by Pn.pxx nuclear division (transverse "T" vs. longitudinal 
"L" vs. no division "N"); x refers to both progeny [46]. The two types of lineages 
that generate vulval cells are 1 o ([TTTT]) and 2° ( [LLTN] or [NTLL]). 
dIn the wild-type animal, after the last round of Pn.p cell division, cells of a 
canonical 1 o lineage move dorsally and detach from the ventral cuticle. By the 
mid-L4 stage, they form a symmetric arch and separate anterio-posteriorly and 
left-right to create a hole so that eggs can pass through it. The 2° lineage is 
E-38 
asymmetric: the distal cells attach to the ventral cuticle; the proximal cells detach 
and migrate dorsally. By the mid-L4 stage, they form a characteristic structure 
(Figure 1C). 
e We used egl-17::GFP expression as a marker to reflect a specific early 1 o vulval 
property and a specific late 2° vulval property [32]. egl-17::GFP is expressed in the 
1 o vulval lineages during early vulval development (mid L3) and C and D 
lineages of the 2° vulval lineage in the mid-L4 stage. 
£ Only seven out of twenty animals have been followed for the expression of egl-
17::GFP in the 1 o and 2° vulval lineages. 
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Table 4. 
let-23(sa62) is epistatic to egl-38(n578) with respect to uvl cell specification. 
Genotype 2uv1 1 uv1 Ouv1 % of specified Number of 
uv1 cells animals 
a. let-23(sa62) 21 0 0 100 21 
b. egl-38(n578) 4 8 15 30 27 
c.let-23(sa62); egl-38(n578) 32 3 0 96 35 
Extent of uv1 differentiation in let-23(sa62), egl-38(n578) and let-23(sa62); egl-
38(n578) strains. In wild-type animals, there are four uvl cells (left and right 
anterior to the presumptive vulval opening, and left and right posterior). 
Number of animals represent the number of animal sides followed. Specified uvl 
(%)indicates the percentage of specified uv1 cells relative to the wild-type 
(100%). 
Full genotypes: 
a, let-23(sa62); him-5(e1490); b, dpy-20(e1282) egl-38(n578); c, let-23(sa62); dpy-
20(e1282) egl-38(n578); him-5(e1490). 
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The RING finger/B-Box factor TAM-1 
and a retinoblastoma-like protein LIN-35 
modulate context-dependent gene 
silencing in Caenorhabditis elegans 
Jenny Hsieh, 1•2 Jing Liu, 3•4 Stephen A. Kostas, 1•2 Chieh Chang, 3 Paul W. Sternberg, 3 
and Andrew Fire1•5 
'Carnegie Institution of Washington, Department of Embryology, Baltimore, Maryland 21210 USA; 2 Johns Hopkins 
University, Biology Graduate Program, Baltimore, Maryland 21218 USA; 3 Division of Biology and Howard Hughes Medical 
Institute, California Institute of Technology, Pasadena, California 91125 USA 
Context-dependent gene silencing is used by many organisms to stably modulate gene activity for large 
chromosomal regions. We have used tandem array transgenes as a model substrate in a screen for 
Caenorhabditis elegans mutants that affect context-dependent gene silencing in somatic tissues. This screen 
yielded multiple alleles of a previously uncharacterized gene, designated tam-1 (for !andem-!!.JTay-modifier). 
Loss-of-function mutations in tam-1 led to a dramatic reduction in the activity of numerous highly repeated 
transgenes. These effects were apparently context dependent, as nomepetitive transgenes retained activity in a 
tam-1 mutant background. In addition to the dramatic alterations in transgene activity, tam-1 mutants 
showed modest alterations in expression of a subset of endogenous cellular genes. These effects include 
genetic interactions that place tam-1 into a group called the class B synMuv genes (for a Synthetic Multiyulva 
phenotype); this family plays a negative role in the regulation of RAS pathway activity in C. elegans. 
Loss-of-function mutants in other members of the class-B synMuv family, including lin-35, which encodes a 
protein similar to the tumor suppressor Rb, exhibit a hypersilencing in somatic transgenes similar to that of 
tam-1 mutants. Molecular analysis reveals that tam-1 encodes a broadly expressed nuclear protein with RING 
finger and B-box motifs. 
[Key Words: TAM-1; Chromatin Silencing; RING finger; C. elegans; Rb; RAS Pathway] 
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Eukaryotes have evolved a number of concerted mecha· 
nisms that allow extended domains of individual chro· 
mosomes to be rendered inaccessible to the transcription 
apparatus. The use of such gene silencing mechanisms 
requires two different mechanistic operations. First, a 
cell must choose specific regions of the genome for si· 
lencing. Second, a silent state must be enforced. The 
most surprising feature of chromatin silencing (and the 
feature that distinguishes silencing from more localized 
modulation of gene expression) is the substantial dis· 
tance at which silencing effects are seen. One striking 
example of this is the inactivation of the human X chro· 
mosome, which extends from a single locus (Xist) 
throughout a chromosome of 108 bases (Riggs and Porter 
1996). 
Present address: 4 Department of Neurobiology, Stanford University 
School of Medicine, Stanford, California 94305·5125 USA. 
5 Corresponding author. 
E·MAD..: !ire@maill.ciwemb.edu; FAX (410) 243·6311. 
The silencing apparatus can apparently be recruited by 
a variety of distinct features at the DNA sequence level. 
ln many cases, a specific sequence element in DNA can 
be identified as necessary and sufficient for silencing of a 
surrounding domain. Examples of silencing effects with 
a clear nucleation point include telomere and mating-
type silencing in yeast (Grunstein 1998; Haber 1998). ln 
these cases, binding of a multiprotein silencing complex 
to the cis-silencing site is thought to nucleate an ex-
tended change in local chromatin structure. 
Heterochromatin in many organisms includes regions 
of highly repetitive structure, and extensive speculation 
has attempted to link this repetitive structure to silenc-
ing properties of heterochromatin (Henikoff 1998). A po· 
tentially related class of silencing effects has been in-
ferred from studies with transgenic fungi (Selker 1997), 
plants (Assaad eta!. 1993; Ye and Signer 1996) and ani-
mals (Garrick eta!. 1998). ln these cases, a sequence that 
can be active as a single-copy locus in the genome be-
comes partially or completely inactive when repeated. 
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Sttong effects generally require that the repeats are 
present at a single site in the genome, often as a tandem 
repeat. The identification of tandemly repeated se-
quences as appropriate for silencing could conceivably 
occur by two distinct mechanisms. In the first model, a 
weak cis-silencing element might be present in each 
member of the tandem repeat. In this case, the repetition 
would initiate silencing by juxtaposing several copies of 
the weak cis-silencing element. Alternatively, the organ-
ism could possess a mechanism allowing repeated struc-
tures to be recognized by virtue of repeated character and 
not of any specific sequence. The latter seems to be the 
situation in Neurospora (Selker et al. 1987; Cambareri 
et al. 1989; Selker 1997) and Ascobolus (Goyon and Fau-
geron 1989; Rossignol and Faugeron 1994), whereas the 
limited number of transgenic constructs tested for re-
peat-dependent silencing in the other systems leave both 
models open. 
Despite the apparently conserved ability to recognize 
cenain repeated sequences in DNA, there are differences 
between biological systems in the consequences of rep-
etition. Ascobolus, Neurospora, mammals, and plants 
respond to repeated DNA structures by localized meth-
ylation of DNA (although Neurospora has the additional 
consequence of promoting point mutations in the DNA). 
Repeated structures in DNA in Drosophila produce var-
iegated or mosaic expression without any methylation of 
DNA (Dorer and Henikoff 1994, 1997). 
In Caenorhabditis elegans, transgenes are generally 
carried as heritable extrachromosomal structures con-
sisting of long tandem arrays with several hundred cop-
ies of the injected DNA (simple arrays) (Stinchcomb et 
al. 1985; Mello et al. 1991). Although expression (and 
phenotypic rescue) by such tandem arrays is readily ob-
served, a difference in transcriptional activity compared 
with the endogenous locus is seen. The activity is fre-
quently mosaic and expression levels (per copy) are fre-
quently much lower than for the endogenous gene 
(Mello and Fire 1995). This difference is not a simple 
consequence of the extrachromosomal nature of the 
simple arrays; transgenes can be integrated into the chro-
mosome by -y-irradiation producing stable transgenic 
lines, and these integrated arrays can still exhibit mosaic 
expression (e.g., Krause et al. 1994; J. Hsieh and A. Fire, 
unpubl.). Another factor that m ay affect the expression 
of simple arrays is the repetitive character inherent in 
the long tandem array. Consistent with this hypothesis, 
silencing of cenain germ-line and somatic expression 
constructs can be relieved when the plasmid DNAs are 
cotransformed with an excess of C. elegans genomic 
DNA as carrier, producing a more complex array (Kelly 
et al. 1997; S. Xu, and A. Fire, unpubl.). To avoid specific 
assumptions about the role of panicular sequences or 
general repeated structures in the silencing of tandem 
arrays in C. elegans, we will use the term context-de-
pendent gene silencing. This paper describes the genetic 
identification and molecular characterization of one 
component that acts to attenuate the context-dependent 
silencing mechanism affecting tandem array transgenes 
in C. elegans. 
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Results 
Isolation of modifiers of context-dependent 
gene expression 
T o identify factors responsible for context-dependent 
gene silencing, we screened for mutations that altered 
the activity of transgenes present in tandemly repeated 
arrays. We started with a stably integrated myo-3::gfp 
transgene expressing uniformly in all bodywall muscles 
(ccls4251; Fire et al. 1998b). After mutagenesis with eth-
ylmethanesulfonate (EMS), -4500 mutagenized gametes 
were screened. Four putative mutant lines were recov-
ered in which most, if not all, the animals have reduced-
GFP expression (Fig. 1A, B). These strains were out-
crossed to determine whether the reduced-GFP expres-
sion resulted ( 1) from changes in the trans gene array, or 
(2) from (potentially interesting) mutations in endog-
enous genes. One mutation appeared to be dominant and 
linked to the transgene array; this could have reflected a 
change in copy number or in the structure of the array 
and was not analyzed funher. 
The three reduced-GFP expression strains were shown 
to contain chromosomal mutations (cc566, cc567, and 
cc587). All three were recessive and showed a tempera-
ture-sensitive effect with the decrease in myo-3::gfp ex-
pression (relative to the parent line), most pronounced at 
25°C. At 16°C, the mutations had no observable effect on 
GFP levels. Because the mutant effects were temperature 
sensitive, all of the experiments were carried out at 
25°C. Genetic mapping placed the three mutations on 
chromosome V. Complementation tests showed the 
three mutations to be allelic. The corresponding gene 
has been named tam-1 (!andem-j!rray modifier). The 
magnitude of the tam-1(cc567) effect on the myo-3::gfp 
transgene was estimated by optical quantitation of fluo-
rescence to be -18-fold (Fig. 1C). 
The endogenous myo-3 gene is not significantly 
affected by tam-1 
Alteration in the expression of the endogenous myo-3 
locus in a tam-1 background was first tested genetically 
(Table 1). In an unc-54 null mutant background, loss of 
one copy of the endogenous myo-3 locus dramatically 
increases the severity of the muscle phenotype (Waters-
ton 1989). unc-54; tam-1 double mutants do not show a 
more severe phenotype (compared with unc-54 alone), 
indicating that expression of the endogenous myo-3 lo-
cus in a tam-1 background is within twofold of wild 
type. Immunofluorescence experiments with a MY0-3 
antibody similarly showed a lack of difference between 
and tam-1 mutant animals (data not shown). 
Transgene silencing in tam-1 mutants depends 
on chromosomal context 
We took advantage of the ability to manipulate the trans-
gene context as a means to investigate the apparent abil-
ity of tam-1 to distinguish between transgene arrays and 
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Figure 1. tam-1 effects on a repetitive myo-3::gfp transgene. 
An integrated myo-3::gfp transgene was examined in wild-type 
and tam-1(cc567) mutant backgrounds. (A) Wild-type and (B) 
tam-1(cc567) animals photographed under fluorescent illumina-
tion showing GFP in bodywall muscles (the array produces GFP 
in both nuclear and mitochondrial compartments). Scale bars, 
55 J.Im. Quantitative measurements of GFP fluorescence in 
wild-type and tam-1(cc567) mutant backgrounds. Differences in 
fluorescence level were most striking in the central region of 
the animal; thus quantitations were carried out in bodywall 
muscle nuclei in this region. Eight animals were analyzed for 
each genetic background. Fluorescence was quantitated for six 
nuclei in each animal with a Nikon U-ill multipoint sensor 
system. Linearity of fluorescence measurements in the range of 
assay was confirmed by a series of neutral density filters. (wild-
type mean- 140.9, wild-type (s.E.M.)• 5.9; tam-1 mean= 7.2, 
tam-1 s.E.M. - 0.4). A second measure of tam-1 effects on the 
expression of a repeated transgene is observed with a lin-3 trans-
gene (syls1). The average induction of vulval precursor cells 
(VPCs) caused by the expression of syls1 in wild type is 5.8 
VPCs induced (n = 20), however, in tam-1(sy272), there were 3.2 
VPCs induced (n - 1 0) (data not shown). 
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endogenous loci. We used myo-3 as a target for these 
assays, as earlier experiments (above) had shown that 
myo-3::gfp transgenes were affected, whereas the endog-
enous locus was not. The original ccls4251 transgene 
had been produced under a standard set of conditions 
that produce a highly repetitive tandem array carrying 
several hundred copies of the injected plasmid DNAs. 
We considered that differences between endogenous and 
transgene loci could have reflected (1) a difference in the 
genomic context of the endogenous gene and chromo-
somal locus, or (2) a difference between the gfp fusion 
and endogenous gene. T o distinguish between these pos-
sibilities, we examined a n ovel type of transgene (Kelly 
et al. 1997) in which the incoming plasmid DNA was 
cotransformed with an excess of genomic DNA from C. 
elegans. The latter type of transgene (called a complex 
array) has a less repetitive structure, and might thus be a 
closer approximation to the native chromosomal con-
text. Three new myo-3::gfp transgenes were produced in 
which the identical promoter was fused to gfp, but, in 
this case, was diluted 50- to 100-fold with fragmented 
genomic DNA. These complex arrays were strongly ex-
pressed and showed no difference in tam-11+) versus 
tam-11- ) genetic backgrounds (Fig. 2A,B). Taken with the 
strong effect on simple arrays, these data indicate that 
tam-1 effects on transgene activity are context depen-
dent. 
tam-1 mutants have a silencing effect 
on many different repetitive transgenes 
The overexpression of a repetitive lin-3 transgene (sylsl) 
results in a fully penetrant multi vulva (Muv) phenotype 
and provides an alternative screen for decreased trans-
gene activity (lin -3 encodes a diffusible signal for vulval 
induction, Horvitz and Sulston 1980; Hill and Sternberg 
1992) . From a screen of 73,000 EMS-mutagenized ga-
metes, 15 additional alleles of tam-1 were recovered. 
These mutants mapped to chromosome V and failure to 
complement tam-1(cc567) was observed. A representa-
tive allele of this group (sy272) also decreased the activ-
ity of the repetitive myo-3::gfp transgene, w hereas a rep-
resentative of the original group (cc567) showed the abil-
ity to decrease the activity of the lin-3 transgene. As 
with the effects on myo-3::gfp, the tam-1(sy272) effect on 
a lin-3 transgene was temperature dependent: strong sup-
pression was seen at 25°C, w h ereas only limited suppres-
sion was observed at l6°C. The distinct expression pat-
terns of lin -3 (somatic gonad) and myo-3 (bodywall 
muscle) suggested that tam-1 might have effects on gene 
expression in many or all tissues. T o test this hyposthe-
sis, the expression of additional repetitive transgenes 
was analyzed in tam-1 mutants (Table 2A). We observed 
a decrease in the expression of a number of diverse re-
porter constructs with different control signals and pat-
terns of tissue specificity (in cluding mesodermal, endo-
dermal, and n euronal tissues). ln addition, effects were 
seen with bot h lacZ and gfp transgenes. 
As shown in Table 2B, not all reporter transgenes were 
strongly affected by tam-1. No obvious characteristic 
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paralyzed as adult 
L1 arrest 
Viability Reference 
yes Brenner (1974); Epstein et al. ( 1974) 







paralyzed after hatch; reaches adulthood yes Waterson (1989) 
paralyzed as embryo no Waters ton ( 1989) 
paralyzed as adult [looks like unc-54(0) alone] yes this work 
was shared between the transgenes in which we saw no 
tam-1 effect. It is interesting, however, that several ubiq-
uitously expressed transgenes {let-858, rps-5] appeared to 
be unaffected. Two neuronally expressed gfp fusions 
were also in this category. This may not be a universal 
property of neuronal expression: tam-1 had strong effects 
on expression of egl-15::gfp, lin-11::lacZ, gpa-1::lacZ, 
and mab-5::gfp in neuronal tissues. 
tam-! effects on endogenous genes 
Although tam-1 mutants were fertile, they were not wild 
type. Brood sizes were considerably reduced. In three in-
dependent alleles [cc567, cc587, and sy272), average 
brood sizes at 25°C ranged from 55.8-105.1, compared 
with 204 for wild-type and 187 for the parental [gfp fu-
sion] strain. tam-1 mutants also showed defects in X 
chromosome segregation, as evidenced by a high inci-
dence of males [XO animals] derived from XX parents. 
Male frequencies for the three alleles varied between 
0.5% and 8.6% compared with the <0.2% incidence of 
spontaneous males in wild-type animals and in the par-
ent strain PD425l. 
Sensitized genetic assays were used to test for tam-1 
effects on several endogenous genes [Table 3]. No effects 
{i.e., less than a twofold difference] was seen for unc-22 
{data not shown], or for gain-of-function alleles of let-23 
and let-60. In a number of other sensitized genetic as-
says, we found modest enhancement by tam-1, in each of 
these cases [lin-2, let-2, lin-3), a partial loss-of-function 
allele gave a more severe phenotype in a tam-1[- ) genetic 
background. For example, tam-1 reduced vulval differen-
tiation in a lin-3 hypomorphic strain e1417 to the level 
of the e1417 /null hemizygote; thus, there was an ap-
proximately twofold effect. Similar arguments indicated 
that the magnitude of the tam-1 effect on lin-2 and let-2 
activity was also approximately twofold. 
tam-l has properties of a class-B synthetic Muv gene 
Two C. elegans genes were recently identified [lin -35 
and lin-53) with a redundant role in the modulation of 
RAS signaling [Lu and Horvitz 1998). Mutations in these 
genes, like tam-1, are viable and have modest genetic 
interactions with extragenic mutations.lin-35 and lin-53 
encode proteins similar to Rb and Rb-associated protein 
p48, respectively. lin-35 and lin-53 are members of a 
larger class of genes, called class-B synMuv genes, which 
are defined by the observation that null or hypomorphic 
mutations lead to little or no phenotypic effect unless a 
second mutation is present in a distinct set of genes 
termed the class-A synMuv genes {Horvitz and Sulston 
1980; Ferguson and Horvitz 1989). Double mutants car-
rying a class-A and a class-B allele show phenotypes 
characteristic of hyperactivity of the RAS-signaling path-
way [most notably a Muv phenotype). Numerous class-A 
and class-B synMuv genes have thus been identified by 
these studies, with the working model that these sets of 
genes define two redundant pathways inhibiting EGFR-
RAS-signaling activity. 
Given the fact that lin-35 and lin-53, two class-B Syn-
Muv genes, encode factors shown to mediate chromatin 
repression in other systems [Lu and Horvitz 1998; Luo et 
a!. 1998), we investigated the relationship of tam-1 to 
these groups of genes. Double mutants canying a tam-1 
mutation and a mutation in lin-15A {a class-A synMuv 
gene) showed a Muv phenotype at 25°C {Table 4; Fig. 
3A]. In contrast, tam-1(cc567); lin-1 5B(n744) double mu-
tants did not have a Muv phenotype (Table 4). Two other 
class-A synMuv genes were analyzed for interactions 
with tam-1 . Double mutants carrying tam-1{cc567) and 
the class-A synMuv mutation lin-38{n751) showed a syn-
thetic multivulval phenotype, whereas no such pheno-
type was observed in tam-1 {cc567); lin-8(nlll ]. The lat-
ter result may indicate a functional division within the 
A class of synMuv genes, although it should be noted 
that differences in penetrance of the Muv phenotype in 
different A / B combinations have been observed previ-
ously {Ferguson and Horvitz 1989; Thomas and Horvitz 
1999). In any case, it is clear from the interaction with 
lin-15A and lin-38 that tam-1 shares functional proper-
ties with the previously identified class-B synMuvs. 
An additional connection between tam-1 and the 
class-B synMuv family comes from analysis of tandem 
array transgene activity in previously characterized 
class-B synMuv mutants. A mutation eliminating the RB 
GENES &. DEVELOPMENT 2961 






~ X z a ~ X X 
" X X u:,.. 
j(~ j! X 
lfi !ll'i X 
~ xxxx X xx * x~ 
~ 10 ~ d~ ll: ~ ~~ x~"' "" X ~ lf x llx x 
X X 
Individual Worms 
c wild-type tam· t(cdtf1') ~~n74.5) 
myo-3::gtp Slmp!o ++++ + + 
m"'""'glp Complex ++ ++ ++ 
•gJ-15::gtp Simp'- +++ + 
~l-15:.:gtp Comp!n ++ NO ++ 
Figure 2. Assessment of tam-1 effects in a nonrepetitive con-
text. A nonrepetitive transgene array lccEx6172) was compared 
in wild-type and tam·1lcc567) mutant backgrounds. lA) Wild-
type and tam-1lcc567) animals photographed under fluorescent 
illumination showing GFP in bodywali muscles lthe array pro-
duces GFP in nuclei). Scale bar, 55 Jlm. I B) Quantitation of fluo-
rescence was carried out in six nuclei in the central region of the 
body for each of eight animals as in Fig. lB. lwild-type 
mean- 15.2, wild-type S.E.M. = 1.4; tam-1 mean - 15.6, tam-1 
s.E.M. - 1.7). ICJ Analysis of repetitive lsimple) and nonrepeti· 
tive I complex) transgene activity in wild-type, tam-1lcc567) and 
lin-35jn745) backgrounds. Transgenes are as described in Mate-
rials and Methods. 
homolog Lin-35 was tested by simple and complex arrays 
of myo-3::gfp and of egl-15::gfp !Fig. 2C). The two simple 
transgene arrays were both silenced in a lin-35ln745) 
background, whereas no effect of lin-35ln745) on either 
complex array was observed. Five additional class-B mu-
tants llin-9ln112), lin-15Bin744), lin-36ln766), lin-
51(n770), and lin-52ln77lll were tested for silencing of a 
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simple transgene array; all except for lin-36ln766l were 
found t o produce a transgene-silencing phenotype simi-
lar to tam-1 (Fig. 3B,C; data not shown). The class-A 
synMu v mutations lin-Bin111), lin-15Ain767), and lin-
38ln751) sh owed no transgene-silencing phenotype. 
Molecular identification of tam-1 
The tam-1 locus was mapped more precisely to a small 
region of chromosome V very close to the gene unc-46 
(Fig. 4A). On the basis of the known position of unc-46 
on the physical map, IE. Jorgensen, pers. comm.J we ob-
tained cosmids that covered this region, injected pools of 
overlapping cosmids, and assayed for rescue of tam-1 ef-
fects on m yo-3::gfp expression. We found that cosmid 
F26GS rescued the decreased-GFP phenotypes of three 
tam-1 alleles !Fig. 4B). Testing of subcloned fragments 
from this cosmid led to the identification of an 8.6-kb 
fragment with rescuing activity !Fig. 4C). A single gene 
Table 2. tam-1 effects on reporter transgene activity 
Relative intensities of reporters 
Construct expression pattern wild-type tam-1 
A myo-3::gfp body-wall muscle ++++ + 
vulval muscle +++ + 
unc-54::gfp body-wall muscle +++ + 
hlh-1::gfp body-wall muscle ++ 
myo-2::gfp pharyngeal muscle ++++ ++ 
F22B7.9::gfp gut ++ 
egl-15::gfp vulval muscle +++ 
gut + 
neurons near head + 
lin-3::lacZ anchor cell +++ + 
gpa-1::lacZ head neurons +++ + 
plasmid neurons +++ + 
lin-11::lacZ 2 o vulval lineages ++ 
VC motor neurons +++ 
ventral uterine '1T cells ++ 
and their progeny 
mab-S::gfp posterior region + 
neurons near tail + 
B let-858::gfp all somatic nuclei +++ +++ 
rps-S::gfp all somatic nuclei +++ +++ 
glr-1::gfp subset of neurons +++ +++ 
unc-119 ::gfp many neurons +++ +++ 
Expression of tandernly repeated transgenes in wild-type and 
tam-1 mutants. GFP transgenes were examined in tam-
1(cc567), and lacZ transgenes were examined in tam-1(sy272). 
Number of plus signs 1+1 indicate relative intensity of GFP fluo-
rescence or lacZ signal. 1-1 No observable signal. In cases where 
no expression was observed in tam-1 mutants, an outcross was 
performed to confirm the reappearance of reporter expression. 
(A) tam -1 effects were seen on a number of different reporter 
constructs. (B) Other transgenes showed little or no effect in 
tam-1 mutants. Additional myo-3::gfp and rps-S::gfp transgenes 
!independently derived) were tested in wild-type and tam-
1(cc567) backgrounds and showed similar results ldata not 
shown). 
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Table 3. tam-! effects on endogenous gene activity 
Genotype Phenotype 





sterile or semisterile adults (n - 8) 
L1 or L2 lethal (n > 20) 
lin-2(n768) 3.25 VPCs induced (n - 26) p < 0.0001 
lin-2(n768); tam-l{sy272) 1.81 VPCs induced (n - 18) 
lin-3(e1417} 0.66 VPCs induced (n - 102) p < 0.0001 
lin-3{el417); tam-l{sy272) 0.29 VPCs induced (n - 92) 
let-23(sa62) 3.42 VPCs induced (n - 6) p - 0.17 
let-23{sa62); tam-l(sy272) 4.4 VPCs induced (n - 4) 
let-60(n1046} 3.97 VPCs induced (n - 16) p - 0.0029 
let-60{nl046); tam-l{sy272) 4.93 VPCs induced (n - 32) 
Phenotypes are described for a number (n) of animals for each of the genotypes. The state of vulval morphogenesis was assessed by 
counting induced vulval precursor cells (normally three in wild type). Statistically significant differences between wild-type and 
tam-l(sys272) were observed in lin-2(n768}, let60{n1046}, and lin-3{e1417) backgrounds. The average induction of VPCs for lin-
3(e1417)/lin-3(n1059) is 0.34, n - 22 (P.W. Sternberg, unpubl. ). For statistical analysis, a Fisher's exact test was performed using Ins tat 
(GraphPad Software). 
had been predicted in this region (C. elegans Sequencing 




Figure 3. tam-1 has properties of a class-B synMuv gene. (A) 
lin-15A(n767); tam-l(cc567) double mutants are Muv (arrow-
heads indicate the position of vulvae). Scale bar, 27.5 pm. Other 
class-B synMuv mutants have decreased transgene expression. 
(B) The expression of ccls4251(myo-3::gfp) is examined in wild-
type and homozygous lin -15B(n744) animals. Scal e bar, 87.5 
pm. (C) The expression of the same transgene is also examined 
in wild-type and homozygous lin-9(n112) animals. Scale bar, 
87.5 )lin. 
unique Aatii site within the coding region, the resulting 
fragment was incapable of rescuing tam-l(cc567). The 
mRNA structure predicted by the sequencing consor-
tium (Fig. 4D) was correct, as determined by completing 
the sequence of a full-length eDNA clone obtained from 
Y. Kohara [pers. comm.; accession nos. C42160 (5'), 
C31634 (3')]. Next, we identified the molecular lesions 
associated with three of the tam-1 alleles (Fig. 4E). All 
three alleles resulted in nonsense mutations, with cc567 
containing the most amino-terminal stop codon. 
The predicted TAM-1 protein contains two cysteine-
rich regions, a C3HC4 (RING finger) motif and a B-box 
motif. The RING finger and B-box motifs have been de-
fined by primary sequence comparisons; although both 
domains may act as metal (zinc)-binding domains, there 
is not yet any basis to predict specific biochemical func-
tion (Saurin et al. 1996). C. elegans contains 90 RING 
finger proteins (C. elegans Sequencing Consortium 
1998). Several Drosophila proteins with roles in global 
regulation of chromosome activity also contain RING 
finger motifs; these include the Posterior Sex Combs 
(PSC) and Suppressor Two of Zeste [Su(Z)2] proteins 
(which are involved in the maintenance of repressed 
transcriptional states by the polycomb family; Brunk et 







3 VPCs induced (n - 15) 
3 VPCs induced (n - 15) 
4.9 VPCs induced (n - 20) 
2.9 VPCs induced (n - 15) 
The average induction of vulval precursor cells for each geno-
type is shown. All counts of VPC induction were performed 
with L4 staged animals at 25°C. At 20°C, the frequency of mul-
tivulva animals in tam-l(cc567); lin-15A{n767) double mutants 
decreased considerably. 
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TPPPGN~ RRRVDRKPKTEEPEQY.ETE ?V DPVHRAPKRRQT 920 
SAASSSSNCHPSSSAPTTRSQTRL 
Figure 4. Molecular identification of tam-1. lA) Genetic mapping placed the tam-1 locus to the left of the gene unc-46. (B) Pools of 
cosmids were assayed for rescue of the reduced-transgene·expression phenotype of tam-1(cc567). Cosmid F26GS was found to rescue 
the decreased-GFP phenotype of tam-1(cc567); ccls4251jmyo-3::gfp). Rescue was also observed for two other tam-1 alleles, cc587 and 
sy272. (C) Deletion analysis of cosmid F26GS led to the identification of an 8.6-kb fragment (1127) with rescuing activity. Analysis 
of the sequence of this fragment had predicted a single coding region (C. elegans Sequencing Consortium 1998). Creation of a 
frameshift in a unique Aatii site within this coding region abolished rescue. (D) A full-length eDNA was obtained from the Kohara 
laboratory. Sequencing of this eDNA confirmed that the tam-1 mRNA sequence contains seven exons and six introns. (E) Amino acid 
sequence of TAM-1. Underlined are the RING finger (solid line) and B-box (broken line). Sequencing of tam-1 alleles (cc567, sy272, and 
cc587) revealed in each case the conversion of a glutamine codon (CAA) to a nonsense codon (TAA). DNA from tam-1 mutants was 
amplified by PCR; this was done in several segments covering a region from 288-bp upstream of the ATG to 440-bp downstream of 
the deduced tam-1 translational stop. PCR products were directly sequenced, with mutations confirmed by sequencing products from 
at least two different PCR reactions. The three distinct mutations are indicated by arrowheads. 
al. 1991), and MSL-2 !involved in sex-specific activation 
of the X chromosome in males; Zhou et al. 1995). Al-
though these comparisons are intriguing, proteins con-
taining RING finger and B-box motifs have been found in 
many additional biological processes !Fig. 5). The simi-
larity of TAM-I to other characterized RING finger and 
B-box proteins does not extend outside of these two do-
mains. 
TAM-1 protein is present in nuclei 
throughout development 
We raised polyclonal antibodies against two nonoverlap-
ping protein fragments from the carboxyl terminus of 
TAM-1. The two antisera gave identical patterns, with 
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staining in the nuclei of most, if not all, somatic cells in 
wild-type embryos !Fig. 6A,B). The nuclear distribution 
was uniform, with staining beginning at about the 20-
cell stage and persisting throughout development. There 
was also nuclear staining !albeit somewhat fainter) in 
larval and adult cells and germ-line and oocyte nuclei 
(Fig. 6C,D). Antibody specificity was verified by exam-
ining null mutant embryos, larvae, and adults I no detect-
able staining by either antisera). 
tam-1 is not essential for viability 
Several observations support the hypothesis that the vi-
able chain-termination allele tam-1lcc567) is a null mu-
tation: Ill tam-1 icc567) is predicted to result in transla-
F-9 
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Figure 5. Sequence alignments of RING 
finger and B-box motifs of TAM-I with re-
lated segments of other proteins. Con-
served cysteine and histidine residues are 
underlined. A limited number of members 
of each family were chosen arbitrarily. 
GenBank contains >100 entries with 
RING finger motifs. Alignment of RING 
finger motifs: Numbering below each con-
served cysteine refers to zinc binding li-
gands cysteine !-cysteine 7 (Saurin et al. 
1996) . Percent identity refers to just the 
RING finger domain. Alignment of B-box 
motifs: Sources for RING fingers and B-
Box motifs used in this comparison are 
RAD18 (Jones et al 1988); RPT-1 (Patarca 
et aL 1988); PSC, SU(Z)2 (Brunk et al. 
1991); SS-A/Ro (Chan et aL 1991); XNF7 
(Reddy et al. 1991); RAD16 (Bang et aL 
1992)1 PML (Kastner et al. 1992); PAF-1 
(Shimozawa et al. 1992); PwA33(Bellini et 
al. 1993); MEL-18 (Ishida et al. 1993); 
PAR-2(Levitan et al. 1994); BRCAl (Miki 
etal. 1994); HT2A (Fridell et al. 1995); TIS 
(Miki et al. 1991; LeDoyerin et al. 1995); 
RFP (Cao eta!. 1997)1 RING I (Satijn eta!. 
1997)1 BMI-1 (Hemenway et al. 1998); and 
XL43, XL75 (Perrin and Lacroix 1998). 
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tional arrest after synthesis of only 50 amino acids; (2) 
Hemizygous [tam-1(cc567)/nDf32] animals showed a 
phenotype indistinguishable from tam-1(cc567)ftam-
1(cc567) (data not shown); (3) double-stranded RNA in-
terference (Fire et al. 1998b) with a segment of tam-1 
produced a nonlethal reduced-GFP phenotype identical 
to that of tam-1(cc567) (data not shown); (4) viable tam-1 
alleles arose at a high frequency (2.2 x 10-4 after EMS 
mutagenesis) close to reported knockout frequencies for 
C. elegans (Brenner I974); and (5) there was no detectable 
staining with either TAM-I antibody in tam(cc567) (data 
not shown). 
Discussion 
tam-I and context-dependent gene silencing 
We have presented eviden ce that TAM-I, a novel RING 
finger and B-Box factor, plays a role in modulating con-
text-dependent gene silencing. C. elegans transgenes are 
often subject to silencing when present in tandemly re-
peated array structures (simple arrays). This silencing is 
particularly evident in the germ line (Kelly et aL 1997), 
but can also be observed in the soma of C. elegans (Ok-
kema et aL 1993; Krause et aL 1994). This silencing ap-
pears to be context dependent because it can be attenu-
ated or abolished by placing the transgene in a less re-
petitive context (complex arrays). 
In tam-1 null mutants, the silencing of transgenes pre-














comparisons suggest that tam-1 effects on gene expres-
sion are sensitive to chromosomal context. First, the dra-
matic reductions in activity seen with simple arrays 
(e.g., 18-fold for a canonical myo-3::gfp array) were not 
seen with the corresponding endogenous loci (e.g., no 
effect on the endogenous myo-3 locus in an assay in 
which a twofold effect would have been observed). Sec-
ond, complex arrays are much less susceptible to silenc-
ing in a tam-1 null mutant background. This suggests 
that the silencing activity in tam-1 mutants has some 
degree of preference for repetitive transgene arrays. 
Hence, the wild-type TAM-I product appears (directly or 
indirectly) to be attenuating context-dependent silenc-
ing. 
Although tam-1 had no discernible effect on the en-
dogenous myo-3 locus, a number of genes showed an 
apparent decrease in expression levels in a tam-1 mutant 
background. Although the mechanistic basis for these 
modest effects was not investigated further, one possi-
bility is that all effects of tam-1 might reflect a direct 
potentiation of context-dependent silencing; in this 
model, the silencing mechanism might have drastic ac-
tivity for some regions of chromosomes (e.g., regions 
that might behave similarly to highly repeated transgene 
arrays) with a less evident effect on other regions (e.g., 
subtle or indirect effects on genes in partially repetitive 
chromosomal areas). An additional possibility is that 
tam-1 might be a specific transcription factor regulating 
a small number of target genes, including one or more 
genes with a general role in context-dependent silencing. 
Clearly the above models are not mutually exclusive. 
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Figure 6. Immunofluorescence detection of TAM-1 protein in 
nuclei. {AI Embryo population and {CJ an adult stained with 
mouse anti-TAM-1 and visualized with a secondary goat anti-
Cy3 antibody. {B,DJ Corresponding images of DNA localization, 
visualized with DAPI. Photos shown are from antisera to 
TAM-1 residues 594-712. Similar results were seen with anti-
sera to TAM-1 residues 778-856. Signal inC has been augmented 
by electronic contrast enhancement. Scale bars, 27.5 J.lm. 
A connection between context-dependent gene 
silencing and control of the RAS pathway! 
Genes of the class-B synMuv family have been shown to 
play a role in the modulation of EGFR- RAS pathway 
activity during vulval specification. This role is redun-
dant in that loss-of-function mutants in class-B genes 
show vulval specification defects (apparent hyperactivity 
of the RAS pathway) only if a second mutation in a 
class-A synMuv gene is present (Horvitz and Sulston 
1980; Ferguson and Horvitz 1989; Clark et al. 1994; 
Huang et al. 1994). Although much of the genetic analy-
sis of class-B synMuv activity has involved analysis of 
vulval specification, mutants have also been reported to 
exhibit defects in growth and fertility, suggesting addi-
tional functions for these genes outside the vulva (Fer-
guson and Horvitz 1989). 
Our work extends this analysis in two ways. First, 
TAM-1 was shown to have properties of a class-B syn-
Muv factor and also to modulate transgene reporter ac-
2966 GENES &. DEVELOPMENT 
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tivity in a wide variety of nonvulval tissues including 
mesoderm (pharyngeal muscles, body muscles, and so-
matic gonad), endoderm (gut) and at least a subset of 
neurons (from expression of egl-15, lin-11, gpa-1, and 
mab-5). Second, we have observed effects of previously 
characterized class-B synMuv genes (lin-9, lin-15B, lin-
35, lin-51, and lin-52) on transgene activity levels in ex-
tensive subsets of mesoderm. Although not all class-B 
synMuv genes have been examined, and not all cell types 
have been included in the reporter expression patterns 
that were tested, it appears likely that this family of 
genes might act in most or all tissues of the animal. 
Consistent with this hypothesis, tam-1 and several other 
class-B synMuv genes encode proteins with broad ex-
pression patterns (Lu and Horvitz 1998; this work; 
L.Huang, J. DeModena, and P.W. Sternberg, unpubl.). 
What are the natural targets of the class-B synMuv 
family? As noted above for tam-1, one possibility for the 
class-B SynMuv factors is that they form a relatively spe-
cific regulatory complex whose targets include both RAS 
pathway components and (independently) factors in-
volved in the modulation of repetitive transgenes. Under 
these circumstances, there would be no direct link be-
tween RAS signaling and silencing of repetitive arrays. 
We favor the alternative hypothesis that some relation-
ship exists between these two processes. In particular, 
our current working model is that the class-B synMuv 
factors modulate context-dependent silencing of a wide 
variety of biological targets; some of these targets may be 
endogenous genes that are present in areas of repetitive 
sequences or an otherwise inopportune genomic envi-
rontnent. 
At some level, the effects of the class-B synMuv genes 
are likely to involve changes in the acetylation state of 
histones in chromatin. The strongest indication for this 
hypothesis comes from the ability to induce a class-B 
synMuv phenotype by selective disruption of histone 
deacetylase-1 (hda-1) function and from the existence of 
a complex containing LIN-35 (Rb), LIN-53 (p48), and 
HDA-1 (Lu and Horvitz 1998). It is not clear whether 
TAM-1 participates as a part of this complex, or whether 
the complex interacts directly with repetitive transgene 
arrays. The directionality of the class-B synMuv effect 
should be considered in evaluating the following: trans-
gene expression is reduced in the absence of LIN-35 or 
T AM-1 function. Thus, if there were a direct interaction 
in wild-type animals, it would be (unexpectedly) a posi-
tive effect. In many cases, histone deacetylase complexes 
are thought to act as negative regulators of gene expres-
sion (Kuo and Allis 1998). An additional possibility is 
that the class-B synMuvs normally act to direct silencing 
factors to a defined set of targets not including tandem 
array transgenes; under these circumstances, class-B mu-
tants might result in an excess of unused silencing fac-
tors and consequent hypersilencing of certain loci (in-
cluding transgene arrays) with susceptibility to the 
process. A similar proposal involving differential parti-
tioning of a limiting supply of generalized silencing fac-
tors was proposed by Grewal and Klar (1998) in their 
studies of chromosomal silencing in fission yeast. 
Materials and methods 
C. elegans strains and culture 
Conditions for growth and maintenance were as described 
(Brenner 1974). Unless stated otherwise, experiments were con-
ducted at 25°C. Wild-type N2 (var. Bristol) and the standard 
mutant strains listed below are as described by Brenner (1974), 
unless otherwise noted. The following genes and alleles were 
used: LG I, unc-54(e190), lin-35(n745) unc-13(e189) (Ferguson 
and Horvitz 1989); LG II, let-23(sa62) unc-4(e120) (Katz et al. 
1996), lin-8(nlll) dpy-10(e128) (Ferguson and Horvitz 1989), 
lin-38(n751) (Thomas and Horvitz 1999); LG ill, lin-9(n112) (Fer-
guson and Horvitz 1989), lin-36(n766) unc-32(e189) (Thomas 
and Horvitz 1999), lin-51(n770) unc-32(e189) (Thomas and Hor-
vitz 1999), lin-52(n771) unc-32(e189) (Thomas and Horvitz 
1999); LG IV, dpy-20(e1282), lin-3(e1417) (Horvitz and Sulston 
1980), let-60(n1046) unc-31(e169) (Ferguson and Horvitz 1985; 
Han and Sternberg 1990); LG V, tam-1(cc566, cc567, cc587, and 
sy272), unc-46(e177), dpy-11(e224}, unc-42(e270), dpy-11(e224) 
nDf32/eT1 (Park and Horvitz 1986); and LG X, lin-2(n768), let-
2(mn114) unc-3(e151), lin-15A(n767) (Ferguson and Horvitz 
1985), lin-15B(n744) (Ferguson and Horvitz 1985). 
Plasmid constructs used in transgenes 
pSAK-2 (myo-3::Ngfp-lacZ) contains the myo-3 promoter driv-
ing gfp expression in all nonpharyngeal muscles; a nuclear lo-
calization signal (NLS) and lacZ sequences are appended to the 
reporter coding sequence, and lead to predominantly nuclear 
localization (Fire et al. 1998b). 
pSAK-4 (myo-3::Mtgfp) contains the myo-3 promoter driving 
gfp expression in nonpharyngeal muscles; the GFP has a mito-
chondrial localization signal (Fire et al. 1998b). 
pPD96.02 (unc-54::Ngfp-lacZ) contains the unc-54 promoter 
driving NLS::gfp::lacZ in nonpharyngeal muscles (Fire et al. 
1998a). 
pPD105.19 (unc-54::Mtgfp) contains the unc-54 promoter 
driving gfp expression with a mitochondrial localization signal 
in nonpharyngeal muscles (Fire ct al. 1998a). 
pPD93.92 (hlh-l::gfp) is a translational fusion containing the 
hlh-1 promoter and first exon driving gfp expression in m yo-
genic precursor cells and bodywall muscles (derived from 
pPD37.48 (Krause et al. 1990) by substitution of gfp for lacZ). 
pPD118.33 (myo-2::gfp) contains the myo-2 promoter driving 
gfp expression in pharyngeal muscle (S. Xu and A. Fire, unpubl.). 
pPD103.68 (F22B7.9::gfp) is a translational fusion driving gfp 
in the gut (S. Xu and A. Fire, unpubl.). 
pNH#300 (egl-15::gfp) contains the egl-15 promoter driving 
gfp expression in Vm1 vulval muscles (Harle et al. 1998). 
pRH9 (lin -3) is a lin-3 genomic construct (Hill and Sternberg 
1992). 
pCC2 (lin-3::lacZI is a translational fusion of the lin-3 pro-
moter and coding region before the first cytoplasmic domain 
driving lacZ expression in the anchor cell and many other tis-
sues (Chang et al. 1999). 
pjM1HG.ll (gpa-l::lacZ) contains the gpa-1 promoter driving 
lacZ expression in plasmid neurons, PHA and PHB (J. Mendel 
and P.W. Sternberg, unpubl.). 
pGF66 (lin-11::lacZ) is a translational fusion that drives lacZ 
expression in descendants of vulval precursor cells (P5.pp and 
P7.paj, VC motor neurons, and in the ventral uterine p cells and 
their progeny (Freyd 1991). 
pCH22 (mab-S::gfp) contains the mab-5 promoter driving gfp 
expression in cells of the posterior region (Hunter et al. 1999). 
BK48 (let-858::gfp ) contains a complete copy of the let-858 
gene tagged by in-frame insertion of a gfp cassette within the 
F-11 
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coding region, yielding gfp expression in all somatic nuclei 
(Kelly et al. 1997). 
pPD129.51 (rps-5::gfp) contains the promoter for the gene 
TOSE11.1 (encoding ribosomal protein SS) driving gfp expres-
sion in all somatic nuclei () . Fleenor and A. Fire, unpubl. ). 
pG75#KP6 (glr-l::gfp) contains the glr-1 promoter driving gfp 
expression in a subset of neurons (H. Hutter, pers. comm.). 
pDP#MMUGD12 (unc-119::gfp) is a translational fusion con-
taining the unc-119 promoter and unc-119 genomic region driv-
ing gfp expression throughout the nervous system (Maduro and 
Pilgrim 1995). 
pRF4 (rol-6 [su1006J) carries a dominant allele of the gene 
rol-6 that leads to an easily identified rolling phenotype. 
pMH86 (dpy-20{+ ]) carries a wild-type copy of the gene dpy-20 
that provides a ready selection for transgene function in a dpy-
20(e1282ts) background (Han et al. 1993; Clark et al. 1995). 
Transgenic lines 
In some cases (lines referred to as lsi, the transgene arrays had 
been integrated by -y-ray mutagenesis. In all other lines (referred 
to as Ex), the transgene arrays remained extrachromosomal. 
For each transgenc, the comparison of wild-type with tam-
1(-) and/or lin(-) backgrounds was made several generations 
after the strain had been established; at this point simple cul-
ture of the strains produced no evident instability in expression 
or transmission properties. Effects on transgene expression were 
observed in all animals from each affected population (>100 
animals for each transgene). 
Simple array lines were produced by injection of a mixture of 
the circular reporter plasmid and a circular selectable marker 
plasmid, with no other DNA added as carrier (Mello and Fire 
1995). 
ccls4251 pSAK2(myo-3::Ngfp-lacZ), pSAK4(myo-3::Mtgfp), and 
pMH86 (Fire et al. 1998b). The multicopy tandem-array charac-
ter of the ccls4251 transgene was confirmed by Southern blot 
analysis (showing -100 copies each of pSAK2 and pSAK4; data 
not shown). ccls4251 was obtained following treatment with 
-yrays and shows some crossover suppression activity in the cen-
ter of chromosome I. 
ccEx6188 pSAK2(myo-3::Ngfp-lacZ) and pRF4 (this work). A 
simple extrachromosomal transgene w ith expression levels 
comparable with the integrated ccls4251 array, ccEx6188 was 
used to assay mutations on chromosome I (e.g., lin-351 for si-
lencing effects. 
ccls9385 pPD96.02(unc-54::Ngfp-lacZ), pPD105.19(unc-54:: 
Mtgfp), and pRF4 (Fire et al. 1998a). 
ccls7963 pPD93.92(hlh-1::gfp) and pRF4 (K. Dej and A. Fire, 
unpubl.) . 
ccls4792 pPD95.29(pes-10::gfp), pPD118.33(myo-2::gfp), pPD103. 
68(F22B7.9::gfp), and pMH86(M. Edgley, K. Liu, A. Fire, and D. 
Riddle, unpubl.) 
ayls2 pNH#300(egl-15::gfp) and pMH86 (Harle et al. 1998). 
syls1 pRH9(lin-3) and an unc-31 subclone (selectable marker) 
(Hill and Sternberg 1992; this work; J. Liu, unpubl.). 
syEx241 pCC2(lin-3::lacZ), pMH86, and pSK+ as carrier 
(Chang et al. 1999). 
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syls19 cpjM1HG.11(gpa-1::lacZ) and pMH86 (J. Mendel and 
P.W. Sterberg, unpubl.). 
nls2 pGF66(1in-11::lacZ) and pGF60(lin-11 rescuing plasmid) 
(Freyd 1991). 
muls16 pCH22(mab-S::gfp) and pMH86 (Hunter et al. 1999). 
ccEx7997 BK48(1et-858::gfp) and pRF4 (Kelly et al. 1997). 
ccEx8151 pPD129.5l(rps-S::gfp) and pRF4 (J. Fleenor and A. 
Fire, unpubl.). 
rhls4 pG75#KP6(glr-1::gfp) and pMH86 (H. Hutter, pers. 
comm.). 
edls6 pDP#MMUGF12(unc-119::gfp) and pRF4 (Madura and 
Pilgrim 1995). 
Complex array lines were produced by injection of a mixture 
of the linear reporter plasmid, a linear selectable marker plas-
mid, and an excess of Pvuii-fragmented genomic DNA from C. 
elegans as carrier. Plasmids were linearized with a unique 
blunt-cut enzyme in the vector backbone. Mass ratios (genomic 
DNA/plasmid DNA) were -50-100:1, with the concentration of 
plasmid -1-2 pg/ml. 
ccEx6172 pSAK2(myo-3::Ngfp--lacZ) and pRF4, with excess 
genomic C. elegans DNA as carrier. Copy number of pSAK2 
within the ccEx6172 transgene was confirmed to be 1-2(South· 
ern blot analysis; data not shown). 
ccEx6176 pNH#300(egl-15::gfp) and pMH86 with excess geno-
mic C. elegans DNA as carrier. 
Genetic screens 
Screen for decreased expression of myo-3::gfp PD4251 ani-
mals carrying an integrated myo-3::gfp transgene expressing in 
bodywall and vulval muscles were mutagenized with EMS as 
described (Brenner 1974). Nonclonal F2 and F3 populations were 
observed under direct fluorescent illumination and animals 
with uniformly reduced GFP activity recovered for further 
analysis. We screened -9000 F2 animals and identified four in-
dependent mutations with distinctly decreased GFP activity. 
One of these mutations was subsequently shown to be tightly 
linked to the original transgene and was not further character-
ized. The other three mutations (cc566, cc567, and cc587) were 
all recessive and failed to complement, defining the tam-1locus 
on chromosome V. We observed some differences in phenotype 
between alleles; cc566 and cc567 animals showed strongest re-
duction of myo-3::gfp activity in the center of the body, with 
lesser effects in head and tail regions. cc587 showed a less dra-
matic reduction in GFP with no evident differences between 
head, body, and tail. 
Screen for decreased expression of a lin-3 transgene Addi-
tional alleles of tam-1 were identified as part of an independent 
screen for reversion of a Muv defect caused by an integrated 
high-copy lin-3 transgene (syls1). This screen yielded (1) several 
mutants corresponding to known components of the lin-3-sig-
naling pathway (J. Liu and P.W. Sternberg, unpubl.) and (2) 15 
alleles of tam-1 (sy270, sy272, sy273, sy342, sy366, sy372, 
sy394, sy395, sy398, sy399, sy401, sy402, sy410, sy411, and 
sy412). 
Genetic and molecular analysis of tam-! Mapping of tam-1 
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was carried out with allele cc567 by standard methods. Three-
factor mapping was done with unc-46 dpy-11/tam-1; ccls4251. 
16/16 Dpy-non-Unc picked up tam-1, whereas 10/10 Unc-non-
Dpy did not pick up tam-1; also 9/9 Dpy-non-Tam picked up 
unc-46, indicating that tam-1 is very close or to the left of unc-
46. A genetic deficiency in this region, nDf32 failed to comple-
ment tam-1. unc-46 has thus been used as a linked marker in 
introducing tam-1 into various genetic backgrounds. unc-46 
(without tam-1) has also been introduced into a variety of trans-
gene-carrying strains and has shown no effect on transgene ex-
pression. 
By use of the intensiry of GFP fluorescence in adults carrying 
the ccls4251 transgene as an assay, all tam-1 alleles tested 
(cc567, cc566, cc587, and sy272) were recessive and showed no 
evidence of maternal effect. This assay was used for all comple-
mentation and genetic rescue assays with tam-1. 
Phenotypic rescue of tam-1 mutants was assayed in trans-
genic lines derived from microinjection of DNAs into homozy-
gous tam-1 mutants (Mello and Fire 1995). Cosmid DNAs were 
injected at 10-20 pg/ ml. To identify transgenic lines, plasmid 
pRF4, which contains the semidominant mutation rol-6 
(su1006), was coinjected at 100 pg/ ml(Mello et al. 1991). For 
each cosmid mixture, several independent transgenic lines were 
recovered and scored for restoration of gfp expression to levels 
comparable with those seen in the parental strain PD4251. A 
positive pool of five cosmids was successively divided, leading 
to the identification of a single rescuing cosmid, F26G5. F26G5 
was shown to rescue three alleles of tam-1 (cc566, cc567, and 
sy272). 
Protein localization To produce antisera recognizing TAM-I, 
two different regions of the eDNA (Pro594--Glu712 and Ala778-
Ser856) were cloned into GST gene fusion vectors (pGEX-2T) 
(Smith and Johnson 1988) to produce fusion proteins of 39 and 
35 kD. SDS-polyactylamide gel slices containing purified fusion 
proteins were prepared for the immunization of mice. Poly-
clonal mouse sera were collected and used for immunohisto-
chemistry as described (Miller and Shakes 1995 ). Freeze-cracked 
adult C. elegans were freeze substituted in methanol(-20°C, 4 
min) and fixed with 4% formaldehyde (23°C, 30 min). 
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ABSTRACT ''TKO" is an expression vector that knocks 
out the activity of a transcription factor in vivo under genetic 
control. We describe a successful test of this concept that used 
a sea urchin transcription factor of known function, P3A2, as 
the target. The TKO cassette employs modular cis-regulatory 
elements to express an encoded single-chain antibody that 
prevents the P3A2 protein from binding DNA in vivo. In 
normal development, one of the functions of the P3A2 tran-
scription factor is to repress directly the expression of the 
Cyllla cytoskeletal actin gene outside the aboral ectoderm of 
the embryo. Ectopic expression in oral ectoderm occurs if 
P3A2 sites are deleted from Cyllla expression constructs, and 
we show here that introduction of an aP3A2·TKO expression 
cassette causes exactly the same ectopic oral expression of a 
coinjected wild-type Cyllla construct. Furthermore, the 
aP3A2·TKO cassette derepresses the endogenous Cyllla gene 
in the oral ectoderm and in the endoderm. OIP3A2·TKO thus 
abrogates the function of the endogenous SpP3A2 transcrip-
tion factor with respect to spatial repression of the Cyiiia gene. 
Widespread expression of OIP3A2·TKO in the endoderm has 
the additional lethal effect of disrupting morphogenesis of the 
archenteron, revealing a previously unsuspected function of 
SpP3A2 in endoderm development. In principle, TKO tech-
nology could be utilized for spatially and temporally con-
trolled blockade of any transcription factor in any biological 
system amenable to gene transfer. 
In this communication we describe a means of blocking a 
specific gene regulatory interaction in living sea urchin em-
bryos. Sea urchins have a relatively simple process of embry-
ogenesis, and an efficient and straightforward method of gene 
transfer has been developed, affording the opportunity to 
introduce expression constructs into thousands of eggs per day. 
Sea urchin eggs and embryos have thus emerged as a major 
experimental system for analysis of developmental cis-
regulatory functions (1-3). Quantitative temporal and spatial 
patterns of reporter-gene expression can be conveniently 
assessed (e.g., refs. 3- 5). Many relevant sea urchin transcrip-
tion factors have been purified by using affinity chromatog-
raphy after identification of their cis-regulatory target sites and 
subsequently have been cloned (6). Antisense oligonucleotides 
can be used to destroy maternal mRNAs encoding transcrip-
tion factors; however (7), there has been no general or direct 
way to examine the function of specific transcription factors in 
sea urchin embryos by blocking their activity in vivo. This 
would afford the opportunity to compare the effects of can-
celing transcription factor activity with the effects of mutations 
of the relevant target sites in an expression vector (8). More 
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generally, it would provide a means of determining down-
stream functions of the targeted factor. 
Here we demonstrate the functional blockade of a tran-
scription factor that had previously been shown to be respon-
sible for spatial control of a developmentally regulated sea 
urchin embryo gene. This was accomplished by introducing 
into fertilized eggs an expression construct that encodes a 
single-chain antibody that binds to the factor and prevents it 
from forming complexes with its DNA target sites. We term 
this a "TKO" (Transcription factor Knock Out) vector. 
The TKO vector described herein was designed to attack the 
SpP3A2 transcription factor (9), the initial member of a small 
family of transcription factors that now includes Drosophila 
erect wing (10), chicken IBR/ F (11), and human NRF-1 (12). 
P3A2 was cloned and characterized (9, 13) after identification 
of two of its target sites in the cis-regulatory element of the 
Cyllla cytoskeletal actin gene, which were found to be re-
quired for correct spatial expression of this gene. This gene is 
normally expressed only in aboral ectoderm lineages beginning 
early in development. Cyllla·CA T expression constructs re-
produce the aboral expression of the parent gene, but if either 
of the P3A2 sites in the wild-type construct is destroyed, 
expression spreads dramatically to the oral ectoderm (14). 
Similarly, if the endogenous P3A2 factor is titrated away from 
the Cyllla·CAT expression construct by cointroduction of 
excess target-site, ectopic oral ectoderm expression is also 
observed (15). Our objectives in this work were threefold: first, 
to develop a TKO vector that would effectively sequester 
endogenous P3A2 transcription factor (aP3A2·TKO), the 
functionali ty of which could be assayed by determining its 
effects on spatial expression of Cyllla·CAT; second, to deter-
mine whether we could affect the expression of the endoge-
nous Cyllla gene during embryonic development; and third, to 
look for any other phenotypes in aP3A2·TKO embryos that 
may indicate additional embryonic functions of the P3A2 
transcription factor. 
MATERIALS AND METHODS 
DNA-Binding Inhibition Assays. P3A2 DNA-binding elec-
trophoretic mobility-shift assays (EMSAs) were performed as 
previously described by Calzone et al. (9) using the P3A2 
binding site (top strand: 5' -GATCfTTTCGGCfTCfGCG-
CACACCCCACGCGCATGGGC-3 ' ) and crude nuclear ex-
tracts. Inhibition assays were performed by incubating P3A2 
DNA binding reactions with serial dilutions of supernatant 
from hybridoma-producing aP3A2 mAbs. The aP3A2 mAbs 
Abbreviations: EMSA, electrophoretic mobility-shift assay; WMISH, 
whole-mount in situ hybridization; scFv, single-cha in antibody; GFP, 
green fluorescent protein; H 2b, histone 2b . 
f Present address: Stazione Zoologica, Anton D ohrn, Villa Comunale-
Napoli 80121, I taly. 
§To who m reprint requests should be addressed at: Division of Biology 
156-29, California Institute of Technology, Pasadena , CA 91125. 
e-mail: davidson@mirsky.caltech.edu . 
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were created in the Caltech Monoclonal Antibody Facility 
(16). Hybridoma ascites fluid and bacterial extracts containing 
the aP3A2 sites were similarly assayed. In these assays, inhi-
bition of P3A2-DNA complex formation was estimated quan-
titatively as described in Fig. 1. 
Production of the Single-Chain Anti-P3A2 Antibody. Hy-
bridoma poly(A) RNA was purified by using the Stratagene 
RNA Isolation kit and Dynal (Great Neck, NY) oligo(dT) 
beads as described by the manufacturers. Heavy- and light-
chain cDNAs were isolated from hybridoma eDNA libraries 
constructed by using the Stratagene Uni-Zap vector system. 
Subsequently, the variable heavy- and light-chain coding re-
gions of these cDNAs were fused in-frame (separated by an 
encoded flexible Gly/Ser linker) into the pCANTAB 5 vector 
by using the expression module of the Pharmacia single-chain 
antibody (scFv) system. 
Construction of TKO and Green Fluorescent Protein (GFP) 
Expression Cassettes. The TKO cassette was constructed in 
steps. First, the simian virus (SV)40 large T 3' untranslated 
intron, transcriptional attenuation, and polyadenylation sig-
nals isolated from the pNL vector (17) were cloned into the 
EcoRI site of pBluescript II KS- [BSpoly(A) construct). 
Second, the coding region of the aP3A2 scFv was recovered 
from the positive pCANT AB 5 phagemid by PCR, using either 
the Abl 5' primer to make the TKO expression cassette or the 
Ab3 5' primer to make a missense control cassette. Primers 
were as follows: Abl, 5'-GGGCGGCCGCCACCATGGCC-
ACCGCCCCAAAGAAGAAGCGTAAGGCCCAGGTGA-
AACTGCAG-3' . The italicized base is deleted in primer Ab3 






FIG. 1. Measurement of inhibitory activity of mAb with respect to 
specific P3A2-DNA complex formation. Relative occupancy of oli-
gonucleotide probe (Y) is plotted against an antibody dilution series 
(A). The intercept, Yo {here Yo= 0.78 of total probe in the reaction) 
represents the probe occupancy in the absence of antibody (A = 0). 
The inhibitory activity is quantitatively estimated as the value of kA, 
the slope; here, kA = 1.26 x 1010 M- 1. The data are fit to the function 
Y = akA·A +Yo (Eq. 1). Here Yis occupancy of oligonucleotide probe; 
i.e., where PD(A) dilution (antibody concentration was measured after 
purification of the antibody from the hybridoma ascites fluid) and Do 
is concentration of total probe in the reaction: Y = PDA/ Do. In Eq. 1, 
a= -2Po, where Po is the molar quantity of P3A2 transcription factor 
in the reaction; in these experiments, Po ranged from 2 to 5 X 10-11 
M. kA is defined as the equilibrium constant for the reaction of a mAb 
molecule with two P3A2 mo lecules, i.e., kA = APz/ A · Po2• Eq. (1) 
follows from the assumption that all P3A2 molecules will be in 
complex with either the antibody or the DNA probe and that the 
P3A2-DNA reaction is bimolecular, i.e., PD(A) = koP(A) · D(A), where 
P(A) and D(A) are the molar concentrations of the free P3A2 protein 
and the DNA probe at given antibody dilutions. 
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Sequences encoding a nuclear localization site following the 
ATG site: Ab-reverse, 5 '-GGGACT AGTCTTGTCGTCGT-
CGTCCTTGTAGTCCACCGGCGCACCTGCGGC-3 '. 
Standard PCR was carried out in 100-J.LI volumes containing 50 
pmol of each primer, IX Deep Vent buffer (New England 
Biolabs), 2 J.Lmol of dNTPs, =10 ng of target sequence, and 
sterile HzO. Reactions were heated to 94•c for 2 min, 5 units 
of Deep Vent polymerase was added (New England Biolabs), 
and the mixture was cycled 25 times (30 sec, 94•c; 30 sec, 6o•c; 
60 sec, n·q in a Perkin-Elmer 9600 thermocycler. The PCR 
products were digested with Not!, purified, and ligated into the 
BSpoly(A)l vector. The final TKO and missense cassettes were 
made by ligating either the cis-regulatory element (18) of the 
SpH2b early histone gene into the Sacll site or the SpHE 
hatching enzyme gene cis-regulatory element (a gift from L. 
Angerer, University of Rochester, Rochester, NY; see ref. 19) 
into the Sacl site of the respective TKO and missense con-
structs. The histone gene regulatory sequences were amplified 
from the SpH2b clone (18) with the following oligonucleotide 
primers: H2b5, 5' -CCCGCGGCCGCGGTCTCAAAATATG-
ATTGGCAGCTTAATTTGG-3' and H2b3, 5 '-CCCCCGCG-
GGATGATTGTGATTCTCACGAATGC-3'. The hatching 
enzyme gene regulatory sequence was amplified from the 
parent SpHE-pNL clone by using HE5: 5'-CCCCCGCGGA-
AGCTTGTTTTGATTGGTTTGTTTGG-3' and HE3: 5'-C-
CCCCGCGGGATGATAAGAAGTGATAATGATTTTC-3' . 
The pCANT AB5 anti-P3A2 scFv and TKO inserts were 
sequenced in an Applied Biosystems 373 sequencer. TKO and 
aP3A2·TKOmis (missense) plasmids were linearized with Clal 
for microinjection. A pHE/ GFP expression vector was con-
structed by amplifying the SpHE regulatory element with 
primers HESI5, 5' -CCCGAGCTCAAGCTTGTTTTGATTG-
GTTTGTTTGG-3' and HE3, 5'-CCCGAGCTCGATGATAA-
GAAGTGATAATGATTTTC-3' and ligating the product into 
the GFP expression vector pGL3-Basic (5). The resulting plasmid 
was linearized with Kpnl for microinjection. 
Microinjection, Whole-Mount in Situ Hybridization, and 
Fluorescence Microscopy. Microinjection and culture of 
Strongylocentrotus purpuratus embryos were performed essen-
tially as described (14). However, when multiple constructs 
were coinjected, we maintained the total amount of DNA 
injected at a constant level by proportionately lowering the 
amount of carrier DNA. Detection of endogenous Cyllla 
expression by whole-mount in situ hybridization (WMISH) was 
carried out following the protocol of Ransick et al. (24) with 
the following modifications: The fixation step was lengthened 
to 20 min and the probe concentration was raised to 0.4 ng/ J.Ll. 
The Cyllla antisense probe was generated by in vitro tran-
scription from the T7 promoter of the Cyl!la-Hgal vector that 
had been digested with Pvull. This generates a digoxigenin-
labeled probe containing 147 bases of the Cyllla, 3' untrans-
lated region, and an 873-bp tail of pBiuescript II SK- (pro-
cedure of David G.-W.Wang, personal communication). Flu-
orescence microscopy, sorting, and WMISH of GFP-injected 
embryos were performed as described (5). 
RESULTS 
aP3A2 mAb and aP3A2·TKO Construct. The TKO expres-
sion construct was designed to express, translate, and transport 
an anti-P3A2 reagent into the nucleus so as to inhibit P3A2 
from carrying out its developmental regulatory functions in 
vivo. A set of aP3A2 mAbs was generated against the full-
length P3A2 protein. These were screened for their ability to 
inhibit this protein from binding to its target DNA sequence 
by adding them to gel-shift reactions a t increasing dilutions. 
Inhibitory activity was measured quantitatively as described in 
Fig. 1. Inhibition constants were determined for 12 different 
hybridoma subclones. mAb 7B12/2E7 displayed the strongest 
inhibitory effects on P3A2 DNA binding and was chosen as the 
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Developmental Biology: Bogarad et al. 
basis for the aP3A2·TKO vector. The same mAb was used for 
an extensive series of measurements of P3A2 prevalence 
throughout embryological development (16). The specificity of 
this antibody was confirmed by the observation that it reacted 
with only a single molecular species of the known size of the 
P3A2 transcription factor in total nuclear extracts from all 
stages of development as well as in total egg lysate (Fig. 1 of 
ref. 16). 
To build the aP3A2·TKO vector, the mRNA was extracted 
from 7B12/2E7 hybridoma cells, and by using the universal 
IgG primers amplified DNAs encoding the heavy-chain and 
light-chain V -regions were cloned in-frame into the Pharmacia 
pCANTAB vector surrounding a flexible Gly /Ser linker. Thus, 
a construct encoding a single-chain antibody was produced. 
Gel-shift inhibition assays were repeated to test the inhibitory 
activity of the aP3A2 scFv, which was extracted for this 
purpose from bacteria expressing the pCANTAB vector. Its 
activity was found to be quantitatively equivalent to that of the 
starting mAb. As described in Materials and Methods, the 
aP3A2 scFv was then incorporated into an expression cassette, 
the organization of which is summarized in Fig. 2. In addition 
to the scFv itself, the major features of the aP3A2·TKO 
construct are: (i) a nuclear localization site intended to in-
crease the concentration of the scFv in the nucleus relative to 
that of the endogenous nuclear P3A2 factor; (ii) simian virus 
(SV)40 intron, 3' trailer, termination, and poly(A) addition 
sites, features that are conventionally used in most sea urchin 
gene-transfer vectors; and (iii) a cis-regulatory control ele-
ment. This last design feature, in principle, permits expression 
of the TKO vector to be targeted to any domain of the embryo 
for which a cis-regulatory element is available. However, in the 
present experiments we utilized instead ubiquitously, or nearly 
ubiquitously, active cis-regulatory elements derived from a 
histone H2b gene (18) and from a hatching enzyme gene (19). 
Stable incorporation of exogenous DNA in sea urchin embryo 
blastomeres is mosaic, although entirely random with respect 
to lineage (20), and therefore embryos are obtained that have 
incorporated the exogenous DNA into every possible spatial 
domain. In some of the experiments that follow, the 
aP3A2·TKO vector was coinjected with a GFP reporter under 
control of the same cis-regulatory element, so that the partic-
ular cells incorporating the aP3A2·TKO construct could be 
identified visually by GFP expression following the procedures 
of Arnone eta/. (5). Thus, we could examine embryos in which 
the construct was present in endoderm, aboral ectoderm, or 
oral ectoderm, as desired. 
aP3A2·TKO Effects on Spatial Expression of a Wild-Type 
Cyllla·CAT Construct. When Cyllla·CAT constructs lacking 
the two known P3A2 target sites are injected into eggs, ectopic 
oral ectoderm expression is observed in an average of 34% of 
stained embryos (14). Because this is statistically equivalent to 
the percentage of embryos that incorporate exogenous DNA 
into oral ectoderm founder cells, it follows that essentially all 
--L~~t~f~RBmBaB~~DlBaRmmR~~ 
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Promoter Encoded scFv Processing 
FIG. 2. The TKO expression cassette. Histone 2b or hatching 
enzyme cis-regulatory elements (A) employed in the cassette are 
modular and can easily be exchanged with any other regulatory 
sequence. The start of transcription (B) is set to be at least 20 bp 
upstream of a canonical Kozak ATG (C) and a nuclear localization 
sequence (D) that are best fit to sea urchin initiators and codon usage. 
The heavy- (E) and light·chain (G) variable regions of the anti-P3A2 
scFv are separated by an encoded flexible Gly/ Ser linker (F). To 
process, stabilize, and terminate the TKO transcripts, we inserted the 
SV40 large T 3' intron (1), polyadenylation (J), and transcriptional 
termination (K) sequences after the stop codon (H). 
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oral ectoderm cells will express the Cyllla·CAT construct if 
interactions with the P3A2 repressor are obviated by deletion. 
In the Cyllla·CAT experiments summarized in Table 1, 
aP3A2·TKO or a missense frame shift control differing from 
aP3A2·TKO by deletion of only 1 bp were coinjected with 
wild-type Cyllla·CAT (14). Wild-type Cyllla·CAT and 
AP3A2·HF, the Cy/1/a·CAT construct lacking the two P3A2 
sites, were injected at the same time as the TKO constructs and 
performed as reported (14). When coinjected with wild-type 
Cy/lla·CAT, the missense aP3A2·TKO had no effect (2% oral 
expression). However, a remarkable result was obtained when 
wild-type Cyllla·CATwas coinjected with aP3A2· TKO: 26% of 
stained embryos now displayed oral ectoderm expression, as 
illustrated in the example reproduced in Fig. 3 c and d. The 
26% value could represent a slight underestimate of 
aP3A2·TKO effects or Cy//la·CATexpression because in these 
experiments only morphologically normal stained embryos 
were counted, and as we discuss below, a significant fraction 
of embryos receiving aP3A2·TKO develop abnormally. In any 
case, the results are those predicted if the aP3A2·TKO vector 
effectively sequesters the endogenous P3A2 factor, thus pre-
venting its interaction with the Cy/1/a·CAT regulatory target 
sites. That is, as Table 1 shows, the fraction of ectopically 
expressing embryos is about the same as when P3A2-
Cyllla·CA T interactions are instead prevented by deletion of 
these target sites. 
We note here that coinjection of the anti-P3A2 antibody 
protein into eggs together with Cyllla·CA T also led to ectopic 
oral expression of the Cyllla·CAT reporter (C. Kirchhamer 
and E .H.D., unpublished results). These effects were not 
observed when an irrelevant antibody was injected. However, 
this approach can be applied only to early embryos; further-
more, the aP3A2 and the control IgG caused lethal arrest of 
development in an unacceptably large fraction of embryos. 
aP3A2·TKO Effects on Spatial Expression of the Endoge-
nous Cyllla Gene. The foregoing results confirm the role of the 
P3A2 transcription factor as a spatial repressor of Cyllla·CAT 
expression and raise the question whether the endogenous 
gene could be similarly affected by aP3A2·TKO. This was not 
obvious a priori, because we had found earlier that the stability 
of endogenous Cy/lla regulatory complexes exceeds that of the 
equivalent Cy/lla·CAT complexes: thus, in vivo competition 
with excess target sites for a number of Cy/Ila factors stoi-
chiometrically reduced expression of exogenous Cyllla·CAT, 
whereas expression of the e ndogenous Cyllla gene was unaf-
fected in the same embryos (22). 
The normal aboral ectoderm expression of the endogenous 
Cy/1/a gene is displayed by WMISH in Fig. 3 a and b. When 
eggs were injected with aP3A2·TKO and endogenous Cy/lla 
expression was similarly monitore d, ectopic expression of the 
Table 1. Effect of aP3A2·TKO and control constructs on 
Cy/1/a·CAT and Cyllla expression 
Ectopic 
mRNA mRNA 
48-hr in oral in aboral 
embryo ectoderm,% ectoderm, % 
Construct no. tested* Cyl/Ia CAT CyJIIa CAT 
Cyiiia·CATt 
(wild type) 531 3.2 96 
I.\.P3A2·HFt 192 34 95 
aP3A2·TKO 108 26 83 
aP3A2·TKOmis 184 2 99 
aP3A2·TKO 70 27 100 
aP3A2·TKOmis 35 8 100 
*Data are reproduced for interpretably stained embryos (60-901 of all 
those injected in ref. 14 and this study). 
tData reproduced from Kirchhamer and Davidson (14) for compar-
ison. 
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FIG. 3. Effects of aP3A2·TKO on expression of Cy/1/a·CAT, endogenous Cy/1/a, and the lethal embryonic phenotype. In a-J, the H2b 
cis-regulatory element was used to drive expression of the injected TKO constructs, and in g-l, the hatching enzyme cis-regulatory element was 
used (see Materials and Methods). (a, b) Endogenous Cy/1/a expression monitored by WMISH using an antisense Cyllla probe (see Materials and 
Methods). (a) Embryo viewed laterally, oral side to the right; here and in following panels the arrows bracket the oral ectoderm where neither Cy!Ifa 
nor wild-type Cy/1/a·CAT expression occurs. (b) Anal view, oral side to the top. (c, d) Cy!lla·CAT coinjected with aP3A2·TKO, driven by the H2b 
cis-regulatory element, lateral views. Clones of cells expressing CAT mRNA in the oral ectoderm are displayed by using WMISH. As observed 
when the P3A2 sites are deleted (14), these injections produce embryos displaying normal patterns of aboral ectoderm expression (i.e., embryos 
in which the exogenous DNA resides in the aboral ectoderm); embryos displaying both normal and ectopic oral ectoderm expression; and embryos 
displaying oral expression only (i.e., the exogenous DNA is only in oral ectoderm lineages); only the latter are illustrated here. (e, f) Effects of 
aP3A2·TKO on endogenous Cyllla gene expression, monitored as in a and b. Both embryos are shown from the blastopore, and both display ectopic 
oral staining as well as staining in clones of archenteron cells in addition to aboral ectoderm expression. (g) Pluteus-stage (72-hr) embryo viewed 
from anal side. This embryo bears the aP3A2·TKOmis construct and is normal in morphology. (h) Gastrulation-defective phenotype at 72 hr caused 
by injection of the a:P3A2·TKO construct. (i) Gastrulation-defective embryo at 48 hr viewed from blastopore, in which Endol6 transcripts are 
displayed by using WMISH. U) Normal 48-hr embryo viewed laterally and bearing GFP-expressing clones of exogenous DNA in aboral ectoderm 
and archenteron. These clones also include the aP3A2·TKOmis control construct. (k, I) Gastrulation-defective embryos as in j , but bearing 
aP3A2·TKO construct present in large endodermal clones. 
endogenous gene was observed. As summarized in Table 1, 
27% of these embryos display clear expression in clones of oral 
ectoderm, and frequently in limited clones of gut cells as well. 
Examples are reproduced in Fig. 3 e and f. Three embryos that 
displayed ectopic expression in the missense control were also 
found (Table 1). Because the endogenous Cyll/a gene is never 
expressed erroneously, the single base mutation that distin-
guishes aP3A2·TKOmis from aP3A2·TKO might not have 
entirely prevented synthesis of a functional TKO product. For 
example, a partially functional protein might have been gen-
erated by use of a downstream ATG. In any case, the percent-
age of ectopic oral expression observed in the aP3A2·TKO 
sample is very similar to that seen with either the mutated 
Cy/1/a reporter lacking P3A2 sites (14) or in the coinjections 
of aP3A2·TKO and wild-type Cyllla reporters (Table 1). This 
is as expected, because ectopic oral expression depends on 
clonal incorporation of the aP3A2·TKO construct in oral 
ectoderm cells in all three experiments. 
A Specific atP3A2·TKO Embryonic Phenotype. Embryos 
developing from eggs injected with aP3A2·TKO display a 
specific lethal phenotype. This occurs in a relatively high 
fraction of embryos, 44% in the experiment tabulated in Table 
2, although in other experiments somewhat more modest 
frequencies of 20- 30% were recorded. The aP3A2·TKOmis 
control resulted in only 5% abnormal embryos (Table 2). This 
phenotype is best described as a failure to form a complete 
archenteron, caused by a disorganization of the endoderm. Fig. 
3g shows a normal 72-hr prism-stage embryo that developed 
from an egg that had been injected with the missense control 
construct, whereas the embryo in Fig. 3h displays the 
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Table 2. aP3A2·TKO effect on embryo development 
Embryos, Gastrulation-
Construct no. tested defective, % 
aP3A2·TKO 419 44 
aP3A2·TKOmis 345 5 
aP3A?·TKO phenotype. This embryo has not completed gas-
trulation. Its endoderm consists of a pile of nonadherent cells 
and the form of the embryo is round rather than triangula/ 
The secondary mesoderm appears unaffected, however. Such 
~mb~yo~ apl?ear to develop normally up to gastrulation. The 
1mpltcat10n 1s. that P3A2 transcription factor is necessary for 
morphogenesis of the archenteron, a previously unknown 
function. 
To further investigate the role of the P3A2 transcription 
factor in archenteron formation, we performed a series of 
coinjection experiments making use of GFP as a marker to 
determine location of the aP3A2·TKO construct in the exper-
imental embryos. GFP expression constructs can be used to 
determine the mosaic expression domain of a coinjected 
construct if both constructs are driven by the same cis-
regulatory elements, because shortly after injection the exog-
enous DNAs are all ligated together into a concatenate and are 
then incorporated into the same blastomeres (5). In these 
experiments, the hatching enzyme cis-regulatory element was 
used to drive both the GFP and aP3A2·TKO constructs. 
Results are listed in Table 3. Significantly, all of the embryos 
bearing aP3A2·TKO that failed to gastrulate express the GFP 
marker in the endoderm (89 of 89), and less than 10% of the 
set of embryos in which GFP is expressed in the endoderm 
develop normally. All of those that do are distinguished by 
small GFP clone sizes (not shown). On the other hand, most 
of the 48% of the embryos injected with the missense control 
that contained endodermal clones developed normally, even 
though these clones were often quite large. An example is 
shown in Fig. 3j. Embryos bearing aP3A2·TKO that failed to 
gastrulate and that contained the exogenous DNA in the 
endoderm are illustrated in Fig. 3 k and /. The disorganized 
endoderm cells in these embryos retain their endodermal state 
of specification; that is, they continue to express the Endo16 
marker (2, 23, 24), as shown, for example, in Fig. 3i. A few 
embryos in the missense control experiment also showed 
gastrulation defects (Table 3 ), and all of these contained large 
e.ndodermal clones. This result again supports a weak expres-
SIOn of an aP3A2·TKO activity because of override of the 
frameshift, as considered above. 
To explore further the relation between location of clonal 
incorporation and occurrence of the gastrulation phenotype, 
we carried out the experiment summarized in Table 4. Em-
bryos bearing aP3A2·TKO plus GFP constructs were sorted 
according to the locus of incorporation of the expression 
constructs, and Cy/1/a expression was then monitored by 
WMISH in the sorted samples. Table 4 shows that the locus of 
incorporation correlates perfectly with the effect of 
aP3A2·TKO on Cyl/Ia expression. All embryos selected for 
large endoderm clones again were gastrulation-defective (19 of 
19), whereas 9 of 10 embryos that contained large oral-
ectoderm clones displayed ectopic expression of Cy/l/a in the 
Table 3. Expression of GFP in aP3A2·TKO and 
a3PA2·TKOmis embryos 
Embryos, Endomeso- Ectoderm, 
Construct Phenotype no. tested derm, % % 
aP3A2·TKO Normal 77 9 95 
aP3A2·TKO GD 89 100 73 
aP3A2·TKOmis Normal 186 48 78 
crP3A2·TKOmis GD 15 100 73 
GD, gastrulation defective. 
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Table 4. Cyllla transcripts in presorted embryos bearing GFP and 





















GD, gastrulation-defective; ND, not done. Oral and aboral ecto-
dermal domains are difficult to distinguish in gastrulation-defective 
embryos, because of their abnormally rounded form (see Fig. 3h, for 
example). 
oral ectoderm. Conversely, all embryos bearing large aboral 
ectoderm clones displayed normal Cyl/la expression. 
It may be concluded from these experiments that the 
function of ~3A2 in archenteron morphogenesis is cell-
autonomous, 1.e., that the factor is needed in the archenteron 
cells themselves. Similarly, we confirm that the function of 
P3~2. in ~ral ectoderm as a spatial repressor of Cyllla tran-
scnptlon 1s also autonomous, as proposed earlier (14). 
DISCUSSION 
We describe here the use of a genetic expression vector that 
abrogates the act~ity of a transcription factor in a living 
embryo. Three mam results were obtained. First, the intracel-
lular efficacy of a scFv for this purpose was established by 
demonstration of the same ectopic expression of the 
Cyl/Ia_-CAT vec~o~ as is caused by deletion of the target sites 
for thts transcnptton factor. Second, we confirmed that the 
P3A2 factor indeed serves as a spatial repressor for the Cy/1/a 
gene and extend this observation from Cy/1/a·CAT expression 
constructs to the endogenous Cy/Ila gene. Third, we discov-
ered a hitherto unknown function of P3A2 in archenteron 
morphogenesis. Both this function and the effects of the P3A2 
factor on Cy/1/a expression are cell autonomous. 
It is striking that Cyl/la·CA T and Cyl/la gene expression are 
so e!ficiently expan?ed to the oral ectoderm in embryos 
beann~ aP3A2·TKO moral ectoderm clones. P3A2 is initially 
a relattvely prevalent maternal factor, present in about 2 x 106 
molecules per embryo (16) and is later zygotically transcribed; 
there are a few thousand to a few hundred molecules per 
nucleus throughout development (16, 25). The affinity of the 
scFv encoded by the aP3A2·TKO vector for the P3A2 factor is 
s!gnificantly higher than that of the factor for its DNA target 
sne (9, 13) as calculated from experiments such as that shown 
in Fig. 1. Thus, the scFv apparently acts as a very effective 
intracellular sequestering agent. Nor is any nonspecific early 
embryonic lethality observed, in contrast to the general del-
~terious effect of injecting the mAb per se into eggs (unpub-
hshed results). Furthermore, use of a genetic vehicle for 
producing the aP3A2 scFv ensures that it will continue to 
function through development (depending of course on the 
cis-regulatory element driving its expression), which is never 
reliably the case for either protein or mRNA introduced 
directly into the egg. The results shown in this paper confirm 
that aP3A2·TKO continues to function through embryogenesis 
(Fig. 3). 
An unexpected aspect of the spatial derepression of the 
endogenous Cyll/a gene caused by introduction of aP3A2·TKO 
is that ectopic expression was observed not only in oral 
ectoderm but also in gut (Fig. 3 e and f). Recent studies (ref. 
14, and earlier observations reviewed therein) proved that the 
two P3A2 sites deleted in the experiments of Kirchhamer and 
Davidson (14) are required to prevent ectopic oral-ectoderm 
expression of Cyllla·CAT constructs, but no ectopic out ex-
pression was observed in these experiments. However: there 
are additional potential P3A2 sites in the Cyll/a cis-regulatory 
element, and these may be responsible for controlling expres-
sion in gut. 
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A new role for P3A2 in archenteron formation was revealed 
when we examined the postgastrular lethal phenotype pro-
duced by aP3A2·TKO injection into fertilized eggs. This effect 
occurs only when the construct is present in large clones of 
archenteron cells. These cells fail to adhere to one another so 
that the archenteron disintegrates into a wholly or partially 
disorganized pile of endoderm cells. Yet these cells retain their 
state of specification, as monitored by expression of an 
endoderm-specific gene, Endol6. The implication is that genes 
encoding some cell surface proteins are controlled by P3A2 
either directly or indirectly. If directly, it is possible that P3A2 
acts positively in this context, although its function is clearly 
negative in regulation of the Cyi/Ja gene. 
There are many obvious possible extensions of the TKO 
technology described here, both in research and potentially for 
gene therapy (26). We are now extending the TKO approach 
to several other sea urchin embryo transcription factors. This 
may become a general method for examination of trans-
regulatory functions. One powerful potential advantage of the 
TKO method is the possibility of exactly controlling the time 
and place of TKO expression. This depends directly on the 
cis-regulatory system employed to drive the transcription of 
the TKO vector. Thus, for example, TKO vectors could be built 
and inserted into the mouse genome that would blockade given 
transcription factors only in given cell types at given stages of 
development. This could provide a decisive advantage given 
that transcription factors are often utilized at many stages of 
the life cycle and used for many diverse developmental pur-
poses. 
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